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GENERAL INTRODUCTION
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Chapter 1
DEPRESSION 
Everyone occasionally experiences depressive feelings. When these feelings become long-
lasting, disabling and interfering with daily life, this results in a clinical diagnosis of major 
depressive disorder (MDD). Symptoms of depression are persistent depressed mood and loss of 
interest or pleasure, and other varying symptoms including feelings of hopelessness, decreased 
energy, feelings of guilt or low self-worth, disturbed sleep or appetite and poor concentration 
for at least two weeks1. Other forms of depressive disorders, varying in severity, frequency and 
duration of the symptoms, are persistent depressive disorder (dysthymia), psychotic depression, 
perinatal depression, bipolar disorder and seasonal affective disorder 2. The aetiology of 
depression is a combination of biological (genetic susceptibility, other (cardiovascular) illnesses, 
medications), psychological (neuroticism, dysfunctional coping, negative self-image) and social 
factors (impaired social support, childhood trauma, negative life events, low socioeconomic 
status)3-5. Depression has not only a negative impact on quality of life and functioning, but is also 
associated with increased physical morbidity and mortality, the latter partly due to suicide6-8.
Depression is a common mental health condition, affecting around 350 million people 
worldwide1. Lifetime prevalence of MDD – meeting the criteria for MDD at some point in life – 
is 12.8%, and women (16.5%) are affected twice as often as men (8.9%). In the past 12 months 
preceding the diagnostic interview, 3.9% reported MDD9. In the Netherlands, lifetime MDD 
prevalence is almost 19% and 12-month prevalence 5.2%10. Depression often has a recurrent 
nature after a first depressive episode1,8. Whether age is a risk or a protective factor is still not 
agreed upon3,11,12. In Dutch older adults, the one-month prevalence of clinically relevant levels 
of depressive symptoms was approximately 15% in 1992/1993, of which MDD accounted for 
2.0%13. Depression was the fourth leading cause of the global disease burden in 2002 and is 
expected to rise to the second place by 203014. Given its very high burden and substantial 
economic costs, strategies for the prevention of depression are imperative.
In clinical practice and research, ‘clinical depression’ is often used, meaning a diagnosis of MDD 
according to a classification system, such as the Diagnostic and Statistical Manual of Mental 
Disorders (5th ed.; DSM-5)15. Besides, especially in research, the term ‘depressive symptoms’ is 
often used, which is measured with self-report symptom rating scales, such as the Center for 
Epidemiologic Studies Depression scale (CES-D)16, Patient Health Questionnaire-9 (PHQ-9)17 
and Geriatric Depression Scale (GDS)18. Persons who score above a certain cutoff are said to 
have ‘clinically relevant/significant depressive symptoms’, and only a minority of them fulfil the 
diagnostic criteria for MDD19. In this thesis, ‘depressive symptoms’ are topic of interest.
Treatment options for depression consist of basic psychosocial support combined with 
psychotherapy (e.g. cognitive behavioural therapy or interpersonal psychotherapy) and/or 
antidepressant medication1. Although effective treatments are available, almost half of the 
persons with depression do not receive any treatment20,21. Therefore, it is very important 
to additionally focus on the prevention of depression. Preventive interventions have shown 
significant reductions in the incidence of depressive episodes; however, most of these trials 
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consisted of cognitive behavioural therapy or interpersonal psychotherapy22-24. Besides 
these individual-oriented therapies, it is important to identify other modifiable risk factors of 
depression, such as lifestyle factors25,26. Thus, more research is needed on lifestyle factors that 
may help to lessen the enormous burden of depression by preventing depressive symptoms, 
and one of these factors is diet.
NUTRITION AND DEPRESSION
Nutrition has become of increasing interest in the field of mental health because evidence for 
a link between diet and depression is growing27. Diet influences physiologic processes that 
may be involved in the development and progression of depression, such as neurotransmitter 
imbalances, hypothalamic-pituitary-adrenal axis disturbances, oxidative stress, neurogenesis 
and neuronal plasticity, mitochondrial disturbances and inflammation28,29. Specific nutrients, 
food groups and dietary patterns have been studied in relation to depression. 
Nutrients and depression
Several studies have examined the association of individual nutrients with mental health. 
Nutrient status, as assessed by nutrient levels in the blood plasma or serum, as well as nutrient 
intake, i.e. intake from food and/or supplements, have been studied in relation to mood because 
of their potential role in the aetiology of depression. Examples are omega-3 polyunsaturated 
fatty acids (e.g. eicosapentaenoic acid)30-32, magnesium33,34, selenium35,36 and zinc32,37,38. Some 
of the most promising nutrients are B vitamins and vitamin D.
B vitamins have been of interest in relation to depression as they are involved in the methylation 
and synthesis of monoamines, including the neurotransmitters serotonin, dopamine and 
noradrenaline. Since the serotoninergic and noradrenergic systems can modulate brain areas 
involved in feelings, thoughts, eating and sleep, one of the major theories of the pathogenesis 
of depression is based on abnormalities in the metabolism of these neurotransmitters. A 
marker for a disturbed one-carbon metabolism, causing such abnormalities, is an elevated 
plasma homocysteine level, which is in turn indicative of low levels of some B vitamins39-41. 
As deficiencies in B vitamins are common, research has studied associations between these 
vitamins and depression. First, higher levels of folate, or vitamin B
11
, were associated with less 
depressive symptoms in meta-analyses of observational studies42,43. However, meta-analyses 
of randomised controlled trials (RCTs) in depressed persons did not show a beneficial effect of 
folate adjunctive to antidepressants32,44. Second, prospective cohort studies showed inverse 
associations between the intake of vitamin B
6
 and depressive symptoms in older adults45 
and older women46. There are no RCTs with supplementation of vitamin B
6
 only. The latter 
also holds for a third B vitamin: vitamin B
12
, or cobalamin, has only been studied in RCTs that 
investigated the effects of supplementation of vitamin B
12
, (vitamin B
6
) and folate. These trials 
showed conflicting results for both treatment and prevention of depression in middle-aged 
and older adults32,47-50. A meta-analysis of RCTs concluded that short-term use of vitamin B
12
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and/or folate does not reduce depressive symptoms but prolonged use may reduce severity 
and onset in populations at risk51. Prospective studies did show associations between low 
vitamin B
12
 levels or intakes and depression incidence in older adults45,52 or only in men46.
Vitamin D might play a role in the development of depression. In areas of the human brain 
that are related to mood, vitamin D receptors and the activating enzyme 1-α-hydroxylase 
have been found53,54. Moreover, the active metabolite of vitamin D, 1,25-dihydroxyvitamin D, 
influences the synthesis of monoamine neurotransmitters, such as serotonin. This metabolite 
also affects the regulation of neurotrophic factors and stimulates anti-inflammatory actions in 
the brain53,55,56. Meta-analyses of observational studies showed an inverse association between 
serum 25-hydroxyvitamin D (25(OH)D) and depression57,58. A systematic review indicated 
that vitamin D deficiency may be a risk factor for late-life depression based on observational 
data but not on experimental data59. Evidence for a beneficial effect of supplementation was 
suggested by one of four meta-analyses of RCTs; this meta-analysis found this effect only in 
trials without biological ‘flaws’ but not in those with ‘flaws’ (e.g. a 25(OH)D level sufficient 
or not measured at baseline)60. However, all meta-analyses showed substantial heterogeneity 
among the included trials, which differed between the meta-analyses, and highlighted the 
need for further high-quality studies60-63.
Overall, there are indications that specific nutrients are linked to depression; however, the 
existing evidence is limited and inconsistent. For vitamin B
12
, no firm conclusion can be 
drawn from experimental studies, mostly treatment trials, mainly because supplementation 
was always a mix of B vitamins. Cross-sectional and a few prospective studies inconsistently 
showed an association. To get a better insight into the temporality of the association, 
prospective studies with a long follow-up period, data on vitamin B
12
 levels (instead of intake), 
data on many potential confounders and sensitive measures of depressive symptoms (instead 
of a dichotomous outcome) are required. For vitamin D, the protective associations from 
observational studies were generally not confirmed by (meta-analyses of) trials; however, 
many trials were not properly designed, including short follow-up, sufficient or not measured 
baseline 25(OH)D levels and ineffective supplementation. Not only well-designed trials are 
of interest, but also prospective studies on 25(OH)D levels and depressive symptoms that 
have a long follow-up, adjust 25(OH)D levels for season, use longitudinal statistical analysis 
techniques and use multiple measurements of 25(OH)D level (instead of a single measurement 
at baseline). Thus, more longitudinal research on vitamin B
12
 as well as vitamin D is needed, 
especially in older adults who are often deficient in these vitamins. 
Food groups and depression
Next to nutrients, food groups have traditionally been studied in relation to diseases in 
nutritional epidemiology. More importantly, food groups and individual foods can be useful for 
communication in public health, and many dietary guidelines are food based64,65. Associations 
between the intake of several food groups and depression have been investigated. The 
literature mainly constitutes of cross-sectional studies, although some prospective studies 
13
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and meta-analyses for food groups have been performed. The latter two are described below, 
from a high level of evidence (meta-analyses) to a lower level of evidence (single prospective 
studies).
Fruit is one of the most studied food groups in relation to depression. Two meta-analyses 
indicated that a higher fruit intake was associated with less depressive symptoms in both 
cross-sectional and prospective studies separately66,67. These meta-analyses drew the same 
conclusion for vegetable intake66,67. However, another recent meta-analysis of prospective 
studies confirmed the inverse association for vegetables but not for fruit68. This meta-analysis 
also found no associations for legumes or meat68. Several meta-analyses showed that a high 
intake of fish was related to a reduced risk of depression in both cross-sectional and prospective 
studies68-70. Similarly, a meta-analysis found that coffee consumption might lower the risk of 
depression, also when stratified by study design71. Other food groups have only been studied 
in single prospective studies. A lower depression risk was found for a higher intake of olive 
oil72,73 and whole grains74. In contrast, a higher depression risk was shown for a higher intake 
of non-whole grains74, sweet foods75-77 and sweet beverages75,78. For dairy products, positive, 
inverse and null associations were prospectively found79-82. 
Next to these studies per food group, two systematic reviews on (cross-sectional and) prospective 
studies examined associations between several food groups and depression; however, they 
often included only one study per food group and could, therefore, not draw firm conclusions83,84. 
A recent meta-analysis included more prospective studies, but for four of the nine examined 
food groups, the conclusion was still based on one or two studies68. No intervention studies with 
specific food groups have been performed in relation to depressive mood. Hence, research has 
indicated associations between food group intakes and depressive symptoms, but to different 
extents. For most food groups, the evidence is not yet conclusive or very limited (i.e. mostly 
cross-sectional), illustrating the need for longitudinal studies on food groups and depression.
Dietary patterns and depression
Over the past decades, dietary patterns have increasingly been studied in nutritional 
epidemiology, complementary to nutrients and foods. Reasons for this are that people do not 
consume single dietary components but meals containing foods with complex combinations 
of nutrients and that nutrients are often highly correlated having interactive and synergistic 
effects85. Generally, two types of methods are used to define dietary patterns: 1) empirically 
derived dietary patterns (a posteriori) and 2) theoretically defined dietary patterns (a priori). A 
posteriori patterns are statistically derived from the data at hand, commonly by factor analysis 
or cluster analysis86. A priori diet indices or scores are predefined summary measures to assess 
overall diet quality based on nutrition knowledge. Most indices include food variables that 
represent current guidelines or recommendations (e.g. Alternative Healthy Eating Index 
(AHEI) and Diet Quality Index (DQI)), other indices are developed for the prevention of a 
specific disease (e.g. Dietary Approaches to Stop Hypertension diet (DASH)), and others are 
culturally based (e.g. Mediterranean and Japanese diet)87-89. 
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Both a posteriori and a priori dietary patterns have been studied in relation to depression. 
Several reviews and meta-analyses concluded that ‘healthy’, ‘traditional’ and ‘Mediterranean’ 
dietary patterns may have a beneficial role, whereas ‘unhealthy’ and ‘Western’ dietary 
patterns may possibly have a detrimental role in risk of depression68,90-94. ‘Healthy’ patterns 
are typically characterised by high intakes of fruit, vegetables, fish, nuts, legumes, whole grains 
and reduced-fat dairy products. They were associated with reduced odds of depression based 
on nine cross-sectional and four prospective studies combined90 and on seventeen prospective 
studies68. Nine studies with different versions of the Mediterranean diet also showed a pooled 
lower risk of depression91. Pooled findings from a priori diet quality indices confirmed these 
lower risks, particularly for the Mediterranean diet score (MDS)94. In contrast, ‘unhealthy’ 
dietary patterns consists of high intakes of non-whole/refined grains, (red and processed) meat, 
processed foods, soft drinks, high-sugar and high-fat foods. In the meta-analyses, although 
statistically non-significant, these patterns were associated with higher odds of depression 
based on two cross-sectional and two prospective studies90 and on ten prospective studies68. 
A pro-inflammatory diet95 was significantly associated with a higher depression incidence94.
Dietary patterns have also been studied in the first RCTs on the diet-depression link. A Spanish 
prevention trial found that adherence to a Mediterranean dietary pattern, although non-
significant, lowered the 3-year depression incidence in persons at high risk for cardiovascular 
disease96. However, depression was not the primary outcome and irregularities in the 
randomisation were found97. Two Australian treatment trials showed that, in depressed adults, 
dietary advices improved diet quality and had positive effects on depressive symptoms and 
other mental health outcomes after respectively 3 and 6 months98,99.
Based on observational studies, a healthy dietary pattern seems to be associated with lower risk 
of depressive symptoms and depression; nonetheless, studies vary in many aspects and findings 
are not consistent. Further, no conclusion can be drawn based on only a few experimental studies. 
So, there is an urgent need for more longitudinal and intervention research on dietary patterns. 
REVERSE DIRECTION: DEPRESSION TO DIET 
In the field of nutritional psychiatry, the ‘reverse causality hypothesis of diet and depression’ is 
an important issue. It might be that the link between diet and depression also exists in the other 
direction whereby a poor diet may not be one of the causes of depression but (also) a consequence. 
Depressive mood and stress can influence food intake via physiological effects that change appetite 
or other behaviours100. Depression and stressful events can lead to more unhealthy food choices 
and, subsequently, to obesity101,102. Studies on the depression-diet link showed that depressive 
mood or MDD was associated with a poorer diet, including a higher intake of saturated fat, sugar 
and sodiume.g. 103,104,105 and lower scores on diet quality indices106. However, most studies were cross-
sectional, which impedes ascertainment of causality. Another study on the reverse link found that 
current depression was associated with a less healthy dietary pattern, while history of depression 
was associated with a more healthy pattern; however, past depression was asked retrospectively107. 
15
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Furthermore, some prospective studies that investigated the link from diet to depressive 
symptoms have also examined the reverse link. This was done by either excluding participants who 
reported depressive symptoms at baseline from the analysis82,108-110 or by analysing the association 
in the reverse direction (i.e. bidirectional design within one cohort)75,111-114. Most of these studies 
on different dietary patterns or food groups suggested that diet influences depression but not vice 
versa. To our knowledge however, no other previous studies have investigated the association 
from depression to diet (nutrients, food groups or patterns) in a prospective way. Such studies are 
warranted to know whether the diet-depression link is bidirectional or not.
AIM OF THIS THESIS
The overall aim of this thesis is to investigate longitudinal associations of nutrient status, food 
groups and dietary patterns with depressive symptoms in adults.
Research questions
The aim will be addressed in the following research questions:
1. What is the longitudinal association between nutrient status and depressive symptoms? 
a. What is the association between serum vitamin B
12
 and (subsequent) depressive 
symptoms?
b. What are the associations between (change in) serum vitamin D and (change in) 
depressive symptoms?
2. What is the bidirectional, longitudinal association between food group intakes and 
depressive symptoms?
3. What is the association of depressive symptoms and history with diet quality indices? 
THE MOODFOOD PROJECT 
The present thesis is part of the MooDFOOD project. The ‘Multi-country cOllaborative project 
on the rOle of Diet, FOod-related behaviour, and Obesity in the prevention of Depression’ is 
funded by the European Commission 7th Framework program (grant number 613598). The 
MooDFOOD project aims to investigate how food intake, nutrient status/intake, food-
related behaviour and obesity are linked to the development of depression and its underlying 
psychological, lifestyle and environmental pathways115. 
DATASETS USED IN THIS THESIS
The research described in this thesis is performed using data from two population-based cohort 
studies that were part of the MooDFOOD project: the Longitudinal Aging Study Amsterdam 
and the Invecchiare in Chianti study. 
16
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Longitudinal Aging Study Amsterdam (LASA)
The LASA study is an ongoing population-based cohort study and was originally designed 
to investigate the determinants, trajectories and consequences of physical, cognitive, 
emotional and social functioning in the aging Dutch population. Participants, stratified by 
age, sex, urbanisation grade and expected 5-year mortality rate, were recruited from three 
geographic regions in the Netherlands (around Amsterdam, Oss and Zwolle), constituting a 
nationally representative sample of the Dutch older population. At the start in 1992/1993, 
3107 subjects aged 55 to 85 years were enrolled in the first LASA cohort. In 2002/2003 and 
2012/2013, a second (n=1002) and third cohort (n=1023) were recruited, respectively, of 
participants aged 55 to 65 years. Every three years, measurement cycles have been carried 
out at the participants’ homes, that consist of a main interview, a medical interview and a self-
administered questionnaire. At some cycles, blood samples were also collected in subsamples 
of LASA participants. Next to the regular cycles, side studies have been performed among 
subsamples. In 2014/2015, the ‘Nutrition and Food-related Behaviour study’ was conducted. 
A questionnaire was sent to all LASA participants of the three cohorts, and included a food 
frequency questionnaire (FFQ) as well as questions on food-related behaviour, body weight 
and mental wellbeing. Detailed information about the LASA study can be found elsewhere116,117. 
Chapters 2, 3, 4 and 6 are based on LASA data.
The Invecchiare in Chianti study (InCHIANTI)
The InCHIANTI study (Invecchiare in Chianti = aging in the Chianti area) is a prospective, 
population-based cohort study of older adults in Tuscany (Italy). It was originally designed to 
investigate factors contributing to decline in mobility. From 1998 to 2000, the recruitment of 
a sample of 1453 persons was performed at two sites (Greve in Chianti and Bagno a Ripoli), 
using a multistage, stratified sampling method. A total of 1155 participants were aged 65 to 
102 years, with those aged ≥90 years oversampled, and 298 participants were aged 20 to 64 
years. Baseline data collection consisted of a home interview, a medical evaluation at the study 
clinic, blood drawing and 24-hour urine collection. Follow-up measurements were performed 
3, 6 and 9 years after baseline (respectively 2001-2003, 2004-2006 and 2007-2009). At each 
cycle, dietary intake was assessed using an FFQ. A more detailed description of the study 
rationale, design and method is given elsewhere118. Data from the InCHIANTI study were used 
in Chapter 5.
OUTLINE OF THIS THESIS 
Figure 1 shows a schematic overview of the studies presented in this thesis. 
Part I: Nutrient status and depressive symptoms
In Chapter 2, the cross-sectional and prospective associations of serum vitamin B
12
 and plasma 
homocysteine with depressive symptoms in older adults are described. Chapter 3 reports 
17
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the cross-sectional and prospective associations between serum 25(OH)D and depressive 
symptoms. In addition, the mediating role of physical functioning in this association is 
examined. Chapter 4 proceeds with vitamin D by studying the association between change in 
serum 25(OH)D and parallel change in depressive symptoms over time.
Part II: Food groups and depressive symptoms
In Chapter 5, the focus is on the bidirectionality of the diet-depression link, by examining 
prospective associations between intakes of thirteen food groups and depressive symptoms 
in two directions. 
Part III: Depressive symptoms and dietary patterns 
Chapter 6 provides a description of a study on depressive symptoms and a priori dietary 
patterns. The associations of current, short-term changes in and long-term history of 
depressive symptoms with three diet quality indices (MDS, AHEI and DASH) are reported.
Finally, Chapter 7 summarizes and discusses the main findings of the studies included in 
this thesis. Methodological strengths and limitations, directions for future research and 
implications for public health and clinical practice are also addressed.
Figure 1 | Schematic overview of the studies in this thesis. 
The arrows indicate the direction of the investigated associations and in which chapter (Ch) they are 
addressed.
18
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ABSTRACT 
Background/Objectives 
The roles of vitamin B
12
 and homocysteine concentration in depression are not clear. We 
investigated cross-sectional and prospective associations of serum vitamin B
12
 and plasma 
homocysteine with depressive symptoms in Dutch older adults.
Subjects/Methods
In the Longitudinal Aging Study Amsterdam (LASA), blood was collected in 1995/1996 
among 1352 men and women aged ≥65 years. Depressive symptoms were assessed with 
the Center for Epidemiologic Studies Depression scale (CES-D) six times from 1995/1996 
to 2011/2012. Multiple linear regression and mixed models were used to assess whether 
vitamin B
12
 and homocysteine were associated with severity at baseline and course of 
depressive symptoms over 16 years. Cox regression analyses were performed for the 
associations with incidence of depression (CES-D ≥16 and/or antidepressant use). All 
analyses were adjusted for socio-demographic characteristics and lifestyle factors. 
Results 
Vitamin B
12
 was neither cross-sectionally (n=1205) nor prospectively (n=1012) associated 
with depressive symptoms (adjusted B for CES-D over time, lowest vs. highest quartile:
-0.04 (95% CI: -0.15-0.06)). We also found no association with incident depression (n=853), 
except for a higher risk of depression over time in younger participants (aged 64.8-73.4y) 
(continuous vitamin B
12
 adjusted hazard ratio per SD: 1.38 (95% CI: 1.10-1.72)). For 
homocysteine, no associations were found, except for a lower risk in younger participants.
Conclusions 
Our study did not confirm earlier shown associations of serum vitamin B
12
 and plasma 
homocysteine with severity and course of depressive symptoms and incidence of 
depression in older adults. Further research into the influence of homocysteine metabolism 
on mental health is needed.
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Vitamin B
12
, homocysteine and depressive symptoms
INTRODUCTION
A low vitamin B
12
 status, which results in altered cellular metabolism, does not only lead 
to hematologic abnormalities and irreversible neurological complications, but might also 
be linked to age-related problems including cardiovascular disease, cognitive decline and 
osteoporosis1-3. Among older adults, 10 to 38% may exhibit vitamin B
12
 deficiency1. However, 
there is no consensus on the cutoff level of serum vitamin B
12
 to define vitamin B
12
 deficiency, 
and diagnosis preferably includes measurements of other biomarkers, such as homocysteine, 
methylmalonic acid and holotranscobalamin3-5. Deficiency in older adults is mostly linked to 
improper absorption rather than low dietary intake3. 
Depression is one of the most prevalent diseases, also in later life. Clinically relevant 
depressive symptoms are present in 7.2 to 49% of the older Caucasian population6. A 
relationship between vitamin B
12
 and depression has been hypothesized, mainly based on the 
monoamine hypothesis. In detail, vitamin B
12
, as well as folate, is an essential cofactor in the 
remethylation of homocysteine to methionine. Methionine is the precursor of S-adenosyl-
methionine (SAM), which is the methyl donor of many methylation reactions in the brain. SAM 
is needed for the synthesis of monoamine neurotransmitters, including serotonin, dopamine 
and noradrenaline7-9. Abnormalities in the metabolism of these neurotransmitters may cause 
depression10, providing an explanation for the link between homocysteine metabolism and 
mental health. 
Hyperhomocysteinemia can be caused by deficiencies in vitamin B
12
 and other B vitamins. 
Experimental studies that investigated the effects of supplementation of B vitamins on 
depression severity, remission and onset of depressive symptoms have shown conflicting 
results. Some studies have shown no effects of vitamin B
12
, (vitamin B
6
) and folic acid 
supplementation on depression outcomes in older11,12 and middle-aged adults13, while one trial 
in middle-aged adults showed a positive effect when these three B vitamins were combined 
with antidepressants14. Injections of only vitamin B
12
 showed no effect on depressive symptoms 
in older adults15, while in a small study sample of adults, B
12
 injections in combination with 
antidepressants showed greater decline in depressive symptoms than antidepressants only16. 
A meta-analysis of 11 trials, of which 5 included vitamin B
12
 supplementation in older and 
middle-aged adults, indecisively concluded that treatment with vitamin B
12
 and/or folate does 
not reduce depression symptoms within a short period of time, but prolonged use may reduce 
severity and onset in populations at risk17.
Observational research on the association between vitamin B
12
 and depression also showed 
mixed results. Several cross-sectional studies in middle-aged18 and older adults18-22 have 
reported that deficiency of vitamin B
12
 was associated with a higher prevalence of depression 
or depressive symptoms, while other studies conducted in older23-25, middle-aged25,26 and 
younger study populations27,28 did not find any association. A recent meta-analysis of 9 cross-
sectional studies among older age populations concluded that low levels of vitamin B
12
 are 
associated with depressive symptoms, with an indication of an association mainly in older 
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women29. Furthermore, three prospective studies found a higher incidence of depression 
or depressive symptoms in older adults who had low vitamin B
12
 levels22 or low vitamin B
12
 
intakes30,31, of which one only in men31. Cross-sectional studies on homocysteine levels and 
depression have shown positive associations in older22,25,32, middle-aged25,26 and younger 
adults33; however, others did not find associations in older18-21,34, middle-aged18 and younger 
adults27. One prospective study found that a high baseline homocysteine concentration and 
an increase in homocysteine concentration were associated with late-life depression 2 years 
later22.
More research on the adverse mental health consequences resulting from low vitamin B
12
 
levels and high homocysteine levels in older adults seems warranted, especially longitudinal 
studies with a sex-specific focus. The aim of this study was to examine the association of serum 
vitamin B
12
 concentration and plasma homocysteine with the severity of depressive symptoms 
(cross-sectional), the course of depressive symptoms and the incidence of depression over 
time (prospective).
SUBJECTS AND METHODS
Study population
Data for this study were collected within the Longitudinal Aging Study Amsterdam (LASA). 
LASA is an ongoing cohort study originally designed to investigate the determinants, 
trajectories and consequences of physical, cognitive, emotional and social functioning in the 
aging Dutch population. The sampling and data collection procedures have been described 
in detail elsewhere35-37. Briefly, a nationally representative sample of community dwelling 
older adults aged 55-85 years, stratified by age, sex, urbanization grade and expected 5-year 
mortality rate, was recruited from three geographic regions in the Netherlands. At the start in 
1992/1993, 3107 subjects were enrolled. Every 3 years a measurement cycle is carried out at 
the participants’ homes, including a main interview, a medical interview and a questionnaire. 
All participants gave informed consent, and the Medical Ethics Committee of the VU University 
Medical Center (VUmc) approved this study. 
Participants
For the present study, persons participating in the medical interview of the second measurement 
cycle (1995/1996, the ‘baseline’ cycle of this study) and born in or before 1930 (aged 65 years 
or older as of January 1st 1996), were selected (n=1509). Blood samples were collected in 1352 
of these persons; in 1331 of these persons, measurements could be performed. Persons with 
no or incomplete data on the Center for Epidemiologic Studies Depression scale (CES-D) were 
excluded (n=38). For the vitamin B
12
 analyses, we additionally excluded those with missing 
serum vitamin B
12
 concentration (n=55), vitamin B
12
 concentration >3000 pmol/l (n=9) and 
missing data on relevant confounders (n=24). This resulted in an analytical sample of 1205 
persons for the cross-sectional analyses. For the prospective analyses, CES-D data from 
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baseline (1995/1996) to the sixth measurement cycle (2011/2012) were used. An additional 
exclusion criterion for these prospective analyses was having no CES-D data at any follow-up 
cycle (n=193), which resulted in an analytical sample of 1012 persons. Persons with depressive 
symptoms at baseline (CES-D ≥16 and/or using antidepressants, n=159) were additionally 
excluded for the prospective incidence analyses, resulting in a sample of 853 persons. For the 
homocysteine analyses, exclusion criteria were similar. Next to the criterion of no CES-D data 
(n=38), persons with missing data on homocysteine concentration (n=29), a homocysteine 
concentration >40 μmol/l (n=9) and missing data on confounders (n=24) were excluded, which 
resulted in a sample of 1231 persons for the cross-sectional analyses. For the prospective 
course analyses, those with no follow-up CES-D data (n=191) were additionally excluded 
(n sample=1040). Persons with depressive symptoms at baseline (n=168) were additionally 
excluded for prospective incidence analyses, resulting in a sample of 872 persons.
Depression measurements
Depressive symptoms in the previous week were measured by the CES-D, a self-report 
symptom rating scale consisting of 20 items38. Total scores can range from 0 to 60, with higher 
scores indicating higher levels of depressive symptoms. The generally accepted cutoff score 
of ≥16 indicates clinically relevant depressive symptoms. The CES-D has been shown to have 
good psychometric properties in samples of older adults39. Data on medication use were 
retrieved during the medical interviews at each measurement cycle. The medication names 
were recoded into Anatomical Therapeutic Chemical (ATC) codes that were used to define use 
of antidepressants (yes/no).
Blood measurements
Morning blood samples were drawn in 1995/1996. Participants were allowed to take tea 
and toast for breakfast, but no dairy products. Samples were centrifuged and stored at -20 
Celsius degrees until determination in 2001/2002. Serum vitamin B
12
 concentrations were 
measured using a competitive luminescence immunoassay on an automated ACS system 
(Bayer Diagnostics, Mijdrecht, the Netherlands) at the Endocrine Laboratory of the VUmc 
and rounded to whole values. The interassay coefficient of variation was 5%. The same 
as Dhonukshe-Rutten et al.40, the cutoff point of <200 pmol/l was used for a ‘low vitamin 
B
12
 concentration’. Total homocysteine concentrations in EDTA-treated plasma samples 
were measured using a fluorescence polarization immunoassay on an IMx analyzer (Abbott 
Laboratories, Abbott Park, IL, USA) at the Laboratory of Clinical Chemistry of the VUmc. The 
interassay coefficient of variation was 4%.
Covariates
Information on age and sex was derived from the municipal registries. Marital status was 
divided into never married, married, divorced and widowed. The highest attained level of 
education was asked to the participant and categorized in low (elementary school or less), 
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middle (general secondary, intermediate vocational, intermediate general and lower vocational 
education) and high (university education, college or higher vocational). BMI was calculated by 
dividing measured body weight (in kg) by the squared measured body height (in m). Categories 
of smoking status were never (or stopped smoking >15 years ago), former (stopped ≤15 years 
ago) and current smoking. Self-reported use of alcohol was based on the Garretsen index and 
categorized in no, light, moderate and (very) excessive41. Physical activity was assessed using 
the LASA Physical Activity Questionnaire (LAPAQ), a validated interviewer-administered 
questionnaire that evaluates duration and frequency of walking outdoors, cycling, light and 
heavy household activities and a maximum of two sports activities during the past 2 weeks 
(min/d)42. The number of chronic diseases was obtained by self-report using questions on major 
diseases: pulmonary disease, cardiac disease, peripheral arterial disease, diabetes mellitus, 
stroke, osteoarthritis/rheumatoid arthritis, malignancies, hypertension and other chronic 
diseases. ATC codes were used to define use of vitamin B
12
 supplements, both injections and 
pills (yes/no). 
Statistical analyses
Linear regression analyses for the baseline characteristics were used to examine linear trends 
in the continuous variables across quartiles of serum vitamin B
12
. For categorical variables, chi-
square (linear-by-linear association) tests were used. For the cross-sectional and prospective 
analyses, vitamin B
12
 and homocysteine quartiles were used to compare ‘extreme’ groups; 
the highest B
12
 quartile and the lowest homocysteine quartile served as reference categories. 
To enhance statistical power, vitamin B
12
 and homocysteine were also used as continuous 
determinants, expressed per standard deviation (SD). Since the CES-D score – the outcome 
measure – was highly skewed to the right, a natural log-transformation was performed on the 
CES-D scores, after a value of one was added to the overall scores to prevent zero scores.
The cross-sectional associations between vitamin B
12
/homocysteine and severity of 
depressive symptoms (transformed, continuous CES-D score) were analyzed by multivariable 
linear regression models. To test for effect modification, interaction terms between vitamin 
B
12
/homocysteine and the potential effect modifiers – age and sex – were included in the 
regression models. A P-value <0.10 for the interaction term(s) was considered statistically 
significant. Three models were made adjusted for variables that appeared to be important 
based on the literature or when regression coefficients changed by more than 10%: model 1 
was adjusted for socio-demographics, model 2 was additionally adjusted for lifestyle factors 
and model 3 was additionally adjusted for number of chronic diseases (as this covariate might 
be a confounder and/or mediator of the association). A P-value for trend was calculated to 
examine linear trends across the quartiles, using the categorical variable as a continuous 
variable.
The prospective associations between vitamin B
12
/homocysteine and course of depressive 
symptoms (transformed, continuous CES-D score) from the second cycle (1998/1999) to the 
sixth cycle (2011/2012) were analyzed by linear mixed models with only a random intercept. 
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The first cycle (baseline) was not included because the models would then be partly cross-
sectional. Time (in years after baseline) and interaction terms with time were included in 
the models to examine whether the association varied with time. Effect modification and 
confounding in these prospective course analyses were handled the same as the cross-
sectional analyses, except for the additional adjustment for baseline CES-D score to interpret 
the regression coefficients as change compared to baseline.
To study whether vitamin B
12
 and homocysteine concentrations were associated with the 
incidence of depression (CES-D ≥16 and/or new use of antidepressants) at the second to the 
sixth cycle, Kaplan-Meier curves of the quartiles were plotted and compared with the log-rank 
test. Participants were censored at the date of their last main interview that included data 
on the CES-D and/or antidepressant use. Hazard Ratios (HRs) of incident depression were 
estimated using Cox proportional hazards models. The proportional hazards assumption was 
checked by visual inspection of the Kaplan-Meier curves and log minus log plots, and tested 
by creating a time-dependent determinant; evidence of non-proportionality was not found. 
Effect modification and confounding were handled as described for the prospective course 
analyses.
To test the robustness of the results, sensitivity analyses were performed. Cross-sectional and 
prospective course analyses were performed excluding participants using antidepressants at 
baseline and excluding participants who had ever used antidepressants at one or more of the 
measurement cycles. Further, participants using vitamin B
12
 supplementation (injections or 
pills) were excluded in a similar way and cross-sectional, prospective course and prospective 
incidence analyses were repeated. To investigate prospective associations between baseline 
vitamin B
12
/homocysteine and depressive symptoms 3 years later, linear regression analyses 
were performed with depressive symptoms at only the second cycle (1998/1999) as outcome, 
adjusted for baseline CES-D score (post hoc).
All analyses were performed in SPSS version 21 (SPSS Inc., Chicago, IL, USA). Two-sided 
P-values ≤0.05 were considered statistically significant.
RESULTS
Baseline characteristics
Participants in the vitamin B
12
 sample (n=1205) were 74.6 years old (median, interquartile 
range (IQR) 69.5-80.6), the median serum vitamin B
12
 was 266 pmol/l (IQR: 214-336) and 
216 participants (17.9%) had a vitamin B
12
 concentration below 200 pmol/l. The median 
total homocysteine was 13.4 μmol/l (IQR: 11.0-16.8). Participants in the lowest quartile of 
serum vitamin B
12
 were older, more often male, had less chronic diseases and higher plasma 
homocysteine than the other quartiles (Table 1). The characteristics of the 1231 participants 
in the homocysteine sample were very similar to those in the vitamin B
12
 sample. When 
comparing the homocysteine quartiles, participants in the highest quartile were older, more 
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often male, less physically active, had more chronic diseases and lower serum vitamin B
12
 than 
the other quartiles (data not shown).
Comparison of included (n=1205) and excluded (n=304) participants showed that participants 
excluded at baseline were older (P<0.001), lower educated (P=0.003), less often married 
(P<0.001), less physically active (P<0.001), had more chronic diseases (P<0.033) and had more 
depressive symptoms (P<0.001), compared to the included participants. The same comparison 
for participants included in the prospective course analyses (n=1012) and those excluded 
(n=193) showed comparable results.
At baseline and subsequent measurement cycles, the prevalence of clinically relevant 
depressive symptoms (CES-D ≥16) was 172/1205 (14.3%), 187/1009 (18.5%), 154/811 
(19.0%), 104/560 (18.6%), 76/407 (18.7%) and 64/267 (24.0%); attrition was mainly due to 
mortality36.
Cross-sectional associations: severity
Serum vitamin B
12
 quartiles were not significantly associated with CES-D scores at baseline 
in both crude and adjusted models (Table 2). Similar results were seen when vitamin B
12
 was 
treated as a continuous determinant. As the analyses were performed after logarithmic 
transformation of the CES-D score, the betas in Table 2 should be interpreted as follows: a 
change of 169 pmol/l in serum vitamin B
12
 is associated with an increase in CES-D score of 
2% (eB = e0.02 = 1.02) in model 2. No interactions with sex and age were observed. Plasma total 
homocysteine (in quartiles and continuous) was neither significantly associated with baseline 
depressive symptoms (Table 2).
Prospective associations: course 
Serum vitamin B
12
 was also not prospectively associated with change in CES-D score over 16 
years (Table 3). There were no significant trends (P for trend=0.255 in model 2), as well as 
no interactions with sex and age. No clear time interactions were found in the mixed models, 
indicating that the association of serum vitamin B
12
 with the course of depressive symptoms 
did not differ over the measurement cycles. No significant associations were found between 
homocysteine concentration and change in CES-D score (Table 3).
Prospective associations: incidence
Over a median (IQR) follow-up of 6.0 (3.0-12.9) years, 254/853 participants in the vitamin 
B
12
 sample (29.8%) developed clinically relevant depressive symptoms and/or started to use 
antidepressants: vitamin B
12
 quartile 1 24.6%, quartile 2 31.0%, quartile 3 30.8% and quartile 
4 32.6%. The Kaplan-Meier curves did not significantly differ from each other (log-rank test 
P=0.239). In the Cox regression models, the interaction term of continuous vitamin B
12
 with 
age was significant (P=0.010). Therefore, analyses were stratified by the median of age (73.4 
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y). No interactions with sex were observed. In the younger participants, the significant lower 
risk of incident depression over time of the lowest quartile disappeared after adjustment for 
lifestyle factors (model 2 and 3, Table 4). Continuous serum vitamin B
12
 also showed a positive 
association, but remained significant after adjustment (HR per SD increase adjusted model 
2: 1.38 (95% CI 1.10-1.72)). In the older participants, no significant associations were found. 
Results for homocysteine were comparable to vitamin B
12
. Of the 872 participants, 264 (30.3%) 
developed depressive symptoms and/or started to use antidepressants: homocysteine quartile 
1 34.0%, quartile 2 29.1%, quartile 3 32.7% and quartile 4 24.1%. The Kaplan-Meier curves did 
not significantly differ from each other (log-rank test P=0.220). Age was an effect modifier in 
the Cox regression models. In the older participants (>73.7 y), no significant associations were 
found, neither for the quartiles in the younger participants. Only continuous homocysteine 
concentration was negatively associated with incident depression over time in the younger 
participants, but significance disappeared after adjustment for lifestyle factors (model 2 and 
3, Table 4).
Sensitivity analyses 
Findings did not change when participants who used antidepressants at baseline were 
excluded (vitamin B
12
 analyses vs. homocysteine analyses: cross-sectional analyses: n=33 
vs. n=33, prospective course: n=28 vs. n=28) or when participants who had ever used 
antidepressants at one or more of the cycles were excluded (prospective course: n=88 vs. 
n=90). Similarly, exclusion of participants using vitamin B
12
 supplementation at baseline 
(cross-sectional, prospective course and prospective incidence analyses: n=4 vs. n=9) or ever 
using supplementation (prospective course: n=13 vs. n=19; prospective incidence: n=11 vs. 
n=17) did not alter any findings. Further, with depressive symptoms 3 years after baseline as 
outcome, findings were comparable to those with course over 16 years.
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DISCUSSION
In this study, serum vitamin B
12
 concentration and plasma total homocysteine were not 
associated with depressive symptoms in Dutch older adults. We observed no associations of 
vitamin B
12
 concentration and plasma total homocysteine with severity of depressive symptoms 
or with change in CES-D scores over time. There was also no association with incidence of 
depression, except for a higher risk of depression over time in younger participants (aged 64.8-
73.4 y) with higher vitamin B
12
 concentrations.
The direction of the betas of our cross-sectional and prospective course analyses of vitamin 
B
12
 was contrary to expectations (higher vitamin B
12
 concentration / higher B
12
 quartile was 
related to higher CES-D score, i.e. more depressive symptoms). However, the betas were very 
close to zero and trends were not statistically significant. This also holds for the prospective 
course and prospective incidence homocysteine analyses. In contrast, in the cross-sectional 
homocysteine analyses, the direction of the betas was as expected (higher homocysteine 
concentration / higher homocysteine quartile was related to higher CESD-score); however, 
they were also not significant. Additional adjustment for number of chronic diseases did not 
substantially influence our results, so this does not suggest a mediating role in the studied 
relationships. Sensitivity analyses did also not change our findings.
A possible explanation for our null results is that serum vitamin B
12
 concentration might not 
be a good measure of vitamin B
12
 deficiency in older adults3,4. However, there was also no 
association between plasma homocysteine and depressive symptoms, supporting our null 
results of vitamin B
12
. Another possible explanation is the long period between vitamin B
12
/
homocysteine and mood: vitamin B
12
 status might not be related to mood up to 16 years later. 
Therefore, we performed post hoc sensitivity analyses with depressive symptoms 3 years after 
baseline as outcome. Results did not differ for both vitamin B
12
 and homocysteine, indicating 
also no prospective associations for a shorter follow-up. The higher risk of incident depression 
over time for higher B
12
 concentrations in the younger age group was unexpected. Although 
adjustment for socio-demographic and lifestyle factors made the significance disappear for 
the vitamin B
12
 quartiles, it did not for continuous vitamin B
12
. In line with this, we found an 
unexpected lower risk for higher homocysteine concentration. Significance was neither 
changed after the exclusion of participants who had ever used vitamin B
12
 supplements (to 
rule out the possibility that the lower hazard of those with low vitamin B
12
 concentrations was 
driven by participants using supplements at later measurement cycles resulting in higher B
12
 
concentrations). Thus, we cannot explain this and consider it a chance-finding.
Our findings are not in line with other prospective studies on vitamin B
12
. Kim et al.22 showed 
that lower baseline serum vitamin B
12
 concentrations as well as a decline in vitamin B
12
 
concentrations were predictive for depression 2 years later in Koreans aged ≥65 years. The 
contrast with our prospective incidence findings might be due to the different outcome 
measures (Geriatric Mental State schedule vs. CES-D) or different ethnicities. In US older 
adults, Skarupski et al.30 found that higher vitamin B
12
 intakes from food and supplements were 
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associated with a decreased likelihood of developing depressive symptoms over a mean of 7.2 
years, while intakes only from food were marginally significant. Gougeon et al.31 also studied 
vitamin B
12
 intakes, but reported only in men a decreased 3-year incidence of depression with 
higher B
12
 intakes from food; they did not find associations with intakes from both food and 
supplements or in women. The discrepancy with our prospective null results might be because 
nutrient status (serum concentrations) differs from intake. 
We found no cross-sectional associations between vitamin B
12
 concentrations and depressive 
symptoms, similar to previous cross-sectional studies23-28,34. However, others did find inverse 
associations18-22, which may be explained by differences between studies in measures of B
12 
status, measures of depression/depressive symptoms, study population or statistical methods. 
The meta-analysis of Petridou et al.29, showing an increased risk of depression for low vitamin 
B
12
 concentrations in older populations (odds ratio: 1.20 (95% CI: 1.02-1.42)), also mentioned 
this heterogeneity as a limitation. A study in Finnish middle-aged adults showed that vitamin 
B
12
 concentration was cross-sectionally associated with melancholic depressive symptoms, 
but not with non-melancholic depressive symptoms43. Unfortunately, a distinction between 
both subtypes of depression was not possible in our study.
Our null results, suggesting that serum vitamin B
12
 might not be an essential factor in relation 
to depression, are in line with most experimental studies among middle-aged and older 
adults, which have shown no beneficial effects of supplementation of vitamin B
12
 only15 or in 
combination with other B vitamins11-13 on depression measures. The conclusion of a meta-
analysis of 11 trials on vitamin B
12
 supplementation (1 trial), folate supplementation (10 trials) 
and supplementation of both (4 trials) was indecisive17.
Previous observational studies on homocysteine and depression have shown conflicting 
results. Our null results are similar to other studies in older and middle-aged populations18-21. 
Though, some found an association between higher homocysteine levels and higher depressive 
symptoms in older22,25,32, middle-aged25,26 and younger adults33. These inconsistencies might 
be attributable to differences in study populations, measures of depression, measures of 
homocysteine concentration and statistical methods.
Strengths of this study include the large, nationally representative sample of older adults 
in the Netherlands, longitudinal design with 16 years of follow-up, use of mixed models as 
longitudinal analysis technique, different aspects of depressive symptoms (severity, course 
and incidence) and the possibility to adjust for a large number of potential confounders. Some 
limitations have to be considered as well. Vitamin B
12
 and homocysteine concentrations were 
only measured once, which impedes studying the change in concentration over time. Further, 
concentrations of folate and methylmalonic acid (a more specific marker for functional vitamin 
B
12
 status) were only assessed in a small subgroup (n=582) and therefore not included in 
this study. The study sample was also relatively healthy as most participants had to visit the 
hospital for blood sampling. This was reflected in the comparison of included and excluded 
participants: they were less healthy (physically and mentally) and less physically active, as 
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well as older, lower educated and less often married compared to included participants. 
Lastly, depressive symptoms were measured every 3 years by the CES-D scale, which refers 
to the previous week; as depression fluctuates, we may have missed intermediate depressive 
episodes.
In conclusion, this study shows no cross-sectional and prospective associations of vitamin 
B
12
 and homocysteine with depressive symptoms in older men and women. Still, more 
investigations are required to find out whether homocysteine metabolism plays a role in mental 
health; specifically, prospective studies in middle-aged adults with data on vitamin B
12
 status 
(serum levels and intake) and data on homocysteine, methylmalonic acid, holotranscobalamin 
and folate levels. In contrast to previous experimental studies, it would be interesting to 
examine in a randomized controlled trial the causal effect of supplementation of only vitamin 
B
12
 – and no other vitamins – on the prevention and treatment of depression. 
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ABSTRACT
Objectives
Depressive symptoms and low vitamin D status are common in older persons and 
may be associated, but findings are inconsistent. This study investigated whether 
25-hydroxyvitamin D (25(OH)D) concentrations are associated with depressive symptoms 
in older adults, both cross-sectionally and longitudinally. Secondary, it was examined 
whether physical functioning could explain this relationship, to gain a better understanding 
of the underlying mechanisms. 
Methods
Data from two independent prospective cohorts of the Longitudinal Aging Study 
Amsterdam were used: an older cohort (≥65 years, n=1282, assessed from 1995-2002) 
and a younger cohort (55-65 years, n=737, assessed from 2002-2009).
Measurements
Depressive symptoms were measured at baseline and after 3 and 6 years with the Center 
of Epidemiological Studies Depression Scale. Cross-sectional and longitudinal linear 
regression techniques were used to examine the relationship between 25(OH)D and 
depressive symptoms. The mediating role of physical functioning was examined in the 
longitudinal models.
Results
Cross-sectionally, associations were not significant after adjustment for confounders. 
Longitudinally, women in the older cohort with baseline 25(OH)D concentrations 
up to 75 nmol/l experienced 17-24% more depressive symptoms in the following six 
years, compared to women with 25(OH)D concentrations >75 nmol/l. Reduced physical 
performance partially mediated this relationship. In men and in the younger cohort, no 
significant associations were observed. 
Conclusions
Older women showed an inverse relationship between 25(OH)D and depressive symptoms 
over time, which may partially be explained by declining physical functioning. Replication 
of these findings by future studies is needed.
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INTRODUCTION
Worldwide, depression is a leading cause of disability, resulting in significant individual 
and societal burden1. In addition, low 25-hydroxyvitamin D (25(OH)D) concentrations are 
common, especially among older persons2,3. Meta-analyses have shown an inverse association 
between 25(OH)D concentrations and depressive symptoms, but findings are inconsistent 
and longitudinal studies are scarce4,5.
A large Italian population-based cohort of older adults found that persons with low baseline 
25(OH)D had more depressive symptoms after 3 and 6 years, compared to persons with 
higher baseline 25(OH)D6. Chan et al.7 found an inverse cross-sectional, but no prospective 
association between 25(OH)D and depressive symptoms in older persons, whereas Williams 
et al.8 observed the opposite pattern. Furthermore, older adults with low 25(OH)D had an 
almost threefold risk of major depressive disorder (MDD) after one year, compared to persons 
with normal 25(OH)D concentrations in a population with cardiovascular disease9.
Biologically, a link between vitamin D status and depressive symptoms is plausible, due to 
protective functions of vitamin D metabolites in the brain10-12 and presence of the vitamin D 
receptor in depression-related brain areas, such as the hippocampus13. To better understand 
the mechanisms underlying the presumed association between 25(OH)D and depression, a 
mediating role of physical functioning in this relationship can also be considered. Physical 
functioning is associated with both 25(OH)D and depression: low 25(OH)D concentrations 
were associated with lower and declining physical performance14,15, and bidirectional cross-
sectional and prospective relationships between  physical functioning and depression have 
been observed16-20.
The present cohort study investigated whether 25(OH)D concentrations are associated 
with the severity (cross-sectionally) and the course and onset (longitudinally) of depressive 
symptoms in older adults. In secondary analyses, this study investigated whether physical 
functioning explains the association between 25(OH)D and depressive symptoms. Data from 
two independent cohorts of the Longitudinal Aging Study Amsterdam (LASA) were used21. Part 
of this data was also used in a cross-sectional study by Hoogendijk et al.2, on which the present 
study elaborates. Hoogendijk et al. observed that depressive symptoms (as determinant) 
were associated with lower 25(OH)D in one LASA cohort. The present study additionally 
investigated a second LASA cohort and examined longitudinal associations. By studying 
two independent cohorts, we aimed to provide more insight into the relationship between 
25(OH)D and depressive symptoms across a wide age range.
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METHODS
Design and study sample
LASA is an ongoing population-based prospective cohort study that investigates the 
predictors, consequences and time course of physical, cognitive, emotional and social 
functioning in multiple cohorts of older adults21. Participants were recruited from municipality 
registries in three regions in the Netherlands, together comprising a representative sample of 
the Dutch older population. Every 3 years, LASA participants are invited for interviews and 
questionnaires. Interviews are conducted at the participants’ homes by trained interviewers. 
Data from two LASA cohorts were used. In 1992, 3107 participants aged 55-85 years were 
included in the first LASA cohort (‘older cohort’). As 25(OH)D was first assessed in 1995/1996, 
we took this second measurement cycle as baseline for this cohort. Participants of ≥65 years 
who agreed to have an additional medical interview (n=1509) were asked to donate a blood 
sample. Serum 25(OH)D was available from 1320 participants. 
The second LASA cohort commenced in 2002/2003 with 1002 participants aged 55-65 
years (‘younger cohort’). Of the 919 participants who agreed to the medical interview, 739 
participants had data on 25(OH)D.
Follow-up time for the present study was  6 years. Follow-up data were collected at the 
subsequent two measurement cycles: in 1998/1999 and 2001/2002 (older cohort), and in 
2005/2006 and 2008/2009 (younger cohort).
All participants gave written informed consent prior to the start of the study. The LASA study 
was approved by the Medical Ethics Committee of the VU University Medical Center (VUmc). 
Detailed information about LASA and its participants can be found elsewhere21.
Measurements
Depressive symptoms
The Center for Epidemiological Studies Depression Scale (CES-D)22 was assessed at baseline, 
3 and 6 years in both cohorts. The CES-D is a widely-used screening instrument that contains 
20 items about depressive symptoms as experienced in the previous week. Scores range from 
0-60, with higher scores indicating more depressive symptoms. A score of ≥16 is indicative 
for clinically relevant depressive symptoms. The CES-D displays high reliability23 and good 
criterion validity24 in several older populations.
Blood sampling and measurement of 25(OH)D
Morning blood samples for the assessment of serum 25(OH)D (in nmol/l) were obtained in 
1995/1996 (older cohort) and 2002/2003 (younger cohort). Participants were allowed to have 
a light breakfast without dairy products. Samples were centrifuged and stored at -20°C until 
25(OH)D determination in 1997/1998 (older cohort) and 2010/2011 (younger cohort). The 
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analyses were carried out by the VUmc Endocrine Laboratory. A competitive protein-binding 
assay (Nichols Diagnostics Capistrano, CA, USA; interassay coefficient of variation (CV): 10%) 
was used for the sample determinations in the older cohort, whereas a radioimmunoassay 
(Diasorin, Stillwater, Minnesota, USA; interassay CV: 10%) was used for the younger cohort. 
For the statistical analyses of the present study, 25(OH)D was divided into four categories 
using commonly used cutoff values: <30 nmol/l (deficiency), 30-50 nmol/l (insufficiency), 50-
75 nmol/l and >75 nmol/l25,26.
Potential effect modifier and confounders
Sex was examined as a potential effect modifier, as previous studies observed different 
associations between 25(OH)D and depressive symptoms in men and women6,9. Education level 
(years), smoking habits (never, former, current smoker), alcohol consumption (grams/week, 10 
g per consumption), presence of the most prevalent somatic chronic diseases among Dutch 
older adults (asthma/chronic obstructive pulmonary disease, cardiac disease (myocardial 
infarction, coronary artery disease, heart failure, disease of the cardiac valves, arrhythmia), 
peripheral arterial disease, diabetes mellitus, cerebrovascular accident/stroke, osteoarthritis/
rheumatoid arthritis, cancer, hypertension, and other diseases that are present for at least three 
months) and general cognitive functioning (Mini-Mental State Examination)27 were obtained 
during the interviews and questionnaires. To control for seasonal variations in 25(OH)D 
concentrations28, the blood collection dates were dichotomized into winter (October-March) 
and summer (April-September). Body mass index (BMI) was calculated by dividing measured 
body weight (in kilograms) by measured body height squared (in meters). Information on 
physical activity in the previous 2 weeks (walking, cycling, sports, heavy household activities, 
in minutes/day, plus the question whether these activities were representative compared to 
the previous year) was taken from the LASA Physical Activity Questionnaire (LAPAQ)29.
Potential mediating variables
To cover a broad domain of physical functioning, both objective performance tests and 
self-reported functional limitations were examined for their possible mediating role in the 
association between 25(OH)D and depressive symptoms. A modified version of the Short 
Physical Performance Battery (SPPB)15,30 was used to assess physical performance. The 
SPPB includes three tests: walking speed (walking 3 meters, turning around and walking 
back 3 meters as fast as possible), chair stands (standing up from a chair without using hands 
five times consecutively, as fast as possible) and standing balance (standing with one foot 
directly in front of the other for up to 10 seconds). In the older cohort, the total score of the 
SPPB ranged from 0-12. As the balance test was not administered to the younger cohort 
at baseline, the SPPB score for this cohort was composed of the walking speed and chair 
stands scores only, resulting in a score range of 0-8. Higher scores indicate better physical 
performance.
Functional limitations were measured with six questions assessing common daily activities: 
climbing stairs, cutting toenails, walking five minutes without resting, rising from a chair, 
(un)dressing and using own/public transportation31. The participants indicated whether they 
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had difficulty performing these activities (score range: 0-6). Higher scores indicate more 
functional limitations.
Statistical analyses
As the two cohorts differed in age range, assessment period and 25(OH)D assay, analyses 
were conducted separately for both cohorts. All analyses were conducted with SPSS version 
22 (SPSS Inc. Chicago, IL, USA), except for the mediation analyses, which were conducted 
with Mplus (version 7.2) and R statistical software (version 3.2.5). A double-sided P-value 
of less than 0.05 was considered statistically significant. Baseline descriptive statistics were 
calculated and presented as n / percentage for categorical variables or as median / interquartile 
range for skewed continuous variables. Cross-sectional and longitudinal non-response 
analyses comparing included and excluded participants were conducted with Pearson χ2 tests 
for categorical variables or with non-parametric Mann-Whitney tests for skewed continuous 
variables.
As the distribution of the CES-D scores was skewed to the right, these scores were log-
transformed using the formula ln(1 + CES-D score). The four 25(OH)D categories were entered 
as three dummy variables in the regression analyses, with the >75 nmol/l group as reference 
category. To test the association of 25(OH)D with depressive symptoms, we first looked at the 
overall, 3 degrees of freedom (df) tests of the 25(OH)D dummies. If this test was statistically 
significant, we subsequently looked at the associations of the separate dummy variables with 
depressive symptoms. The Bs, standard errors (SEs) and confidence intervals (CIs) of the 
regression analyses were transformed back to obtain interpretable ratios (eB = ratio). These 
ratios reflect the percentage of change in the outcome per one unit change in the determinant. 
As these ratios and resulting percentages were calculated from a log-transformed scale, note 
that they do not correspond to the same change in CES-D across all CES-D scores: higher 
scores change more than lower scores. For instance: with a ratio of 1.23 and corresponding 
percentage change of 23%, a CES-D score of 20 changes 4.6 points (23% of 20), whereas a 
CES-D score of 10 changes 2.3 points (23% of 10).
Cross-sectional analyses
Multiple linear regression analyses with the 25(OH)D categories as determinants and the 
CES-D score as outcome were conducted. To assess effect modification, sex and interaction 
terms of the 25(OH)D categories with sex (25(OH)D dummies × sex) were added to the 
unadjusted model. If an interaction term had a P-value of less than 0.05, stratified analyses 
for men and women were conducted. If no effect modification was present, sex was added as 
a confounder to the analyses. Adjustments for demographic variables (age, (sex,) education 
level, season of blood collection) were made in model 1; additional adjustments for lifestyle/
health confounders (smoking, alcohol consumption, BMI, number of chronic diseases, physical 
activity and cognitive functioning) were made in model 2.
55
3
Serum vitamin D, physical functioning and depressive symptoms
Longitudinal analyses
To study the course of depressive symptoms over time, linear mixed-models analyses were 
conducted with the 25(OH)D categories at baseline as determinants, the CES-D scores after 
3 years and 6 years as outcome and the baseline CES-D score as covariate. These analyses 
included participants who had baseline 25(OH)D and CES-D data and at least one follow-up 
CES-D measurement. A random intercept was added to the longitudinal CES-D variable to 
control for dependency of individual measures over time. A time-interaction term was added 
to the models to examine possible differences in the association between 3 and 6 years of 
follow-up.
To study whether 25(OH)D predicts the onset of clinically relevant depressive symptoms 
over time, logistic regression analyses were conducted in a subgroup of participants without 
depressive symptoms at baseline (CES-D <16) and at least one follow-up measurement. The 
outcome was defined as presence of clinically relevant depressive symptoms (CES-D ≥16) in 
the 6-year follow-up period. Models and effect modification procedures were similar to the 
cross-sectional analyses.
Finally, the possible mediating effect of physical performance and functional limitations in 
the relationship between 25(OH)D and depressive symptoms was examined in secondary 
analyses. To account for the temporal, stepwise character of this hypothesized relationship, 
two longitudinal mediation models were fitted in which physical performance and functional 
limitations after 3 years of follow-up were considered as the mediator variables. Using 
structural equation modeling, the effect of 25(OH)D on physical functioning and the effect 
of physical functioning on depressive symptoms, adjusted for 25(OH)D, were simultaneously 
modelled. Mediation was examined only in analyses that showed a statistically significant 
relationship between 25(OH)D and depressive symptoms. With these mediation analyses, 
the total effect of 25(OH)D on depressive symptoms was separated into direct and indirect 
effects. The direct effect represents the effect of 25(OH)D on depressive symptoms, adjusted 
for physical functioning, whereas the indirect effect represents the multiplied effects of 
25(OH)D on physical functioning and physical functioning on depressive symptoms, adjusted 
for 25(OH)D. This indirect effect can be seen as the mediating effect of physical functioning 
in the association of 25(OH)D with depressive symptoms32. Because of the usually skewed 
distribution of indirect effects, we used 95% Monte Carlo simulated confidence intervals 
(20,000 replications)33. The mediation analyses were performed separately for physical 
performance and functional limitations and were conducted in the adjusted models (model 2). 
Pooled analyses
In additional secondary analyses, both cohorts were pooled to increase the n and to investigate 
the consistency of the findings. Since the cohorts used different 25(OH)D assays, the 25(OH)D 
values of the older cohort (Nichols assay) were calibrated towards the values of the younger 
cohort (Diasorin assay), using the formula Diasorin = 3.7778 + 0.8889 × Nichols28. The cross-
sectional and longitudinal regression analyses were repeated in the pooled dataset, with 
cohort as additional confounder.
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RESULTS
Of 1320 participants with a 25(OH)D measurement in the older cohort, 38 participants were 
excluded due to missing CES-D scores, leaving 1282 participants available for analysis. In 
this cohort, 217 participants (16.9%) had vitamin D deficiency (25(OH)D <30 nmol/l) and 
400 participants (31.2%) had insufficient 25(OH)D concentrations (30-50 nmol/l). Clinically 
relevant depressive symptoms (CES-D ≥16) were present in 193 participants (15.1%) at 
baseline, in 202 of 1071 participants (18.9%) at 3 years and in 169 of 853 participants (19.8%) 
at 6 years of follow-up. Non-response analyses comparing analyzed participants (n=1282) 
with initially eligible participants who were excluded from the cross-sectional analyses 
(n=227) showed that non-respondents were older (U=104,475.5, P<0.001), less educated 
(U=130,516.0, P=0.02), smoked more (χ2
(2)
=8.9, P=0.01), drank less alcohol (U=121,669.5, 
P<0.001), had more depressive symptoms (U=96,413.0, P=0.01), were less physically active 
(U=74,118.0, P<0.001), had worse cognitive functioning (U=95,058.0, P<0.001) and physical 
performance (U=72,670.5, P<0.001) and more functional limitations (U=87,667.5, P<0.001), 
compared to included participants. Non-response analyses comparing participants who were 
excluded from the longitudinal analyses (n=207) with included participants (n=1075) showed 
similar results as above. Furthermore, excluded participants were more often male (χ2
(1)
=34.6, 
P<0.001) and had more chronic diseases (U=538,854.0, P=0.01).
Of the 739 participants with a 25(OH)D measurement in the younger cohort, two participants 
were excluded from analysis due to either a very high 25(OH)D concentration (182 nmol/l) 
or a missing CES-D score. Of the resulting 737 participants, 56 participants had vitamin D 
deficiency (7.6%) and 243 participants had insufficient vitamin D status (33.0%). Clinically 
relevant depressive symptoms were present in 100 participants (13.6%) at baseline, in 95 
of 703 participants (13.5%) after 3 years and in 69 of 648 participants (10.6%) after 6 years. 
Cross-sectional non-response analyses in this cohort revealed that non-respondents (n=182) 
smoked more (χ2
(2)
=14,5, P=0.001) compared to included participants (n=737). Longitudinal 
non-response analyses showed that excluded participants (n=33) had more depressive 
symptoms (U=39,562.0, P=0.04), were more often smokers (χ2
(2)
=11,3, P=0.004) and had more 
functional limitations (U=33,340.0, P<0.001) compared to included participants (n=704). 
Table 1 displays baseline characteristics of both cohorts.
Cross-sectional analyses
Table 2 presents the results of the baseline regression analyses. Sex was not an effect modifier 
in both cohorts (cohort 1: t(1274)= -1.08 to -1.64, P= 0.10 to 0.28; cohort 2: t(729)= -0.48 to -1.17, 
P= 0.24 to 0.63). In the older cohort, participants with 25(OH)D <50 nmol/l had significantly 
more depressive symptoms compared to participants with 25(OH)D >75 nmol/l (<30 nmol/l: 
ratio=1.25, 95% CI: 1.0-1.5; 30-50 nmol/l: ratio=1.17, 95% CI: 1.0-1.4). However, this 
association was attenuated after adjustment for lifestyle/health variables. Similarly, in the 
younger cohort, no statistically significant cross-sectional relationship between 25(OH)D and 
depressive symptoms was seen in the adjusted model.
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Longitudinal analyses
In the older cohort, the interaction of sex with the third 25(OH)D dummy had a P-value of 
0.052 (t
(1011)
=1.95). As this value was very close to our preset 0.05 cutoff, we decided to stratify 
the mixed-models analyses for men and women, so we would not miss any potentially relevant 
effects (Table 3). No significant associations were observed in men, whereas women in 
baseline 25(OH)D categories below 75 nmol/l experienced more depressive symptoms after 
3 and 6 years, compared to women with 25(OH)D of >75 nmol/l (adjusted model: <30nmol/l: 
ratio=1.23, 95% CI: 1.02-1.49; 30-50 nmol/l: ratio=1.17, 95% CI: 1.00-1.37; 50-75 nmol/l: 
ratio=1.24, 95% CI: 1.06-1.45). Corresponding to these ratios, participants with 25(OH)D 
concentrations below 30 nmol/l had a 23% higher CES-D score over 6 years than persons with 
25(OH)D >75 nmol/l. Similarly, participants with 25(OH)D concentrations of 30-50 nmol/l had 
a 17% higher CES-D score over 6 years, and persons with 25(OH)D concentrations of 50-75 
nmol/l had a 24% higher CES-D score over 6 years compared to persons with 25(OH)D >75 
nmol/l. It should be noted that the overall test of the 25(OH)D categories for the adjusted 
model had a P-value of 0.051 (F
(3,553)
=2.60), but we still interpreted the associations of the 
separate dummy variables as this value was so close to the cutoff. This slightly higher P-value 
was caused by the association of the second dummy (30-50 nmol/l) being less strong than the 
other two dummies.
In the younger cohort, sex was not an effect modifier (t
(686 to 691)
= -0.53 to 0.25, P= 0.60 to 0.89). 
After adjustment for lifestyle/health confounders, a significant relationship between baseline 
25(OH)D and depressive symptoms over time was no longer observed (Table 3).
Time-interaction terms were not significant in both cohorts (cohort 1: t(941 to 1010)= -0.85 to 0.65, 
P= 0.40 to 0.85; cohort 2: t
(670 to 673)
= -0.30 to 0.49, P= 0.63 to 0.77), indicating that the effect 
of 25(OH)D on the course of depressive symptoms did not differ between 3 and 6 years of 
follow-up.
In the logistic regression analysis of the older cohort, sex was an effect modifier for the first 
and third 25(OH)D dummy (Wald(1)=3.96, P=0.047 and Wald(1)=6.83, P=0.009, respectively). 
Hence, the analyses were stratified for men and women. In the stratified analyses, however, 
the overall tests for the association of the 25(OH)D dummies with the onset of depressive 
symptoms were not statistically significant for both men and women (Wald(3)=5.59, P=0.13 and 
Wald(3)=4.78, P=0.19, respectively), so analyses for the separate 25(OH)D dummy variables 
were not performed. However, due to the small number of cases in the stratified analyses, 
the reliability of these results is uncertain. Similarly, in the younger cohort, no associations 
between 25(OH)D and the onset of depressive symptoms were observed (Wald(3)=0.57, 
P=0.90).
58
Chapter 3
Ta
b
le
 1
 | 
B
as
el
in
e 
ch
ar
ac
te
ri
st
ic
s 
o
f t
h
e 
tw
o
 L
A
SA
 c
o
h
o
rt
s
Se
ru
m
 2
5
(O
H
)D
O
ld
er
 c
o
h
o
rt
 (n
=
1
2
8
2
)
Y
o
u
n
ge
r 
co
h
o
rt
 (n
=
7
3
7
)
<
3
0
 n
m
o
l/
l
(n
=
2
1
7
)
3
0
-5
0
 n
m
o
l/
l
(n
=
4
0
0
)
5
0
-7
5
 n
m
o
l/
l
(n
=
4
3
4
)
>
7
5
 n
m
o
l/
l
(n
=
2
3
1
)
<
3
0
 n
m
o
l/
l
(n
=
5
6
)
3
0
-5
0
 n
m
o
l/
l
(n
=
2
4
3
)
5
0
-7
5
 n
m
o
l/
l
(n
=
3
1
0
)
>
7
5
 n
m
o
l/
l
(n
=
1
2
8
)
D
ep
re
ss
iv
e 
sy
m
p
to
m
s
C
ES
-D
 s
co
re
 
9 
[4
-1
5]
7 
[3
-1
3]
5 
[2
-1
0]
4 
[2
-9
]
10
 [3
-1
6]
6 
[3
-1
2]
5 
[2
-1
0]
6 
[2
-9
]
C
ES
-D
 ≥
16
46
 (2
1.
2)
7
0
 (1
7
.5
)
5
2
 (1
2
.0
)
2
5
 (1
0
.8
)
1
5
 (2
6
.8
)
3
8
 (1
5
.6
)
3
2
 (1
0
.3
)
1
5
 (1
1
.7
)
W
o
m
en
 
1
3
5
 (6
2
.2
)
24
0 
(6
0.
0)
20
1 
(4
6.
3)
8
3
 (3
5
.9
)
2
8
 (5
0
.0
)
1
3
5
 (5
5
.6
)
1
5
8
 (5
1
.0
)
7
8
 (6
0
.9
)
A
ge
 (y
ea
rs
)
80
.9
 [7
5.
5-
84
.5
]
76
.3
 [7
0.
9-
82
.1
]
72
.8
 [6
8.
8-
78
.5
]
70
.7
 [6
7.
6-
75
.8
]
61
.7
 [5
8.
0-
63
.2
]
59
.7
 [5
6.
9-
62
.6
]
60
.4
 [5
7.
5-
62
.6
]
59
.5
 [5
6.
6-
62
.0
]
E
d
u
ca
ti
o
n
 (y
ea
rs
) 
9 
[6
-1
1]
9 
[6
-1
1]
9 
[6
-1
1]
9 
[6
-1
1]
11
 [7
-1
5]
10
 [9
-1
2]
10
 [9
-1
1]
10
 [9
-1
1]
Se
as
o
n
 o
f b
lo
o
d
 c
o
lle
ct
io
n
: 
W
in
te
r
14
7 
(6
7.
7)
2
2
6
 (5
6
.8
)
21
5 
(4
9.
7)
10
8 
(4
6.
8)
42
 (7
5.
0)
18
2 
(7
4.
9)
2
1
3
 (6
8
.7
)
8
6
 (6
7
.2
)
Su
m
m
er
7
0
 (3
2
.3
)
17
2 
(4
3.
2)
2
1
8
 (5
0
.3
)
1
2
3
 (5
3
.2
)
14
 (2
5.
0)
6
1
 (2
5
.1
)
9
7
 (3
1
.3
)
42
 (3
2.
8)
Sm
o
ki
n
g 
C
ur
re
nt
45
 (2
0.
7)
7
5
 (1
8
.8
)
6
8
 (1
5
.7
)
42
 (1
8.
2)
2
2
 (3
9
.3
)
8
5
 (3
5
.0
)
7
2
 (2
3
.2
)
2
3
 (1
8
.0
)
Fo
rm
er
75
 (3
4.
6)
16
7 
(4
1.
8)
2
3
1
 (5
3
.2
)
12
1 
(5
2.
4)
2
1
 (3
7
.5
)
10
8 
(4
4.
4)
1
6
1
 (5
1
.9
)
6
7
 (5
2
.3
)
N
ev
er
97
 (4
4.
7)
1
5
8
 (3
9
.5
)
1
3
5
 (3
1
.1
)
68
 (2
9.
4)
1
3
 (2
3
.2
)
5
0
 (2
0
.6
)
77
 (2
4.
8)
3
8
 (2
9
.7
)
A
lc
o
h
o
l c
o
n
su
m
p
ti
o
n
 (g
/w
k)
 
10
 [0
-7
0]
20
 [0
-7
0]
30
 [5
-1
20
]
60
 [1
0-
21
0]
60
 [5
-2
10
]
70
 [2
0-
20
0]
70
 [3
0-
21
0]
70
 [4
5-
21
0]
B
o
d
y 
m
as
s 
in
d
ex
 (k
g/
m
2
) 
26
.8
 [2
3.
5-
29
.6
]
27
.3
 [2
4.
7-
30
.0
]
26
.5
 [2
4.
3-
29
.2
]
25
.6
 [2
3.
4-
28
.2
]
26
.5
 [2
4.
1-
29
.1
]
27
.6
 [2
4.
5-
30
.3
]
26
.6
 [2
4.
2-
29
.1
]
26
.4
 [2
4.
6-
29
.0
]
N
u
m
b
er
 o
f c
h
ro
n
ic
 d
is
ea
se
s 
2 
[1
-3
]
2 
[1
-3
]
2 
[1
-2
]
1 
[1
-2
]
2 
[1
-3
]
1 
[0
-2
]
1 
[0
-2
]
1 
[0
-2
]
C
o
gn
it
iv
e 
fu
n
ct
io
n
in
g 
(M
M
SE
)
27
 [2
4-
28
]
28
 [2
6-
29
]
28
 [2
6-
29
]
28
 [2
7-
29
]
28
 [2
6-
29
]
28
 [2
7-
29
]
28
 [2
7-
29
]
28
 [2
7-
29
]
P
h
ys
ic
al
 a
ct
iv
it
y 
(m
in
/d
) 
21
.4
 [5
.4
-5
4.
3]
38
.6
 [1
5.
0-
65
.4
]
56
.8
 [3
0.
0-
99
.6
]
61
.5
 [2
8.
8-
10
2.
1]
48
.0
 [1
6.
4-
86
.6
]
66
.4
 [3
5.
4-
10
9.
3]
72
.9
 [4
2.
5-
12
9.
5]
62
.9
 [3
7.
9-
11
0.
0]
P
h
ys
ic
al
 p
er
fo
rm
an
ce
a
6 
[2
-8
]
7 
[5
-9
]
9 
[7
-1
0]
9 
[8
-1
1]
6 
[4
-7
]
6 
[5
-7
]
6 
[5
-7
]
6 
[5
-8
]
F
u
n
ct
io
n
al
 li
m
it
at
io
n
s
2 
[0
-4
]
1 
[0
-3
]
0[
0-
2]
0 
[0
-1
]
0 
[0
-2
]
0 
[0
-1
]
0[
0-
0]
0 
[0
-1
]
V
al
u
es
 a
re
 d
is
p
la
ye
d
 a
s 
n 
(%
) f
o
r 
ca
te
go
ri
ca
l v
ar
ia
b
le
s 
o
r 
as
 m
ed
ia
n
 [i
n
te
rq
u
ar
ti
le
 r
an
ge
] f
o
r 
sk
ew
ed
 c
o
n
ti
n
u
o
u
s 
va
ri
ab
le
s.
 2
5
(O
H
)D
: 2
5
-h
yd
ro
xy
vi
ta
m
in
 D
; C
E
S
-D
: C
en
te
r 
fo
r 
E
p
id
em
io
lo
gi
ca
l S
tu
d
ie
s 
D
ep
re
ss
io
n
 S
ca
le
; M
M
S
E
: M
in
i-
M
en
ta
l S
ta
te
 E
xa
m
in
at
io
n
.
a  T
h
e 
p
h
ys
ic
al
 p
er
fo
rm
an
ce
 s
co
re
 r
an
ge
s 
fr
o
m
 0
-1
2
 in
 t
h
e 
o
ld
er
 c
o
h
o
rt
 a
n
d
 f
ro
m
 0
-8
 in
 t
h
e 
yo
u
n
ge
r 
co
h
o
rt
.
59
3
Serum vitamin D, physical functioning and depressive symptoms
Ta
b
le
 2
 | 
C
ro
ss
-s
ec
ti
o
n
al
 a
ss
o
ci
at
io
n
s 
b
et
w
ee
n
 2
5
(O
H
)D
 a
n
d
 d
ep
re
ss
iv
e 
sy
m
p
to
m
s 
in
 t
h
e 
tw
o
 L
A
SA
 c
o
h
o
rt
s
O
ld
er
 c
o
h
o
rt
Y
o
u
n
ge
r 
co
h
o
rt
M
o
d
el
 1
M
o
d
el
 2
M
o
d
el
 1
M
o
d
el
 2
F 
(d
f1
, d
f2
)
P
R
at
io
a  (
SE
)
t (
df
)
P
F(
df
1
, d
f2
)
P
F(
df
1
, d
f2
)
P
R
at
io
a  (
SE
)
t (
df
)
P
F(
df
1
, d
f2
)
P
O
ve
ra
ll
 t
es
t 
o
f 
2
5
(O
H
)D
 
ca
te
go
ri
es
b
3
.9
1
 
(3
, 1
2
7
0
)
0
.0
0
9
2
.1
6
 
(3
, 1
2
3
8
)
0
.0
9
1
3.
40
 
(3
, 7
2
9
)
0
.0
1
7
1
.3
5
 
(3
, 7
1
0
)
0
.2
6
<
3
0
 n
m
o
l/
l
1
.2
5
 (1
.1
0
)
2.
41
 (1
27
0)
0
.0
1
6
1
.3
8
 (1
.1
6
)
2
.2
1
 (7
2
9
)
0
.0
2
8
3
0
-5
0
 n
m
o
l/
l
1
.1
7
 (1
.0
8
)
1
.9
9
 (1
2
7
0
)
0.
04
7
1
.2
0
 (1
.1
0
)
1
.8
7
 (7
2
9
)
0
.0
6
2
5
0
-7
5
 n
m
o
l/
l
0
.9
9
 (1
.0
8
)
-0
.1
0
 (1
2
7
0
)
0
.9
2
1
.0
1
 (1
.1
0
)
0
.0
7
 (7
2
9
)
0.
94
>
7
5
 n
m
o
l/
l
R
ef
er
en
ce
R
ef
er
en
ce
A
n
al
yz
ed
 w
it
h
 m
u
lt
ip
le
 li
n
ea
r 
re
gr
es
si
o
n
 a
n
al
ys
is
. 2
5
(O
H
)D
: 2
5
-h
yd
ro
xy
vi
ta
m
in
 D
; C
E
S
-D
: C
en
te
r 
fo
r 
E
p
id
em
io
lo
gi
ca
l S
tu
d
ie
s 
D
ep
re
ss
io
n
 S
ca
le
.
M
o
d
el
 1
: a
d
ju
st
ed
 f
o
r 
ag
e,
 s
ex
, e
d
u
ca
ti
o
n
 a
n
d
 s
ea
so
n
. 
M
o
d
el
 2
: a
d
d
it
io
n
al
ly
 a
d
ju
st
ed
 f
o
r 
sm
o
ki
n
g,
 a
lc
o
h
o
l u
se
, B
M
I, 
ch
ro
n
ic
 d
is
ea
se
s,
 c
o
gn
it
iv
e 
fu
n
ct
io
n
in
g 
an
d
 p
h
ys
ic
al
 a
ct
iv
it
y.
a 
A
s 
th
e 
o
u
tc
o
m
e 
va
ri
ab
le
 w
as
 ln
(1
+
C
E
S
D
), 
B
s 
an
d
 S
E
s 
w
er
e 
tr
an
sf
o
rm
ed
 b
ac
k 
to
 n
o
rm
al
 s
ca
le
 t
o
 o
b
ta
in
 in
te
rp
re
ta
b
le
 r
at
io
s.
 
b
 T
h
e 
in
d
iv
id
u
al
 2
5
(O
H
)D
 c
at
eg
o
ri
es
 w
er
e 
te
st
ed
 o
n
ly
 if
 t
h
e 
o
ve
ra
ll 
te
st
 o
f 
th
e 
ca
te
go
ri
es
 w
as
 s
ta
ti
st
ic
al
ly
 s
ig
n
if
ic
an
t.
 
60
Chapter 3
Ta
b
le
 3
 | 
Lo
ng
it
ud
in
al
 a
ss
oc
ia
ti
on
s 
be
tw
ee
n 
25
(O
H
)D
 a
nd
 d
ep
re
ss
iv
e 
sy
m
pt
om
s 
in
 th
e 
ol
de
r 
LA
SA
 c
oh
or
t, 
st
ra
ti
fie
d 
fo
r 
se
x 
(A
), 
an
d 
in
 th
e 
yo
un
ge
r 
LA
SA
 c
oh
or
t (
B
)
M
o
d
el
 1
M
o
d
el
 2
M
o
d
el
 1
M
o
d
el
 2
F 
(d
f1
, d
f2
)
P
R
at
io
a  (
SE
)
t (
df
)
P
F 
(d
f1
, d
f2
)
P
R
at
io
a 
(S
E)
 
t (
df
)
P
F 
(d
f1
, d
f2
)
P
F 
(d
f1
, d
f2
)
P
A
. O
ld
er
 c
o
h
o
rt
W
o
m
en
M
en
O
ve
ra
ll
 t
es
t 
o
f 
2
5
(O
H
)D
 
ca
te
go
ri
es
b
3
.3
5
  
(3
, 5
6
7
)
0
.0
1
9
2
.6
0
  
(3
, 5
5
3
)
0
.0
5
1
0.
77
 (3
, 4
80
)
0
.9
7
0.
12
 (3
, 4
64
)
0
.9
5
<
3
0
 n
m
o
l/
l
1
.3
0
 (1
.1
0
)
2
.6
9
 (5
6
9
)
0
.0
0
7
1
.2
3
 (1
.1
0
)
2
.1
3
 (5
5
3
)
0.
03
4
3
0
-5
0
 n
m
o
l/
l
1
.2
3
 (1
.0
8
)
2.
61
 (5
45
)
0
.0
0
9
1
.1
7
(1
.0
8
)
1
.9
2
 (5
3
2
)
0
.0
5
5
5
0
-7
5
 n
m
o
l/
l
1
.2
6
 (1
.0
8
)
2.
92
 (5
44
)
0.
00
4
1.
24
 (1
.0
8)
2
.7
0
 (5
3
0
)
0
.0
0
7
>
7
5
 n
m
o
l/
l
R
ef
er
en
ce
R
ef
er
en
ce
B
. Y
o
u
n
ge
r 
co
h
o
rt
A
ll
O
ve
ra
ll
 t
es
t 
o
f 
2
5
(O
H
)D
 
ca
te
go
ri
es
b
3
.6
2
  
(3
, 6
8
6
)
0
.0
1
3
1
.9
1
  
(3
, 6
7
0
)
0
.1
3
<
3
0
 n
m
o
l/
l
1
.3
1
 (1
.1
2
)
2.
46
 (6
87
)
0.
01
4
3
0
-5
0
 n
m
o
l/
l
0
.9
9
 (1
.0
7
)
-0
.1
8
 (6
8
8
)
0
.8
6
5
0
-7
5
 n
m
o
l/
l
0.
94
 (1
.0
7)
-0
.8
5
 (6
8
9
)
0.
40
>
7
5
 n
m
o
l/
l
R
ef
er
en
ce
A
n
al
yz
ed
 w
it
h
 li
n
ea
r 
m
ix
ed
-m
o
d
el
s 
an
al
ys
is
, w
it
h
 t
h
e 
C
E
S
-D
 s
co
re
 a
ft
er
 3
 a
n
d
 6
 y
ea
rs
 a
s 
o
u
tc
o
m
e 
an
d
 b
as
el
in
e 
C
E
S
-D
 a
s 
co
va
ri
at
e.
 2
5
(O
H
)D
: 2
5
-h
yd
ro
xy
vi
ta
m
in
 D
; C
E
S
-D
: C
en
te
r 
fo
r 
E
p
id
em
io
lo
gi
ca
l S
tu
d
ie
s 
D
ep
re
ss
io
n
 S
ca
le
.
M
o
d
el
 1
: a
d
ju
st
ed
 f
o
r 
ag
e,
 (s
ex
,) 
ed
u
ca
ti
o
n
 a
n
d
 s
ea
so
n
. 
M
o
d
el
 2
: a
d
d
it
io
n
al
ly
 a
d
ju
st
ed
 f
o
r 
sm
o
ki
n
g,
 a
lc
o
h
o
l u
se
, B
M
I, 
ch
ro
n
ic
 d
is
ea
se
s,
 c
o
gn
it
iv
e 
fu
n
ct
io
n
in
g 
an
d
 p
h
ys
ic
al
 a
ct
iv
it
y.
a 
A
s 
th
e 
o
u
tc
o
m
e 
va
ri
ab
le
 w
as
 ln
(1
+
C
E
S
D
), 
B
s 
an
d
 S
E
s 
w
er
e 
tr
an
sf
o
rm
ed
 b
ac
k 
to
 n
o
rm
al
 s
ca
le
 t
o
 o
b
ta
in
 in
te
rp
re
ta
b
le
 r
at
io
s.
 
b
 T
h
e 
in
d
iv
id
u
al
 2
5
(O
H
)D
 c
at
eg
o
ri
es
 w
er
e 
te
st
ed
 o
n
ly
 if
 t
h
e 
o
ve
ra
ll 
te
st
 o
f 
th
e 
ca
te
go
ri
es
 w
as
 s
ta
ti
st
ic
al
ly
 s
ig
n
if
ic
an
t.
 
61
3
Serum vitamin D, physical functioning and depressive symptoms
Mediation of physical functioning
The mediation analyses for physical performance and functional limitations were performed 
for the longitudinal mixed-models analysis of the older women, as this analysis was statistically 
significant (Table 4). The indirect effect (mediation effect) of physical performance was 
statistically significant for the 30-50 nmol/l 25(OH)D category, compared to the reference 
category of >75 nmol/l (ratio of indirect effect: 1.03, bootstrapped 95% CI: 1.0-1.1). The 
corresponding percentage mediation of 20.6% suggests that physical performance after 3 years 
partially mediates the longitudinal association between 25(OH)D and depressive symptoms. 
The indirect effects of the other 25(H)D categories of physical performance and the indirect 
effects of functional limitations were not statistically significant, but the substantial mediation 
percentages of the <30 and 30-50 nmol/l categories suggest that physical functioning may 
have a modest mediating role in the relationship between 25(OH)D and depressive symptoms. 
Table 4 | Mediation effects of physical functioning (after 3 years) in the longitudinal association between 
baseline 25(OH)D and depressive symptoms over 6 years in women of the older LASA cohort
Physical performance Functional limitations
Serum 25(OH)D Indirect effect a 95% CI b % mediationc Indirect effect a 95% CI b % mediationc
<30 nmol/l 1.03 0.99-1.07 12.4 1.04 0.99-1.09 16.7
30-50 nmol/l 1.03* 1.00-1.07 20.6 1.02 0.99-1.06 13.3
50-75 nmol/l 1.01 0.98-1.04 3.3 1.02 0.98-1.05 7.4
>75 nmol/l Reference Reference
As the outcome variable was ln(1+CESD), the Bs and confidence intervals of the indirect effects were transformed 
back to normal scale to obtain interpretable ratios. Mediation analyses were performed in the adjusted model 2. 
25(OH)D: 25-hydroxyvitamin D; CI: confidence interval.
a The indirect effect is the mediating effect of physical functioning on the association between 25(OH)D and 
depressive symptoms. It represents the multiplied effects of 25(OH)D on physical functioning and physical 
functioning on depressive symptoms, adjusted for 25(OH)D. 
b Bootstrapped confidence intervals with Monte Carlo simulation. 
c Percentage mediation calculated by (indirect effect / total effect)×100. Total effects are displayed in Table 3. 
*Statistically significant indirect effect using the bootstrapped confidence interval.
Pooled analyses
The cross-sectional and longitudinal regression analyses were repeated in the pooled 
dataset. Cross-sectionally, participants in 25(OH)D categories up to 50 nmol/l experienced 
significantly more depressive symptoms than participants with 25(OH)D >75 nmol/l in the 
adjusted model (<30nmol/l: ratio=1.20, 95% CI: 1.03-1.40; 30-50 nmol/l: ratio=1.16, 95% CI: 
1.03-1.30; Supplemental Table 1). Corresponding to these ratios, participants with 25(OH)D 
<30 nmol/l had a 20% higher CES-D score than persons with 25(OH)D >75 nmol/l. Similarly, 
participants with 25(OH)D concentrations of 30-50 nmol/l had a 16% higher CES-D score 
compared to persons with 25(OH)D >75 nmol/l. The longitudinal pooled analyses revealed 
no significant associations between 25(OH)D and depressive symptoms in the adjusted 
models (Supplemental Table 2). Due to multiple cohort differences, these results should be 
interpreted with caution.
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Sensitivity analysis
As an additional sensitivity analysis, we examined whether the results would be different if we 
excluded participants who indicated that their physical activity pattern (confounder, LAPAQ) 
of the previous weeks was not representative of the previous year. We repeated the tests for 
interaction of sex and the cross-sectional and longitudinal regression analyses without these 
participants (-28.2% and -31.4% in the older and younger cohort, respectively) and the results 
were very similar to the original analyses and the conclusions did not change (results not 
shown but available from the author on request).
DISCUSSION
This study investigated the baseline and prospective 6-year association between 25(OH)D 
concentrations and depressive symptoms in two large population-based cohorts of older adults. 
Cross-sectionally, this association was not significant after adjustment for confounders, 
although the longitudinal analyses revealed a difference between men and women in the older 
cohort (≥65 years at baseline): women with 25(OH)D concentrations <75 nmol/l at baseline 
experienced 17-24% more depressive symptoms in the following 6 years than women with 
25(OH)D >75 nmol/l. Low physical performance partially mediated this relationship. No 
such associations were observed in men or in the younger cohort (55-65 years at baseline). 
According to Geerlings et al.34, a change of 5 points in the CES-D score can be regarded as 
a meaningful change in depressive symptoms. Hence, it depends on the initial CES-D score 
whether change in 25(OH)D status is associated with a meaningful change in depressive 
symptoms over 6 years. Higher initial CES-D scores are associated with more relevant change.
The observed differences between the two cohorts could be explained by the better general 
health status of the younger cohort. These participants had higher 25(OH)D concentrations, 
better physical functioning, fewer chronic diseases and were physically more active compared 
to the older cohort. This may have enabled the younger persons to better withstand negative 
effects of low 25(OH)D on mood. On the other hand, the smaller sample size of the younger 
cohort may have limited the power of our analyses.
To increase power and to investigate the consistency of the results, both cohorts were pooled 
in secondary analyses. Cross-sectionally, these analyses demonstrated significantly more 
depressive symptoms in persons with lower 25(OH)D concentrations (up to 20%), confirming 
the consistency of the associations in both cohorts. In the longitudinal pooled analyses however, 
the associations were not statistically significant. By comparing the longitudinal analyses of 
the separate and pooled cohorts, it was seen that the associations of the separate cohorts 
seemed to cancel each other out in the pooled analyses, especially in the 30-50 and 50-75 
nmol/l categories (data not shown but available from author on request). This may be explained 
by considerable cohort differences regarding health status and assessment periods. Due to 
cohort differences, the results of the pooled analyses should be interpreted with caution.
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In the older cohort, a longitudinal association between baseline 25(OH)D and the course of 
depressive symptoms was observed in women only. This sex difference could be attributable 
to the generally lower 25(OH)D concentrations in women compared to men (25(OH)D <50 
nmol/l in 56.9% of women and 38.9% of men). Milaneschi et al.6 found a similar sex difference 
in the InCHIANTI study. In contrast, no interaction with sex was observed in the Health ABC 
study8.
We hypothesized that low vitamin D status would reduce physical functioning, which in turn 
would increase depressive symptoms14,15,18-20. Indeed, we observed partial mediation of the 
association of 25(OH)D with depressive symptoms by physical performance in secondary 
analyses. This provides evidence for a potential mediating role of physical functioning in 
the relationship between low 25(OH)D and increasing depressive symptoms. To the best of 
our knowledge, this explanatory role has not previously been investigated prospectively. At 
most, these variables were treated as confounders in former studies6-9,35. The influence of 
physical functioning may in fact be an important reason why we did not observe significant 
associations in men and in the younger participants. Men in the older cohort had better 
physical performance than women (U=174,121.0, P<0.001). Similarly, participants in the 
younger cohort generally had higher physical function scores compared to the older cohort 
(see Table 1). It can be speculated that having adequate physical functioning may act as a 
‘buffer’ to safeguard older persons from the negative impact of low 25(OH)D on their mood. It 
should be noted that this mediating role of physical functioning is still exploratory and should 
be confirmed by other studies.
Hoogendijk et al.2 partly used the same data as the present study and did find a significant cross-
sectional association between depression status and 25(OH)D concentrations. This disparity 
can be explained by their use of different confounders and different operationalization of 
depression. Hoogendijk categorized depression status into ‘no depression’ (CESD <16), ‘minor 
depression’ (CESD ≥16) and ‘MDD’ (diagnosis after psychiatric interview) and analyzed it 
as determinant instead of an outcome. We chose not to use the MDD variable as outcome, 
because the number of participants with MDD is very limited within the LASA study, which 
would substantially reduce the power of our analyses.
The present study combines several strengths. The use of data from two large, population-
based, independent cohorts with a long follow-up increases the value and generalizability 
of our results. In addition, we studied the influence of 25(OH)D on the severity, course and 
onset of depressive symptoms using both cross-sectional and longitudinal analysis techniques, 
adjusted for relevant confounders. By studying 25(OH)D at baseline, physical functioning 
after 3 years and depressive symptoms over 6 years, we explored the potential mediating role 
of physical functioning longitudinally. This method takes into account the temporal character 
of the underlying mechanism. To the best of our knowledge, this is the first study that explored 
physical functioning as a possible mediating factor in the relationship between vitamin D 
status and depressive symptoms.
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This study also has some limitations. Serum 25(OH)D was only measured at baseline, although 
it was shown that 25(OH)D concentrations are relatively stable over time28,36. Furthermore, as 
depressive symptoms were measured only once every 3 years, we did not have information 
about intermediate time points. Because of the fluctuating nature of depression, we may have 
missed episodes of depressive symptoms. Unfortunately, some potential confounders were 
not measured in the LASA measurement cycles that we used. Because of this, we were unable 
to adjust for variables such as diet and vitamin D supplement use, possibly resulting in residual 
confounding. Furthermore, over 99% of LASA participants are Caucasian28, which may have 
limited the generalizability of our findings to other ethnicities, as evidence suggests that 
polymorphisms of the vitamin D binding protein and hence bioavailability of vitamin D may 
differ between ethnicities37 (but see Nielson et al.38). The non-response analyses showed that 
included participants were healthier than excluded persons, which may limit generalizability. 
In addition, the physical activity measure (LAPAQ) only gives information about activities in 
the previous 2 weeks, and no information about the longer-term habitual activity pattern 
of the participants. Therefore, we conducted a sensitivity analysis without participants who 
indicated that their activities were not representative for the previous year. Results of these 
analyses were similar to the regular analyses. Although this suggests that lack of information 
on past-year physical activity does not influence the conclusions, it cannot be ruled out that 
longer-term habitual physical activity may still be a potential confounding factor. 
It should also be noted that we decided to interpret the associations of the separate 25(OH)D 
dummy variables for the women of the older cohort, although the test for the overall effect 
had a P-value of 0.051, which was just above the cutoff of 0.05. This P-value was slightly higher 
because the association of the second dummy (30-50 nmol/l) was less strong compared to 
the other two dummies. In this case, the potential clinical relevance of the findings made us 
decide to interpret the separate dummy associations after all. Replication of our findings by 
future research is therefore especially important in this case. Finally, cohort differences, such 
as different time periods and 25(OH)D assays, may have compromized the comparability of 
the two cohorts.
In conclusion, this study showed that older women with 25(OH)D concentrations below 75 
nmol/l at baseline experienced 17-24% more depressive symptoms over 6 years, compared to 
women with 25(OH)D concentrations >75 nmol/l. This relationship may be partially explained 
by reduced physical functioning. To the best of our knowledge, this longitudinal mediating role 
of physical functioning has not been studied before. Our results suggest that having 25(OH)D 
concentrations >75 nmol/l and adequate physical functioning is especially important for the 
mental health of older women. Randomized controlled trials investigating both vitamin D 
supplementation and behavioral interventions to improve physical functioning should 
examine the causality of these associations further, which may aid treatment or prevention 
strategies for depression.
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Supplemental Table 1 | Cross-sectional associations between 25(OH)D and depressive symptoms in the 
pooled analysis of the two LASA cohorts
Model 1 Model 2
F (df1, df2) P
Ratioa 
(SE)
t (df) P F (df1, df2) P
Ratioa 
(SE) 
t (df) P
Overall test of 
25(OH)D 
categoriesb
6.98  
(3, 2006)
<0.001
3.58  
(3, 1962)
0.013
<30 nmol/l
1.33 
(1.08)
3.50 
(2006)
<0.001
1.20 
(1.08)
2.30 
(1962)
0.022
30-50 nmol/l
1.21 
(1.06)
3.22 
(2006)
0.001
1.16 
(1.06)
2.55 
(1962)
0.011
50-75 nmol/l
1.04 
(1.06)
0.72 
(2006)
0.473 1.03 
(1.06)
0.58 
(1962)
0.563
>75 nmol/l Reference Reference
Analyzed with multiple linear regression analysis. 25(OH)D: 25-hydroxyvitamin D; CES-D: Center for Epidemiological 
Studies Depression Scale.
Model 1: adjusted for age, gender, education, season and cohort. 
Model 2: additionally adjusted for smoking, alcohol use, BMI, chronic diseases, cognitive functioning and physical 
activity. 
a As the outcome variable was ln(1+CESD), Bs and SEs were transformed back to normal scale to obtain interpretable 
ratios. 
b The individual 25(OH)D categories were tested only if the overall test of the categories was statistically significant. 
Supplemental Table 2 | Longitudinal associations between 25(OH)D and depressive symptoms in the pooled 
analysis of the two LASA cohorts, stratified for sex
Women Men
Model 1 Model 2 Model 1 Model 2
F (df1, df2) P F (df1, df2) P F (df1, df2) P F (df1, df2) P
Overall test of  
25(OH)D categories
1.26 (3, 953) 0.29 0.54 (3, 930) 0.65 2.09 (3, 804) 0.10 1.50 (3, 785) 0.21
Analyzed with linear mixed-model analysis, with the CES-D score after 3 and 6 years as outcome and baseline CES-D 
as covariate. 25(OH)D: 25-hydroxyvitamin D; CES-D: Center for Epidemiological Studies Depression Scale.
Model 1: adjusted for age, education, season and cohort. 
Model 2: additionally adjusted for smoking, alcohol use, BMI, chronic diseases, cognitive functioning and physical 
activity.
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ABSTRACT
Objective
Previous prospective studies on the association between vitamin D status and depression 
used a single 25-hydroxyvitamin D (25(OH)D) measurement. We investigated the 
association between change in serum 25(OH)D and parallel change in depressive symptoms 
over time in Dutch older adults.
Design
A population-based, prospective study in two cohorts of older men and women from the 
Longitudinal Aging Study Amsterdam.
Methods
Serum 25(OH)D concentrations were determined at two time points: in 1995/1996 and 
13 years later in the older cohort (aged 65-88y, n=173), and in 2002/2003 and 6 years 
later in the younger cohort (55-65y, n=450). At these time points, depressive symptoms 
were measured with the Center for Epidemiologic Studies Depression scale (CES-D). 
Associations were tested by multiple linear regression analyses.
Results
During follow-up, serum 25(OH)D concentrations increased in 32.4% of the older cohort 
and 69.8% of the younger cohort. In the older cohort, change in 25(OH)D was not associated 
with change in CES-D score. In the younger cohort, no associations were observed in 
participants with higher baseline 25(OH)D concentrations (>58.6 nmol/l), but in those 
with lower baseline 25(OH)D concentrations, an increase in 25(OH)D was associated with 
a decrease in CES-D score (adjusted B per 10 nmol/l 25(OH)D increase: -0.62 (95% CI:
-1.17, -0.07)).
Conclusions
Our study suggests that over 6 years an increase in serum 25(OH)D is associated with a 
small decrease in depressive symptoms in young older adults with lower baseline 25(OH)D. 
Well-designed intervention trials are required to determine causality.
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INTRODUCTION
Depression is a major cause of disability and common in older adults1,2. Clinically relevant 
depressive symptoms affect 8 to 16% of the community-dwelling older population, and 
prevalence estimates of major depression in this population range from 1 to 4%3. Depression 
has adverse health consequences, such as disability, cardiovascular disease, diabetes and 
premature death, as well as social and economic consequences4. However, the aetiology of 
late-life depression is poorly understood.
Several pathways are involved in the aetiology of late-life depression. Vitamin D, a neurosteroid 
hormone, may play a role in the development of depression, as vitamin D receptors and the 
activating enzyme 1-α-hydroxylase are present in areas of the human brain that are related to 
mood5,6. In addition, the active metabolite of vitamin D, 1,25-dihydroxyvitamin D, influences 
the synthesis of monoamine neurotransmitters such as serotonin. This metabolite also 
affects the regulation of neurotrophic factors and stimulates anti-inflammatory actions in the 
brain6-8. Low serum 25-hydroxyvitamin D (25(OH)D) concentrations are highly prevalent in 
older adults, as a result of reduced exposure to sunlight, a decreased efficiency of the skin to 
synthesise vitamin D
3
 and lower dietary intake9.
Previous research has suggested an association between vitamin D status and depression. In 
many cross-sectional studies, lower 25(OH)D concentrations were associated with a higher risk 
of depressive symptoms or depressione.g. 10,11, while in others, vitamin D and depression were 
not associated12,13. Prospective studies showed a higher incidence of depressive symptoms or 
depression over 1 to 6 years in older persons who had low baseline vitamin D levels14-18. However, 
no prospective associations were found over 4 to 15 years in older adults19,20, older men21,22, 
and adults23. Similarly, we recently found no cross-sectional and prospective associations of 
serum 25(OH)D concentrations with depressive symptoms in Dutch older men and women, 
except for a higher risk of depressive symptoms over 6 years in older women with baseline 
25(OH)D concentrations below 75 nmol/l24. Differences in measures of vitamin D status and 
depression, study populations, analysis techniques, covariates and latitude may have given rise 
to these inconsistencies. Furthermore, experimental studies have found inconsistent results 
as welle.g. 25,26. Meta-analyses of randomised controlled trials (RCTs) did not find support for 
the efficacy of vitamin D supplementation in depression; however, heterogeneity between the 
included trials was high27-30. A recent review on observational studies and RCTs has indicated 
that vitamin D deficiency may be a risk factor for late-life depression based on observational 
data but not on experimental data31. 
Previous research thus shows that the potentially causal role of vitamin D status in depression 
risk is currently not clear. Next to well-designed RCTs, prospective studies are of interest to 
gain a better insight into this association in the general population. One of the limitations of all 
previous prospective studies is that only a single measurement of serum 25(OH)D was used14-24. 
Vitamin D levels vary due to changes in sunlight exposure, diet and supplement use32,33; 
therefore, multiple intra-individual measurements are needed for a better understanding 
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of the longitudinal association. To date, no prospective study has addressed the association 
between changes in serum 25(OH)D concentrations and changes in depressive symptoms 
over time. Within two cohorts of the Longitudinal Aging Study Amsterdam (LASA), repeated 
measurements of serum 25(OH)D and depressive symptoms provided the opportunity to 
prospectively study whether changes in serum 25(OH)D over time are associated with parallel 
changes in depressive symptoms in Dutch older adults. We hypothesised that an increase in 
25(OH)D concentration would lead to a decrease in severity of depressive symptoms.
SUBJECTS AND METHODS
Study population
LASA is an ongoing Dutch cohort study on the determinants, trajectories and consequences 
of physical, cognitive, emotional and social functioning in relation to aging. Participants 
were recruited from three geographic regions in the Netherlands, constituting a nationally 
representative sample of the Dutch older population. Measurement cycles are carried out 
every 3 years at the participants’ homes, including a main interview, medical interview and 
questionnaire. The Medical Ethics Committee of the VU University Medical Center (VUmc) 
approved the study, and all participants gave informed consent. A detailed description of the 
sampling and data collection procedures can be found elsewhere34,35. 
Participants
For the present study, data from two LASA cohorts were used. At LASA’s start in 1992/1993, 
3107 subjects aged 55-85 years were enrolled in the first cohort (‘older cohort’). At the 
second measurement cycle (1995/1996, ‘baseline’ of this cohort), persons aged ≥65 years who 
participated in the medical interview (n=1509) were asked to donate a blood sample. Serum 
25(OH)D concentration was measured in 1320 persons. Serum 25(OH)D was again measured 
13 years later (2008/2009, n=390). For this study, persons with 25(OH)D measurements at 
both cycles were selected (n=175). Two persons were excluded because of missing data on 
baseline covariates, resulting in an analytical sample of 173 persons. The recruitment and 
exclusion of persons from the older cohort are shown in Figure 1A; attrition was mainly due 
to mortality (63.0%)34.
In 2002/2003, a second LASA cohort was recruited consisting of 1002 persons aged 55-
65 years (‘younger cohort’). The medical interview was completed by 919 persons. Serum 
25(OH)D concentration was measured in 2002/2003 (baseline, n=739) and 6 years later 
(2008/2009, n=525). A total of 458 persons had 25(OH)D measurements at both cycles, of 
which 8 were excluded due to missing data on the Center for Epidemiologic Studies Depression 
scale (CES-D) at follow-up (n=1) or on baseline covariates (n=7). The recruitment and exclusion 
of persons from the younger cohort are shown in Figure 1B.
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Figure 1 | Flowcharts of the older cohort (A) and the younger cohort (B). 
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; CES-D, Center for Epidemiologic Studies Depression scale. 
Depression measurements
At all measurement cycles, depressive symptoms were assessed by the CES-D, a 20-item self-
report scale about depressive symptoms experienced in the previous week36. The CES-D has 
been widely used in older population-based samples, and is a valid and reliable instrument 
for Dutch older adults37. Total scores range from 0 to 60, with a higher score indicating more 
depressive symptoms. Change in depressive symptoms over 13 or 6 years was calculated by 
subtracting the CES-D score at baseline from the score at the follow-up cycle. 
25(OH)D measurements
Morning blood samples were drawn in 1995/1996 (older cohort) and 2002/2003 (younger 
cohort). Participants were allowed to have tea and toast for breakfast, but no dairy products. 
In 2009 (both cohorts), fasting blood samples were drawn: participants were not allowed to 
take any food or drink from midnight. All samples were centrifuged and stored at -20°C until 
25(OH)D determination in 1997/1998 (1995/1996 samples) and in 2010/2011 (2002/2003 
and 2009 samples). A competitive protein-binding assay was used in 1997/1998 (Nichols 
Diagnostics Capistrano, CA, USA; interassay coefficient of variation (CV): 10%), whereas a 
radioimmunoassay was used in 2010/2011 (Diasorin, Stillwater, Minnesota, USA; interassay 
CV: 10%). All measurements were carried out at the Endocrine Laboratory of the VUmc.
A B
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Before change in 25(OH)D concentration could be calculated, the 25(OH)D measurements 
needed to be (1) standardised for assay and (2) corrected for season. First, as part of the 
7th Framework Programme project ODIN, all serum 25(OH)D data have been standardised 
by applying the Vitamin D Standardisation Program protocols38,39. Without differences in 
assay, 25(OH)D change can be properly calculated30. Second, individual concentrations were 
deseasonalised before calculating the intra-individual change, as blood samples were drawn 
throughout the year and 25(OH)D concentrations vary across seasons (highest in summer and 
autumn, lowest in winter and spring) due to changes in ultraviolet radiation exposure32,40. For 
this, a sinusoidal regression model was fitted:
Original 25(OH)D concentration = β
0
 + β
1
 sin(2πT / 365.25) + β
2
 cos(2πT / 365.25)
where original 25(OH)D concentration denotes the standardised 25(OH)D concentration, T 
denotes the day of the year of blood draw and β
j
 (j=0, 1, 2) are estimated regression coefficients. 
To obtain individual deseasonalised 25(OH)D concentrations, the residuals (difference between 
the predicted value and the original value) from this model were added to the annual mean of 
the model (the intercept: β
0
)41,42. In this way, the seasonal variation of 25(OH)D concentration 
was adjusted for. Deseasonalising was performed separately for each cohort and each 
measurement cycle: for 1995/1996 and 2009 for the older cohort, and for 2002/2003 and 
2009 for the younger cohort. Subsequently, intra-individual change in 25(OH)D concentration 
was calculated by subtracting the standardised, deseasonalised 25(OH)D concentration at 
baseline from the standardised, deseasonalised 25(OH)D concentration at follow-up (13 or 
6 years later). Unless otherwise specified, standardised, deseasonalised 25(OH)D data were 
used and reported in this study.
Other variables
Potential confounders were examined at baseline and included sex, age, education level, 
body mass index (BMI), smoking status, alcohol use, physical activity and number of chronic 
diseases. Data on sex and age were derived from municipal registries. Participants were asked 
about their highest completed level of education, and this was converted into education years. 
BMI was calculated as measured body weight (in kg) divided by squared measured body height 
(in m). Self-reported smoking status was categorised into never, former and current smoking. 
Categories of self-reported alcohol use were no, light, moderate and (very) excessive43. Physical 
activity during the past 2 weeks (walking outdoors, cycling, sports and heavy household 
activities, in min/d) was assessed using the validated LASA Physical Activity Questionnaire44. 
Self-reported number of chronic diseases included seven major somatic diseases: asthma/
chronic obstructive pulmonary disease, cardiac disease, peripheral arterial disease, diabetes 
mellitus, cerebrovascular accident/stroke, osteoarthritis/rheumatoid arthritis and cancer. Use 
of antidepressants (yes/no, only used in sensitivity analyses) was retrieved using ATC-codes of 
the medication names that the participants provided during the medical interview. 
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Statistical analyses 
As age range and follow-up time between the two cycles differed between the two cohorts, 
all analyses were conducted separately for each cohort. Absolute change in 25(OH)D 
concentrations was calculated over 13 years (older cohort) and over 6 years (younger cohort). 
Absolute change in CES-D score was also calculated over these time periods and checked 
for normality. Paired-samples t-tests were performed to assess whether changes over time 
in 25(OH)D and CES-D were statistically significant. Serum 25(OH)D change was used as 
continuous determinant, expressed per 10 nmol/l. To compare participants with relatively 
large 25(OH)D decreases with those with large increases, it was also divided in tertiles 
with tertile 3 (increase in 25(OH)D concentration) serving as reference category. For the 
continuous baseline characteristics, linear regression analyses were used to examine linear 
trends across the tertiles of 25(OH)D change. For the categorical variables, chi-square (linear-
by-linear association) tests were performed to test for trend.
The associations between change in 25(OH)D and change in depressive symptoms over 13 or 
6 years were analysed by multivariable linear regression analysis. Based on previous studies 
on 25(OH)D and depression11,14,15,24, sex was examined as a potential effect modifier. Another 
potential effect modifier was baseline serum 25(OH)D concentration, as this may influence 
the change in serum 25(OH)D45. Effect modification was tested by including sex or baseline 
serum 25(OH)D (dichotomous, median-split) and the interaction term of the potential effect 
modifier with 25(OH)D change in the unadjusted regression models. A P-value <0.10 of the 
interaction term(s) was considered statistically significant. Three models were made: model 1 
was adjusted for baseline serum 25(OH)D (to interpret the regression coefficient for subjects 
with the same 25(OH)D concentration at baseline), model 2 was additionally adjusted for 
age, sex and education level, and model 3 was additionally adjusted for the lifestyle factors 
BMI, physical activity, alcohol use and smoking. To test linear trends across the tertiles, the 
categorical tertile variable was used as a continuous variable to retrieve a P-value for trend.
Three sensitivity analyses were conducted. First, all analyses were additionally adjusted for 
number of chronic diseases in a separate model, as this covariate might confound and/or 
mediate the association causing potential overadjustment. Second, in order to check whether 
changes in lifestyle factors affect the association, model 3 was additionally adjusted for the 
changes in BMI, physical activity (both absolute continuous change), alcohol use and smoking 
(both categorical: stable, increase, decrease). Third, all analyses were repeated after exclusion 
of participants who used antidepressants at baseline or at one or more of the measurement 
cycles during the follow-up period. 
All analyses were performed using SPSS version 23 (SPSS Inc. Chicago, IL, USA). A double-
sided P-value of <0.05 was considered statistically significant.
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RESULTS
Baseline characteristics
Participants from the older cohort (n=173) had a median age of 68.9 years (interquartile range 
(IQR): 67.0-72.3) and the mean baseline deseasonalised serum 25(OH)D was 58.2 nmol/l 
(standard deviation (SD): 16.1) (Table 1). The median age of participants from the younger 
cohort (n=450) was 59.8 years (IQR: 57.0-62.2) and their mean baseline deseasonalised serum 
25(OH)D was 59.5 nmol/l (SD: 17.9). When comparing the 25(OH)D change tertiles from the 
older cohort, participants from tertile 1 tended to be more educated and tended to drink more 
alcohol compared to the other tertiles. In the younger cohort, participants from tertile 1 were 
more often women and tended to have more chronic diseases.
Comparison of included (n=173) and excluded (n=1336, Figure 1A) participants from the 
older cohort showed that excluded participants had lower 25(OH)D concentrations (P<0.001), 
more depressive symptoms (P<0.001), were older (P<0.001), less physically active (P<0.001), 
more often smokers (P=0.002), drank less alcohol (P<0.001) and had more chronic diseases 
(P<0.001). In the younger cohort, this comparison showed that excluded participants (n=469, 
Figure 1B) had more depressive symptoms (P=0.044), were more often smokers (P=0.004) and 
had more chronic diseases (P=0.019) compared to included participants (n=450). 
Absolute change in serum 25(OH)D concentrations and depressive symptoms
Figure 2 shows the absolute, intra-individual change in serum 25(OH)D over 13 years for the 
older cohort and over 6 years for the younger cohort. The difference in distribution between 
the two cohorts becomes clear from the cutoff values of the tertiles. In the older cohort, 117 
participants (67.6%) experienced a decrease in 25(OH)D concentration, whereas this was 
172 (38.2%) in the younger cohort. Mean 25(OH)D of participants from the older cohort 
decreased by 6.9 nmol/l (SD: 20.9, P<0.001). The mean CES-D score increased during the same 
time period by 2.0 points (SD: 6.5, P<0.001), suggesting increasing depressive symptoms over 
time. In the younger cohort, mean 25(OH)D increased by 5.5 nmol/l (SD: 17.8, P<0.001), and 
the mean CES-D score decreased by 0.7 points (SD: 6.5) over 6 years (P<0.027). Change in 
depressive symptoms was normally distributed in both cohorts.
Association between change in serum 25(OH)D and change in depressive symptoms
In the older cohort, change in serum 25(OH)D (as continuous determinant) was not associated 
with change in CES-D score after adjustment for baseline 25(OH)D concentration. Similarly, 
tertiles of 25(OH)D change did not show an association, and the P for trend was not statistically 
significant (0.246). No interactions with sex and baseline 25(OH)D were observed.
In the younger cohort, significant interactions between change in 25(OH)D and both baseline 
25(OH)D (P=0.042) and sex (P=0.087) were observed. After stratification for baseline 
25(OH)D, sex was no longer an effect modifier (P=0.139 and 0.453). Participants below the 
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median of 58.6 nmol/l showed a negative association (B per 10 nmol/l increase, model 3: -0.62 
(95% CI: -1.17, -0.07)), meaning that a more positive 25(OH)D change (indicating less decrease 
or even an increase in 25(OH)D) was associated with a decrease in CES-D score (indicating 
a reduction in depressive symptoms). A similar association was observed for the 25(OH)D 
change tertiles (B tertile 1 vs. tertile 3, model 3: 3.07 (95% CI: 0.73, 5.40)). In participants with 
baseline 25(OH)D above the median, no associations were found (Table 2).
Figure 2 | Histograms of change in deseasonalised serum 25-hydroxyvitamin D over 13 years in the older 
cohort (A) and over 6 years in the younger cohort (B). 
Dashed lines indicate the cutoff values of the tertiles. The mean ± SD changes in 25-hydroxyvitamin D were 
for tertile 1: -27.1 ± 12.0, tertile 2: -9.3 ± 4.2 and tertile 3: 16.2 ± 14.3.
Sensitivity analyses 
Additional adjustment for number of chronic diseases did not markedly change the findings 
in both cohorts. Similarly, additional adjustment for changes in four lifestyle factors did 
not change the findings. Furthermore, findings from the older cohort were similar when 
participants who used antidepressants at baseline (n=4) or during follow-up (n=17) were 
excluded. In the younger cohort, exclusion of baseline antidepressant users (n=17) or follow-
up users (n=26) resulted in somewhat stronger associations in those with a baseline 25(OH)D 
concentration below 58.6 nmol/l (e.g. in n=424: B, tertile 1 vs. tertile 3, model 3: 3.30 (95% CI: 
0.96, 5.63)).
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Table 2 | Associations between change in deseasonalised serum 25(OH)D and change in CES-D score
Model 1 Model 2 Model 3
n B 95% CI B 95% CI B 95% CI
Older cohort, 13 years follow-up (n=173)
Change in 25(OH)D 
(continuous, per 10 nmol/l)
-0.27 (-0.79, 0.26) -0.22 (-0.76, 0.31) -0.16 (-0.70, 0.37)
Change in 25(OH)D in tertilesa
Tertile 1 58 2.21 (-0.36, 4.79) 1.95 (-0.66, 4.57) 1.63 (-0.98, 4.24)
Tertile 2 58 0.05 (-2.34, 2.44) -0.02 (-2.42, 2.38) -0.28 (-2.68, 2.11)
Tertile 3 57 Reference Reference Reference
P for trend   0.103 0.162 0.246
Younger cohort, 6 years follow-up: Baseline deseasonalised 25(OH)D <58.6 nmol/l (n=225)
Change in 25(OH)D 
(continuous, per 10 nmol/l)
-0.63 (-1.16, -0.09)* -0.64 (-1.18, -0.09)* -0.62 (-1.17, -0.07)*
Change in 25(OH)D in tertilesb
Tertile 1 51 3.28 (1.00, 5.56)** 3.30 (0.98, 5.62)** 3.07 (0.73, 5.40)*
Tertile 2 82 1.51 (-0.48, 3.50) 1.48 (-0.52, 3.49) 1.67 (-0.35, 3.69)
Tertile 3 92 Reference Reference Reference
P for trend   0.005 0.005 0.008
Younger cohort, 6 years follow-up: Baseline deseasonalised 25(OH)D >58.6 nmol/l (n=225)
Change in 25(OH)D 
(continuous, per 10 nmol/l)
0.21 (-0.27, 0.68) 0.23 (-0.25, 0.71) 0.27 (-0.22, 0.76)
Change in 25(OH)D in tertilesb
Tertile 1 99 -0.80 (-2.90, 1.30) -0.91 (-3.04, 1.23) -0.85 (-3.00, 1.30)
Tertile 2 68 -1.00 (-3.22, 1.22) -1.12 (-3.35, 1.11) -0.92 (-3.16, 1.31)
Tertile 3 58 Reference Reference Reference
P for trend   0.501 0.451 0.470
Abbreviations: B, unstandardised regression coefficient; CES-D, Center for Epidemiologic Studies Depression scale; 
CI, confidence interval.
a Tertiles older cohort: T1 -78.6 to -16.4, T2 -16.3 to -0.7, T3 -0.6 to 66.2 nmol/l.
b Tertiles younger cohort: T1 -54.0 to -2.7 (n=150), T2 -2.7 to 11.8 (n=150), T3 11.9 to 81.3 (n=150) nmol/l.
* P-value <0.05, ** P-value <0.01.
Model 1: adjusted for baseline standardised and deseasonalised 25(OH)D concentration.
Model 2: additionally adjusted for age, sex and education level.
Model 3: additionally adjusted for body mass index, physical activity, alcohol use and smoking.
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DISCUSSION
In this study, we observed no associations between change in serum 25(OH)D concentration 
and parallel change in depressive symptoms in a cohort of older adults (65-88 years at baseline, 
follow-up 13 years). Neither did we find associations in a younger cohort (55-65 years at 
baseline, follow-up 6 years) with a baseline 25(OH)D concentration above 59 nmol/l. However, 
in participants from the younger cohort with a lower baseline 25(OH)D, we observed that an 
increase in 25(OH)D concentration was associated with a decrease in severity of depressive 
symptoms.
The observed associations between change in 25(OH)D concentration and change in 
depressive symptoms differed between the two cohorts. In the younger cohort, a 10 nmol/l 
increase in serum 25(OH)D was associated with a 0.62 points lower CES-D score, but only if 
baseline 25(OH)D concentrations were relatively low. The null findings in the younger cohort’s 
group with relatively high baseline 25(OH)D concentrations suggest that a change in 25(OH)D 
concentration above a certain level – we used the median of 59 nmol/l – has less influence on 
depressive symptoms. However, this was not confirmed in the older cohort. An explanation for 
the non-significant association in the older cohort may be the small sample size (n=173), which 
limited the statistical power. The betas of the older cohort were in the same direction and of 
comparable size as those in the younger cohort’s group with relatively low baseline 25(OH)D 
concentrations.
To the best of our knowledge, this is the first observational study that investigated intra-
individual change in 25(OH)D in relation to intra-individual change in depressive symptoms. 
Our results suggest that supplementation of vitamin D in those with relatively low baseline 
levels might positively influence depressive symptoms. Indeed, a 12-month vitamin D 
supplementation trial in overweight adults showed that 25(OH)D concentrations increased 
from 55 to 112 nmol/l in the group receiving 40,000 IU vitamin D
3
 per week and from 52 to 88 
nmol/l in the group receiving 20,000 IU per week, compared to no change (from 52 to 50 nmol/l) 
in the placebo group; the treatment groups had a significant greater reduction in depressive 
symptoms than the placebo group25. However, other RCTs, which reported pre- and post-
intervention 25(OH)D concentrations, showed a larger 25(OH)D increase in the treatment 
group but no effect on depression26,46 or mental well-being47,48. Thus, more research is needed 
to further elucidate the potential impact of 25(OH)D change on depressive symptoms.
In our previous prospective study, an inverse association between baseline 25(OH)D and 
depressive symptoms over 6 years was found only in women from the older LASA cohort24. In 
the present study, with change in 25(OH)D as determinant instead of baseline 25(OH)D, sex was 
not an effect modifier in the older cohort. Explanations for this might be differences in the study 
sample and the limited power (n=173 vs. 1282). In addition, De Koning et al.24 found no association 
in the younger cohort, whereas we did for those with low baseline 25(OH)D. This discrepancy 
might be explained by general health status: being healthy might be important to withstand 
negative effects on mood of a low 25(OH)D, but not negative effects of a decrease in 25(OH)D.
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In the present study, we also observed a difference between the two cohorts with respect to 
the distributions of 25(OH)D changes: 62% of the younger cohort had an increase in serum 
25(OH)D concentration over 6 years, compared to 32% of the older cohort over 13 years. This 
difference might be explained by age differences (55-65 years in the younger cohort at baseline 
vs. 65-88 years in the older cohort). Older persons may have reduced their outdoor activities 
with aging due to for example functional limitations, leading to less exposure to sunlight9,49. 
Our results are similar to those of the Tromsø Study, in which subjects older than 65 years at 
baseline had a decrease in serum 25(OH)D of 0.3 nmol/l over 14 years, while those younger 
than 65 years had an increase of 2.0 nmol/l (P<0.05)50. Furthermore, our mean 13-year change 
in 25(OH)D in the older cohort (-6.9 nmol/l) and 6-year change in the younger cohort (+5.5 
nmol/l) were comparable but slightly different to previous findings within LASA that were 
based on different statistical models and on measurements that were not yet standardised. 
Van Schoor et al.40 showed that 25(OH)D concentrations decreased with 6.5 nmol/l in the older 
cohort and increased with 2.4 nmol/l in the younger cohort (see their Table 3: age per year 
(longitudinal)).
Our study has several strengths, including its longitudinal design, a nationally representative 
sample of older adults, and the use of deseasonalised serum 25(OH)D values at two time 
points. Further, the measurements of 25(OH)D were standardised for assay. Limitations of this 
study are the relatively healthy study population – as most participants needed to visit the 
hospital for blood sampling – and the exclusion of participants with only one serum 25(OH)D 
measurement that resulted in smaller and less representative samples. Moreover, our study 
was limited by the use of self-reported depressive symptoms during the past week instead of 
a clinical assessment; however, the CES-D scale has been shown to have good psychometric 
properties in samples of older adults37. Reverse causality is a limitation as well, since we do not 
know when the changes occurred during the 13 or 6 years; an increase in depressive symptoms 
might have occurred before the decrease in 25(OH)D. However, our previous paper showed 
that baseline 25(OH)D was associated with the onset of depressive symptoms over 6 years 
in older women without depressive symptoms at baseline24. This indicated an association in 
the direction from 25(OH)D to depression, which was the assumption for the present study. 
Lastly, no data on supplement use or nutritional intake of vitamin D was available. However, 
measured 25(OH)D concentrations are a more valid estimate of vitamin D status than intake 
from foods and supplements33.
In conclusion, our study suggests that a decrease in serum 25(OH)D concentration over 6 
years is associated with a parallel increase in depressive symptoms in young older adults with 
a low baseline 25(OH)D. We did not observe an association in young older adults with a higher 
baseline 25(OH)D over 6 years, or in older adults over a period of 13 years. Whether specific 
groups may emotionally benefit from an increase in vitamin D concentration (e.g. persons with 
relative low 25(OH)D concentrations) needs further investigation; well-designed RCTs are 
needed to determine the potential causal association between vitamin D and depression.
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ABSTRACT
This study investigated bidirectional associations between intake of food groups and 
depressive symptoms in 1058 Italian participants (aged 20-102 years) of the Invecchiare 
in Chianti study. Dietary intake, assessed with a validated FFQ, and depressive symptoms, 
measured with the Center for Epidemiologic Studies Depression scale (CES-D), were 
assessed at baseline and after 3, 6 and 9 years. Associations of repeated measurements 
of intakes of thirteen food groups with 3-year changes in depressive symptoms, and 
vice versa, were analysed using linear mixed models and logistic generalised estimating 
equations. Fish intake was inversely (quartile (Q) 4 vs. Q1, B: -0.97, 95% CI: -1.74, -0.21) 
and sweet food intake positively (Q4 vs. Q1, B: 1.03, 95% CI: 0.25, 1.81) associated with 
subsequent CES-D score. In the other direction, higher CES-D scores were associated 
with decreases in intakes of vegetables (ratio: 0.995, 95% CI: 0.990, 0.999) and red and 
processed meat (B: -0.006, 95% CI: -0.010, -0.001), an increase in dairy product intake 
(ratio: 1.008, 95% CI: 1.004, 1.013), and increasing odds of eating savoury snacks (OR: 
1.012, 95% CI: 1.000, 1.024). Fruit, nuts and legumes, potatoes, whole grain bread, olive 
oil, sugar-sweetened beverages, and coffee and tea were not significantly associated in 
either direction. Our study confirmed bidirectional associations between food group 
intakes and depressive symptoms. Fish and sweet food intakes were associated with 
3-year improvement and deterioration in depressive symptoms, respectively. Depressive 
symptoms were associated with 3-year changes in vegetables, meat, dairy product and 
savoury snacks intakes. Trials are necessary to examine the causal associations between 
food groups and depression.
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INTRODUCTION
Nutritional epidemiology has traditionally focused on single nutrients and foods, but a 
complementary focus is on dietary patterns1. Dietary patterns as well as food groups have 
been linked to chronic diseases, such as depression2. Reviews and meta-analyses on dietary 
patterns concluded that there seems to be a protective effect of ‘healthy’, ‘traditional’ and 
‘Mediterranean’ dietary patterns, whereas a ‘Western’ dietary pattern may be associated with 
an increased risk of depression; however, they all emphasised that evidence for a true causal 
association is not yet conclusive as findings were not consistent and residual confounding can 
still be present3-7. One of the reasons for the inconsistencies is the differences between studies 
on the used or derived dietary patterns and thus in the included components of these patterns. 
So, by studying a priori and a posteriori patterns, it remains unknown which component(s) of 
the pattern are associated with health. It is therefore of interest to study these individual 
components, which are mostly food groups. Food groups can also be useful for communication 
in public health, and many dietary guidelines are food based8,9.
Reviews and meta-analyses regarding food groups as determinant7,10,11 – including fruit and 
vegetables12,13, fish14,15 and coffee and tea16 – indicated some associations with depression as 
outcome, but their findings are inconsistent, potentially due to the limitations of the included 
individual studies. One of the limitations of many previous studies on diet and depression 
is their cross-sectional design. Although there are prospective studies on the link between 
food groups and depressive symptoms at follow-up measurements, they often only used 
dietary information at baseline, assuming no changes in diet over time. To our knowledge, a 
few previous cohort studies used repeated measurements of dietary intake as determinant. 
Their repeated food group measurements were the average consumption at baseline and 
follow-up17,18, cumulative average of two time points19 or a categorical variable based on 
baseline consumption and 2-year change in consumption20. Besides, only three studies used 
longitudinal statistical methods to capture the repeated measurements of the exposure (i.e. 
food group) and found some prospective associations with incident depression outcomes for 
lower intakes at several measurements of fruit (but not vegetables)21, fruit and vegetables 
combined (unadjusted for other lifestyle factors)22, and higher intake of sugar in men only23.
The link between diet and depression may also exist in the other direction, that is, depressive 
symptoms may cause a change in the intake of food groups (‘reverse causality’). Some studies 
have investigated the association of depression with food groups, dietary patterns and 
nutrients in this direction, but the majority of these studies were cross-sectionale.g. 24,25,26 or 
used retrospective depression data27. A total of three recent prospective studies also examined 
the reverse association and found depression to be associated with a lower fruit and vegetable 
intake (combined) (unadjusted for other lifestyle factors)22, but not with fish intake17 or sugar 
intake from sweet food/beverages23. However, to our knowledge, no other previous studies 
investigated the association of depression with food groups longitudinally.
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Given the inconclusive and incomplete literature about the association between food groups 
and depression, and its direction, more prospective studies on the bidirectional link between 
diet and depression are needed. Except Smith et al.17, Kingsbury et al.22 and Knüppel et al.23, no 
study has investigated this link in both directions within one cohort, which can give insight 
into the reverse causality hypothesis. These studies, as well as most studies on food groups, 
however, examined just one or two food groups, which does not allow comparison of the effect 
sizes of the associations with depression between several food groups. 
In the InCHIANTI study (Invecchiare in Chianti, aging in the Chianti area), the link between 
dietary patterns and depressive symptoms has previously been studied. A Tuscan pattern at 
baseline derived by reduced rank regression (RRR) was cross-sectionally and prospectively 
inversely associated with depressive symptoms28. However, two inflammatory dietary patterns 
at baseline – derived by RRR and characterised by unhealthy foods – were not prospectively 
associated with depressive symptoms29. We aim to extend this previous work by studying the 
individual components of these dietary patterns, that is, food groups. In addition, we use dietary 
data not only at baseline but also at follow-up measurements, and we address the relationship 
in two directions. The aims of this study were to study the prospective associations 1) 
between intake of food groups and change in depressive symptoms and 2) between depressive 
symptoms and changes in intake of food groups, in a large sample of Italian (older) adults.
METHODS
Study population
The InCHIANTI study is a prospective, population-based cohort study of older adults in 
Tuscany (Italy), and was originally designed to examine factors that contribute to decline in 
mobility. In 1998-2000, a sample of 1453 persons was randomly recruited at two sites (Greve 
in Chianti and Bagno a Ripoli) using a multistage, stratified sampling method. A total of 1155 
participants were aged 65-102 years, with those aged ≥90 years oversampled, and 298 
participants were aged 20-64 years. Baseline data were collected in a home interview and 
a medical evaluation at the study clinic. Follow-up measurements were performed 3, 6 and 9 
years after baseline (respectively 2001-2003, 2004-2006 and 2007-2009). A more detailed 
description of the study rationale, design and method is given elsewhere30. All participants 
signed informed consent after full explanation of procedures, and the ethics committee of the 
Italian National Institute of Research and Care on Aging approved the study protocol. 
Participants
A total of 1206 persons had dietary data at baseline and at least at one of the three follow-up 
measurements. Persons with no or incomplete data on depressive symptoms at baseline or at 
any follow-up measurement were excluded (n=69). After exclusion of persons with missing 
data on baseline covariates (on physical activity (n=6) and waist circumference (n=73)), the 
analytic sample consisted of 1058 persons.
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Depression measurements
At baseline and follow-up home visits, depressive symptoms were assessed with the Center 
for Epidemiologic Studies Depression scale (CES-D), a twenty-item self-report scale about 
depressive symptoms in the past week31. The CES-D, ranging from 0 to 60 points, is widely 
used, and has been shown to be a valid instrument for assessing depressive symptoms in 
older adults32 and in Italian adults33. The continuous CES-D scores were used as outcome or 
determinant in the associations, and the cutoff score of ≥20 was used to indicate clinically 
relevant depressive symptoms for descriptive purposes. Although a cutoff of 16 is generally 
used, a higher cutoff has a greater specificity32 and seems to be more appropriate in Italian 
samples33.
Dietary measurements
At baseline and follow-up home visits, usual dietary intake was assessed using the food-
frequency questionnaire (FFQ) developed for the North-Central Italy centres34 of the 
European Prospective Investigation into Cancer and nutrition (EPIC) study35. This 240-item 
FFQ on food consumption during the previous year has been validated for these centers36 as 
well as for the InCHIANTI cohort at population level37. Nutrient data were calculated using 
the Food Composition Database for Epidemiological Studies in Italy38. Based on the FFQ 
data obtained, thirteen food groups were a priori created: fruit, vegetables, nuts and legumes, 
potatoes, whole grain bread, dairy products, red and processed meat, fish and shellfish, olive 
oil, savoury snacks, sweet foods, sugar-sweetened beverages and fruit juices (SSB) and 
coffee and tea (Supplemental Table 1). The selection of food groups was based on the fact 
that these are common components of diet quality indices, such as the Mediterranean Diet 
Score, Alternative Healthy Eating Index and Dietary Approaches to Stop Hypertension diet, or 
as previous studies on the depression-diet link suggested a link between the food group and 
depression (savoury snacks, sweet foods, coffee and tea)16,19,23,25,39-41. Intake in grams per day of 
each food group was calculated. Although the FFQs at the follow-up measurements differed 
somewhat from the FFQ at baseline, the food items included in the thirteen food groups were 
similar. The only considerable difference is that the items ‘fruiting vegetables’ and ‘tomato 
sauce’ in the baseline FFQ were redefined as ‘tomatoes raw’, ‘tomatoes cooked’ and ‘other 
fruiting vegetables’ in the follow-up FFQs.
Other variables
Data on potential confounders and variables used in sensitivity analyses were collected 
at the four measurements. Sociodemographic variables included age, sex, marital status 
(married, never married, widowed/divorced) and education level (years). Lifestyle factors 
included smoking status (never, former, current), alcohol intake (g/d; from the FFQ) and total 
energy intake (kJ/d and kCal/d; from the FFQ). In addition, physical activity level during the 
previous year was self-reported and classified as sedentary (hardly any physical activity or 
mostly sitting/some walking), light (light exercise 2-4 h/week) and moderate to intense (light 
physical activity >4 h/week, moderate physical activity >1 h/week, or intense physical activity 
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/ intense walks many times/week). Instrumental activities of daily living (iADL) disabilities 
were defined as self-report of inability or needing personal help in performing any basic or 
instrumental activities of daily living; the number of disabilities was dichotomised (0=no, 
1-8=yes). At the study clinic, waist circumference (cm) was measured as well as body height 
and body weight that were used to calculate body mass index (BMI, kg/m2). Major diseases 
were ascertained according to standardised, pre-established criteria and algorithms based 
upon those used in the Women’s Health and Aging Study42 using information on self-reported 
history, pharmacological treatments, medical examination data and hospital discharge records. 
These diseases included: hypertension, coronary heart disease including angina pectoris and 
myocardial infarction, congestive heart failure, stroke, peripheral arterial disease, cancer, 
diabetes mellitus, chronic obstructive pulmonary disease, and hip and knee arthritis. The 
number of chronic diseases was categorised into no, 1, or 2 or more diseases. General cognitive 
functioning was assessed with the Mini-Mental State Examination (MMSE), ranging from 0 to 
30 points43. Use of antidepressants in the previous 2 weeks (yes/no) was coded according to 
the Anatomical Therapeutic Chemical classification system.
Statistical analyses
Baseline characteristics were described as means and standard deviations (SD) or medians and 
interquartile ranges (IQR), and as percentages. Mean intakes of the food groups at baseline 
and at follow-up measurements were adjusted for energy intake, so that they are independent 
of total energy intake. This adjustment was performed by using the residual method, where 
food group intakes are regressed on total energy intake44. Presented mean intakes are thus 
the predicted values from this regression. Spearman correlation coefficients were calculated 
between the food group intakes. For whole grain bread, savoury snacks and SSB, the number 
of consumers was small. Therefore, the intakes of these food groups were dichotomised as 
non-consumers vs. consumers.
The prospective associations of food group intakes as determinant with change in depressive 
symptoms as outcome were analysed by linear mixed models (LMM), which account for 
dependency of repeated measurements within individuals. The assumption of conditional 
normality of CES-D scores was assessed by analysis of residuals. A time-lag model was chosen 
by including intakes at baseline, follow-up 1 and follow-up 2, and CES-D scores at follow-up 
1, follow-up 2 and follow-up 3 (both time-varying), resulting in three 3-year cycles. Baseline 
CES-D score was included as covariate to interpret the regression coefficients as change 
compared with baseline. Initially, the models included a random intercept, and random slopes 
for food group intake were added to the model and tested for improvement in fit. However, 
likelihood ratio tests did not show statistically significant improvements (P<0.05) in fit for any 
food group, so the final models included only a random intercept. Standardised food group 
intake residuals were used as determinants to make comparisons between the food groups 
possible. Next to these continuous food group intake residuals, quartiles were made with 
quartile 1 (lowest intake) serving as reference category. Quartiles of standardised intake 
residuals were defined for the four measurements according to the distribution at baseline. 
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To examine linear trends across the quartiles, the categorical quartile variable was used as a 
continuous variable to retrieve a P-value for trend. For the three dichotomous food groups, 
the non-consumer group was used as the reference category.
Effect modification by age and sex was tested by adding interaction terms between the 
standardised food group intake residuals and age or sex to the regression models. A P-value 
<0.10 of an interaction term was considered statistically significant. Potential confounders 
were added to the univariable models, and included in the final models if regression coefficients 
changed >10% in at least one of the food groups. The following three models were made: 
model 1 was adjusted for baseline CES-D score, age, sex, marital status and education level, 
model 2 was additionally adjusted for physical activity, smoking, iADL disabilities, alcohol 
intake and energy intake, and model 3 was additionally adjusted for waist circumference 
and number of chronic diseases (as these variables might be confounders but more probably 
mediators). All confounders were included as time-varying variables (baseline, follow-up 1 and 
follow-up 2), except age, sex and education level (baseline). The analyses were repeated and 
additionally adjusted for the intake of the other food groups in a separate model to examine 
the independent association of the food groups with depressive symptoms. Last, time (years 
after baseline) and interaction terms between food group intake and time were added to the 
models to examine whether the associations varied with time.
The prospective associations of depressive symptoms as determinant with changes in 
continuous food group intake as outcome were analysed by LMM. Standardised food group 
intakes were used, which were checked for normality. As seven food groups were skewed to the 
right, a natural log-transformation was performed on the intakes at each measurement, after 
a value of 1 was added to prevent zero intakes. The regression coefficients (B) and confidence 
intervals (CI) of the regression analyses were transformed back to obtain interpretable ratios 
(eB = ratio). These ratios reflect the percentage of change in the outcome (standardised food 
group intake) per one unit change in the determinant (continuous CES-D score). A 3-year time-
lag model was used by including CES-D scores at baseline, follow-up 1 and follow-up 2, and 
food group intakes at follow-up 1, follow-up 2 and follow-up 3. Baseline intake was included 
as covariate, and models with only random intercepts showed the best fit. Standardised 
intakes were used as outcomes to be able to compare between the food groups. For the three 
food groups used as dichotomous variables, logistic generalised estimating equations (GEE) 
with a logit link function and an exchangeable correlation structure were used. GEE take 
into account the correlation between repeated measurements in the same individual and is 
a more valid method than logistic mixed models for binary outcomes45. Effect modification, 
time interaction and confounding were handled as described above. The following three 
models were made: model 1 was adjusted for the baseline food group intake, age, sex, marital 
status and education level; model 2 was additionally adjusted for physical activity, smoking, 
iADL disabilities, alcohol intake and number of chronic diseases (as these variables might be 
confounders and/or mediators); and model 3 was additionally adjusted for energy intake and 
waist circumference (to examine the influence of these variables separately).
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A total of three sensitivity analyses were performed in the LMM and GEE analyses by the 
exclusion of specific subgroups: 1) participants using antidepressants at any measurement, 2) 
participants with an MMSE score <24 at any measurement (who may have memory problems), 
and 3) participants with an implausible energy intake (<2092 kJ (<500 kCal) or >14,644 kJ 
(>3500 kCal) for women, and <3347.2 kJ (<800 kCal) or >16,736 kJ (>4000 kCal) for men) at 
any measurement46.
SPSS version 23 (SPSS Inc. Chicago, IL, USA) was used for all analyses. P-values ≤0.05 were 
considered statistically significant.
RESULTS
Baseline characteristics
Characteristics of the participants (54.7% women) are presented in Table 1. The mean age was 
65.8 (SD 15.2) years, and 187 participants (17.7%) experienced clinically relevant depressive 
symptoms (CES-D ≥20) at baseline. Comparison of included (n=1058) and excluded (n=395) 
participants showed that excluded participants were older (P<0.001), less often married 
(P<0.001), less educated (P<0.001), less physically active (P<0.001) and less often smokers 
(P=0.021) compared with included participants. Excluded participants also had more iADL 
disabilities (P<0.001), lower intakes of alcohol (P<0.001) and energy (P<0.001), lower cognitive 
function (P<0.001) and more depressive symptoms (P<0.001). Regarding food group intakes, 
excluded participants had a lower intakes of fruit, vegetables, potatoes, red and processed 
meat, fish and shellfish and olive oil, and they ate less often whole grain bread and savoury 
snacks (all P<0.05). These differences were most pronounced at baseline and follow-up 1.
Depressive symptoms and food group intakes over 9 years
Depressive symptoms and energy and food group intakes at the four measurements are 
shown in Table 2. Clinically relevant depressive symptoms ranged from 17.0 to 24.1%. Total 
energy intake was highest after 3 years and lowest after 9 years. Energy-adjusted intakes of 
fruit, vegetables and olive oil decreased over time, while intakes of dairy products, fish and 
shellfish, and sweet foods increased, mainly between the 6- and 9-year measurements. Intakes 
of nuts and legumes, potatoes, red and processed meat, and coffee and tea were quite stable 
over time. For whole grain bread, the percentage of consumers ranged over time from 12.7 to 
25.0%, and for savoury snacks, this was 28.5 to 47.2%. SSB was consumed by about 50% of 
the participants across measurements. In Supplemental Table 2, the correlations between the 
continuous and dichotomous food groups are shown.
Food groups as determinants of change in depressive symptoms 
Results of the LMM analyses with food group intakes as determinants are shown in Table 3 and 
Figure 1. No statistically significant associations were found after adjustment for confounders, 
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except for two food groups. A positive association was found for the continuous standardised 
intake of sweet foods (B, model 2: 0.30, 95% CI: 0.02, 0.58), showing that a higher intake of 
sweet foods was associated with an increase in depressive symptoms 3 years later (Figure 1). 
The highest quartile of sweet foods was also positively associated compared with the lowest 
quartile, and a trend across quartiles was observed (P for trend=0.016). For fish and shellfish, 
the highest quartile was associated with a subsequent decrease in depressive symptoms 
compared with the lowest quartile (B: -0.97, 95% CI: -1.74, -0.21), and a trend was observed 
(P for trend=0.016) (Table 3). Unexpectedly, quartile 2 of potatoes was associated with less 
depressive symptoms compared to quartile 1 (B, model 2: -0.75, 95% CI: -1.48, -0.02).
Additional adjustment for waist circumference and number of chronic diseases (model 3) 
did not change the findings. Significant interaction terms with sex were found for red and 
processed meat, and with age for vegetables, nuts and legumes, and SSB; however, after 
stratification by sex or the median of age, findings remained non-significant in all subgroups 
and no clear trends were found (data not shown). For all continuous food groups, model 2 
was additionally adjusted for the standardised intake residuals of the other nine continuous 
food groups; results did not change, except that the association of sweet foods attenuated (B: 
0.19, 95% CI: -0.11, 0.50). For the food group quartiles, additional adjustment did not change 
the findings, indicating that the associations are independent. Similarly, a model including 
simultaneously the three dichotomous food groups also showed similar results. For sweet 
foods, a significant, positive interaction with time (P=0.018 in model 2) was found, indicating 
that the association became stronger over time.
Depressive symptoms as determinant of change in food groups
Table 4 presents the results of the associations of depressive symptoms with change in food 
group intakes. The LMM analyses showed that a higher CES-D score was associated with 3-year 
decreases in intakes of red and processed meat (B model 2: -0.006, 95% CI: -0.010, -0.001) 
and vegetables (ratio: 0.995, 95% CI: 0.990, 0.999), and an increase in intake of dairy products 
(ratio: 1.008, 95% CI: 1.004, 1.013). The GEE analyses showed that a higher CES-D score was 
associated with a subsequent increase in odds of eating savoury snacks (OR: 1.012, 95% CI: 
1.000, 1.024). No statistically significant associations with the other food groups were found.
Additional adjustment for energy intake and waist circumference (model 3, observations=2260) 
did not change the findings; only the association with savoury snacks was slightly attenuated 
(OR: 1.011, 95% CI: 0.999, 1.024). Significant interaction terms with sex were found for 
coffee and tea, and with age for vegetables, whole grain bread, savoury snacks and SSB. 
After stratification by sex, still no significant associations with coffee and tea were found in 
men and women in model 2. Stratification by the median of age showed the same results for 
the mentioned food groups, except for vegetables: depressive symptoms were significantly 
inversely associated in older participants (those >69 years, ratio: 0.993, 95% CI: 0.987, 1.000) 
but not in younger participants (0.996, 95% CI: 0.990, 1.002). Interactions with time were not 
significant in any of the food groups.
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Table 1 | Baseline characteristics of the InCHIANTI study sample (1998-2000, n=1058)
n   %
Age (years)      
Mean 65.8
SD 15.2
Sex, women 579 55
Marital status
Married 706 66.7
Never married 122 11.5
Widowed/divorced 230 21.7
Education (years)
Mean 6.9
SD 4.2
Physical activity
Sedentary 127 12.0
Light 439 41.5
Moderate to intense 492 46.5
Smoking
Never 585 55.3
Former 262 24.8
Current 211 19.9
iADL disabilities 126 12
Alcohol intake (g/d)
Median 7.9
IQR [0.2-26.8]
Body mass index (kg/m2)
Mean 27.3
SD 4.1
Waist circumference (cm)
Mean 91.5
SD 11.0
Number of chronic diseases
0 chronic disease 365 34.5
1 chronic disease 468 44.2
≥2 chronic diseases 225 21.3
Cognitive functioning (MMSE score)
Mean 26.4
SD 2.8
Depressive symptoms (CES-D score)
Mean 11.9
SD 8.5
Use of antidepressants 44   4.2
Abbreviations: SD, standard deviation; iADL, instrumental activities of daily living; IQR, interquartile range; MMSE, 
Mini-Mental State Examination; CES-D, Center for Epidemiologic Studies Depression scale.
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Table 2 | Center for Epidemiologic Studies Depression scale (CES-D) scores and intakes of energy and food 
groups of the InCHIANTI study sample (n=1058) at baseline and follow-up measurements
Baseline Follow-up 1  Follow-up 2 Follow-up 3 
n 1058   960   853   757  
Mean SD Mean SD Mean SD Mean SD
Depressive symptoms 
Depressive symptoms (CES-D score) 11.9 8.5 14.3 8.6 12.9 7.6 13.5 8.1
Presence of depressive symptoms (%, CES-D ≥20) 17.7 24.1 17.0 19.8
Energy intake
kJ/d 8574 2598 8803 2595 8680 2638 8495 2579
kCal/d 2049 621 2104 620 2074 631 2030 617
Energy-adjusted intake - predicted valuesa (g/d)
Fruit 287 27 273 33 261 21 197 16
Vegetables 184 38 139 34 129 35 124 31
Nuts and legumes 18 1.6 17 1.2 16 2.4 20 2.1
Potatoes 37 11 34 9.7 36 10 36 8.4
Dairy products 174 29 178 23 171 13 191 18
Red and processed meat 80 23 80 20 76 22 81 21
Fish and shellfish 26 3.4 28 3.8 25 3.7 32 3.4
Olive oil 27 6.7 26 6.0 23 6.2 23 5.4
Sweet foods 69 25 72 27 65 18 86 41
Coffee and tea 112 19 114 17 106 9.4 116 6.7
Consumers (%)
Whole grain bread 15.2 16.3 12.7 25.0
Savoury snacks 31.1 28.5 47.2 32.1
Sugar-sweetened beverages + fruit juices 51.8 51.5 55.2 48.7
Abbreviation: SD, standard deviation.
a All predicted values are energy-adjusted by regressing food group intakes on total energy intake (the residual method).
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Table 3 | Prospective associations of intake of food groups (determinants) in relation to change in CES-D 
score (outcome) 3 years later in the InCHIANTI study (n=1058, 9-year follow-up with 2467 observations)a
Model 1b   Model 2c  
    B 95% CI P B 95% CI P
Intake in standardised intake residuals (in quartiles)d,e,f
Fruit
Quartile 1 Reference Reference
Quartile 2 -0.24 -0.98, 0.50 0.522 -0.29 -1.03, 0.45 0.439
Quartile 3 -0.06 -0.81, 0.69 0.870 -0.03 -0.78, 0.71 0.928
Quartile 4 -0.06 -0.83, 0.71 0.883 -0.08 -0.84, 0.68 0.838
P for trend 0.983 0.978
Vegetables
Quartile 1 Reference Reference
Quartile 2 0.16 -0.60, 0.91 0.685 0.06 -0.70, 0.82 0.876
Quartile 3 0.34 -0.40, 1.08 0.363 0.33 -0.42, 1.07 0.390
Quartile 4 -0.52 -1.32, 0.27 0.198 -0.49 -1.28, 0.31 0.228
P for trend 0.312 0.369
Nuts and legumes
Quartile 1 Reference Reference
Quartile 2 -0.11 -0.84, 0.61 0.760 0.06 -0.66, 0.79 0.865
Quartile 3 -0.12 -0.85, 0.60 0.744 0.02 -0.70, 0.74 0.952
Quartile 4 -0.23 -1.01, 0.55 0.558 -0.10 -0.88, 0.67 0.796
P for trend 0.579 0.787
Potatoes
Quartile 1 Reference Reference
Quartile 2 -0.74 -1.46, -0.01 0.046 -0.75 -1.48, -0.02 0.045
Quartile 3 0.15 -0.60, 0.89 0.701 0.08 -0.67, 0.83 0.841
Quartile 4 -0.32 -1.10, 0.45 0.412 -0.35 -1.12, 0.42 0.371
P for trend 0.966 0.947
Dairy products
Quartile 1 Reference Reference
Quartile 2 -0.48 -1.23, 0.28 0.219 -0.45 -1.21, 0.31 0.242
Quartile 3 -0.10 -0.88, 0.68 0.797 -0.02 -0.80, 0.76 0.955
Quartile 4 -0.21 -1.01, 0.59 0.605 -0.21 -1.01, 0.59 0.601
P for trend 0.900 0.928
Red and processed meat
Quartile 1 Reference Reference
Quartile 2 -0.08 -0.81, 0.65 0.831 -0.11 -0.84, 0.62 0.759
Quartile 3 0.38 -0.37, 1.13 0.317 0.35 -0.41, 1.10 0.367
Quartile 4 -0.26 -1.02, 0.49 0.492 -0.39 -1.13, 0.36 0.313
P for trend 0.758 0.530
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Model 1b   Model 2c  
    B 95% CI P B 95% CI P
Fish and shellfish
Quartile 1 Reference Reference
Quartile 2 -0.32 -1.06, 0.41 0.388 -0.30 -1.03, 0.43 0.419
Quartile 3 -0.40 -1.16, 0.36 0.306 -0.35 -1.11, 0.41 0.363
Quartile 4 -0.99 -1.77, -0.22 0.012 -0.97 -1.74, -0.21 0.013
P for trend 0.014 0.016
Olive oil
Quartile 1 Reference Reference
Quartile 2 0.47 -0.25, 1.19 0.203 0.49 -0.24, 1.22 0.186
Quartile 3 0.13 -0.61, 0.87 0.731 0.12 -0.62, 0.87 0.745
Quartile 4 -0.08 -0.85, 0.69 0.843 -0.01 -0.78, 0.76 0.985
P for trend 0.628 0.724
Sweet foodsg
Quartile 1 Reference Reference
Quartile 2 0.29 -0.45, 1.03 0.447 0.24 -0.50, 0.99 0.521
Quartile 3 0.30 -0.45, 1.06 0.431 0.17 -0.59, 0.94 0.656
Quartile 4 1.14 0.36, 1.92 0.004 1.03 0.25, 1.81 0.009
P for trend 0.006 0.016
Coffee and tea
Quartile 1 Reference Reference
Quartile 2 0.09 -0.65, 0.82 0.819 0.11 -0.62, 0.85 0.767
Quartile 3 0.07 -0.69, 0.83 0.858 0.05 -0.71, 0.81 0.905
Quartile 4 0.56 -0.22, 1.34 0.158 0.56 -0.21, 1.34 0.155
P for trend 0.186 0.195
Intake in percentage consumerse
Whole grain bread
Consumer vs. non-consumer -0.03 -0.78, 0.72 0.939 0.16 -0.59, 0.91 0.683
Savoury snacks
Consumer vs. non-consumer 0.01 -0.55, 0.56 0.984 -0.01 -0.55, 0.54 0.984
Sugar-sweetened beverages + fruit juices
Consumer vs. non-consumer -0.23 -0.78, 0.32 0.421 -0.23 -0.78, 0.32 0.420
Abbreviations: CES-D, Center for Epidemiologic Studies Depression scale; B, unstandardised regression coefficient; 
CI, confidence interval.
a Intake of food groups at baseline, follow-up 1 and follow-up 2, and CES-D scores at follow-up 1, 2 and 3.
b Model 1: adjusted for baseline CES-D score, age, sex, marital status and education level.
c Model 2: additionally adjusted for physical activity, smoking, iADL disabilities, alcohol intake and energy intake.
d Intake residuals are energy-adjusted by regressing food group intake on total energy intake (the residual method).
e Analysed with linear mixed models.
f Quartiles of the standardised intake residuals are based on the sample distribution at baseline.
g For sweet foods, there is a positive interaction with time, indicating that the association became stronger over time.
Table 3 - Continued
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Figure 1 | Prospective associations of intake of food groups (determinants) in relation to change in CES-D 
score (outcome) 3 years later in the InCHIANTI study (n=1058, 9-year follow-up with 2467 observations)a 
Abbreviation: CES-D, Center for Epidemiologic Studies Depression scale. 
a Intake of food groups at baseline, follow-up 1 and follow-up 2, and CES-D scores at follow-up 1, 2 and 3. 
Intake residuals are energy-adjusted by regressing food group intake on total energy intake (the residual 
method). Analysed with linear mixed models. Error bars indicate 95% confidence intervals. 
Model 2 is shown: adjusted for baseline CES-D score, age, sex, marital status, education level, physical 
activity, smoking, iADL disabilities, alcohol intake and energy intake. 
b For sweet foods, there is a positive interaction with time, indicating that the association became stronger 
over time.
* P <0.05. 
Sensitivity analyses 
Findings of the food group intake-depressive symptoms analyses did not change when 
participants who had an implausible energy intake (n=36, observations=93) were excluded. 
However, the exclusion of participants who used antidepressants (n=226, observations=673) 
did not influence the fish association, but resulted in a significant inverse association for the 
highest quartile of vegetables (B model 2: -1.20, 95% CI: -2.12, -0.28), and the association 
of sweet foods disappeared (continuous B: 0.13, 95% CI: -0.19, 0.44). Similarly, exclusion of 
participants who had an MMSE score <24 (n=667, observations=1021) did not influence the 
associations of fish and sweet foods, but resulted in a significant inverse association for the 
highest vegetables quartile (B: -1.43, 95%CI: -2.44, -0.43).
103
5
Bidirectional associations food groups and depressive symptoms
For the depressive symptoms-food group intake analyses, exclusion of participants who had 
an implausible energy intake (n=36, observations=94) did not change the findings. Further, 
exclusion of participants who used antidepressants (n=226, observations=701) attenuated the 
associations of red and processed meat (B model 2: -0.004, 95% CI: -0.009, 0.002), vegetables 
(ratio: 0.997, 95% CI: 0.992, 1.003) and savoury snacks (OR: 1.011, 95% CI: 0.997, 1.025). 
Similarly, exclusion of participants who had an MMSE score <24 (n=667, observations=1062) 
led to statistically not significant associations of red and processed meat and vegetables.
Table 4 | Prospective associations of CES-D score (determinant) in relation to change in (log-transformed) 
intake of food groups (outcomes) 3 years later in the InCHIANTI study (n=1058, 9-year follow-up with 2489 
observations)a
Model 1b Model 2c
Intake in standardised intaked B 95% CI  P B 95% CI  P
Fruit -0.004 -0.009, 0.001 0.140 -0.003 -0.008, 0.002 0.313
Red and processed meat -0.006 -0.011, -0.002 0.009 -0.006 -0.010, -0.001 0.016
Olive oil -0.004 -0.009, 0.001 0.081 -0.004 -0.008, 0.001 0.136
Intake in standardised,  
log-transformed intaked
Ratioe 95% CI  P Ratioe 95% CI  P
Vegetables 0.994 0.989, 0.998 0.006 0.995 0.990, 0.999 0.022
Nuts and legumes 0.995 0.990, 1.000 0.051 0.996 0.991, 1.001 0.132
Potatoes 0.998 0.993, 1.003 0.376 0.998 0.993, 1.003 0.375
Dairy products 1.007 1.003, 1.012 0.001 1.008 1.004, 1.013 <0.001
Fish and shellfish 0.999 0.994, 1.004 0.670 0.999 0.994, 1.004 0.733
Sweet foods 1.003 0.999, 1.008 0.120 1.003 0.998, 1.007 0.233
Coffee and tea 1.001 0.996, 1.005 0.786 1.001 0.996, 1.006 0.744
Intake in percentage consumersf OR 95% CI  P OR 95% CI  P
Whole grain bread
Consumer vs. non-consumer 0.991 0.976, 1.008 0.294 0.993 0.976, 1.010 0.429
Savoury snacks
Consumer vs. non-consumer 1.012 1.001, 1.023 0.037 1.012 1.000, 1.024 0.047
Sugar-sweetened beverages + fruit juices
Consumer vs. non-consumer 0.999 0.987, 1.010 0.815 0.996 0.983, 1.008 0.475
Abbreviations: CES-D, Center for Epidemiologic Studies Depression scale; B, unstandardised regression coefficient; 
CI, confidence interval; OR, odds ratio.
a CES-D scores at baseline, follow-up 1 and follow-up 2, and intake of food groups at follow-up 1, 2 and 3.
b Model 1: adjusted for standardised (and log-transformed) baseline food group intake, age, sex, marital status and 
education level.
c Model 2: additionally adjusted for physical activity, smoking, iADL disabilities, alcohol intake and number of chronic 
diseases.
d Analysed with linear mixed models.
e The ratios reflect the percentage of change in the outcome (standardised food group intake) per one unit change in 
the determinant (CES-D score).
f Analysed with generalised estimating equations.
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DISCUSSION
In this study, the bidirectional, prospective associations between thirteen food groups and 
depressive symptoms were investigated in 3-year intervals over a 9-year period. A high intake 
of fish and shellfish was prospectively associated with a decrease in depressive symptoms 3 
years later, while a high intake of sweet foods was associated with an increase in depressive 
symptoms. In the other direction, more depressive symptoms were associated with subsequent 
decreases in the intakes of red and processed meat and vegetables, and increases in the 
intakes of dairy products and savoury snacks. For the other food groups, no associations were 
observed in either direction.
Associations were found in both directions; however, no food group had associations in both 
directions, which implies that reverse causality is not the reason for the observed associations 
in either direction. For example, the increase in depressive symptoms over 3 years in persons 
with a high sweet food intake is not due to the potential higher susceptibility to depression 
of these persons; this higher susceptibility could have led, already at baseline, to a higher 
sweet food intake. As we found no association of depressive symptoms with change in sweet 
food intake over time, there is no support for the reverse causality hypothesis. Besides, we 
shaped the analyses in a ‘prospective’ way using a 3-year time-lag model and by adjustment 
for the outcome at baseline, thereby minimising the issue of ‘cause or consequence’. So, our 
prospective, bidirectional design made it possible to adequately investigate reverse causality; 
however, randomised controlled trials are needed to determine true causal relationships 
between food groups and depression. Prevention trials have not yet been performed, but two 
recent Australian treatment trials showed – in depressed adults – that dietary improvements 
had positive effects on mental health outcomes, including depression symptomatology. 
However, these trials had quite small samples (67 and 152 participants enroled) and did not 
primarily focus on food groups but on a Mediterranean-style diet, and its findings cannot be 
generalised to a more general population sample47,48.
The associations of fish and sweet foods with depressive symptoms were strongest for the 
highest intake quartiles, while the middle quartiles had comparable regression coefficients. 
This seems to indicate a non-linear association for both food groups, as shown before for 
fish18,20. Energy-adjusted intakes of fish and shellfish of more than 28.0 g/d (quartile 4: >0.44 
standardised residuals = >8.2 residuals = >28.0 g/d predicted value) and of sweet foods of more 
than 83.1 g/d (quartile 4: >0.43 standardised residuals = >20.1 residuals = >83.1 g/d predicted 
value) were associated with about one point decrease and increase in CES-D score, respectively. 
All other food groups had regression coefficients of smaller sizes (non-significant), except for 
quartile 2 of potatoes. As there was no trend for the latter, this may represent a chance finding, 
potentially due to multiple testing. In the other direction, a one-point increase in CES-D 
score was associated with a reduced red and processed meat intake of 0.24 g/d (regression 
coefficient: -0.006 standardised intake = -0.006 × 41.2 = 0.24 g/d) and with a 0.8% increased 
dairy product intake (ratio: 1.008 = increase of 0.8%). So, these effect sizes are relatively small. 
As we also did not adjust for multiple testing, our findings need to be interpreted with caution.
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Another reason to be cautious is that our sensitivity analyses showed that some associations 
were not that robust. Exclusion of antidepressant users (n=226) made the association of sweet 
foods with depressive symptoms disappear. This might indicate that the positive sweet foods 
association is mainly driven by those with more severe depression (who used antidepressants). 
In contrast, an inverse association of vegetables appeared, indicating that a high vegetable 
intake might lead to less depressive symptoms only in mentally healthy persons. Such 
beneficial association of vegetables has been shown in recent meta-analyses7,12. Nonetheless, 
the association of fish (quartile 4) remained significant. In the other direction, exclusion of 
antidepressant users (n=226) or participants with low cognitive functioning (n=667) resulted in 
attenuation of the associations of depressive symptoms with red and processed meat, vegetables 
and savoury snacks. This might indicate that these associations mainly exist in persons with more 
severe depression or with low cognitive functioning; however, a more plausible explanation for 
the attenuation is the smaller sample size that reduced the statistical power.
Our findings of the food group intake-depressive symptoms analyses are partly in line with 
previous studies. An inverse association between fish and depression risk has been described 
in recent meta-analyses of observational studies7,14,15 as well as in prospective studies in, for 
example, older Japanese18 and young Australian women17. A negative association between 
sweet foods and mood has also been found in prospective studies on commercial baked goods41, 
sugar intake from sweet food/beverages23 and added sugars19. Both findings are according to 
the hypothesis that ‘healthy’ foods lead to less depressive symptoms and ‘unhealthy’ foods to 
more depressive symptoms. However, we found no associations of intakes of the other food 
groups that have previously been related to (incident) depression, including fruit12,13,21,49-51, 
vegetables7,12,13,49,51,52, legumes50, meat50, grains49, dairy50,53,54 and coffee and tea16,40. It might be 
that for Italian older adults, other factors, such as sleep, socioeconomic status, negative life 
events, social network or comorbidities55-57, are more important risk factors for depression 
than these food groups, or that fish and sweet foods are key food groups that influence mood 
over time.
Two previous studies have been performed within InCHIANTI, using food intake data as 
determinant of depressive symptoms over time. Prospective associations have been shown 
between a Tuscan dietary pattern – characterised by vegetables, olive oil, fish, fruits, grains, 
potatoes, red and processed meat – and depressive symptoms28 but not between two 
inflammatory patterns and depressive symptoms29. These patterns were only measured at 
baseline, whereas we used intake data from baseline and after 3 and 6 years. Changes in food 
group intake over time thus seem to be important as we found no association between most 
Mediterranean food groups and depressive symptoms, except for fish. Similar to the unhealthy, 
inflammatory patterns, we found no associations of unhealthy food groups with depressive 
symptoms, except for sweet foods. Vermeulen et al.29 focused on patterns – reflecting a mix of 
diverse food items – rather than single food groups, which may explain why they did not show 
this association. Also, they excluded participants aged <65 years, while we included these 
younger participants, resulting in a more varied dietary intake. So, our study on food groups 
complements those of Vermeulen et al.28,29 on dietary patterns.
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In the other direction, only a few previous prospective studies have been performed. We did 
not find an association between depressive symptoms and change in sweet food intake, similar 
to Knüppel et al.23. We also did not find an association with fish intake as outcome, which is in 
line with Smith et al.17, except that they showed a lower fish intake after 5 years in young women 
with a recent depression episode. The association of depression with fruit and vegetable intake 
(combined) was shown to be complex, since adjustment for lifestyle confounders (smoking, 
physical activity) attenuated the association in Canadian adults22; however, we investigated 
fruit and vegetables separately and found only an inverse association of depressive symptoms 
with vegetable intake, even after adjustment for smoking and physical activity. A comparison 
of our findings with other previous studies on the depression-diet link is rather difficult, since 
these studies were cross-sectional and did not investigate food groups comparable to ours24-26.
Our finding that more depressive symptoms led to a higher consumption of savoury snacks 
is in line with the hypothesis that depressed persons may increase the consumption of less 
healthy (high-fat/salty) foods, owing to an increased appetite as in atypical depression58 or to a 
preference for consuming palatable ‘comfort foods’59. In contrast, the association of depressive 
symptoms with a decreased intake of both red and processed meat and vegetables may reflect 
a reduced energy intake in depressed persons; this can result from a decreased appetite, 
which is one of the symptoms of the melancholic type of depression60,61 and common in older 
age (75% of our study sample was aged ≥65 years)62. However, more depressive symptoms 
were also associated with increased intakes of dairy products and savoury snacks in our study, 
so this reduced energy intake in depressed persons must have been food group-specific. The 
increased intake of dairy products might be explained by a preference of depressed persons for 
easy-to-prepare foods, such as milk, yogurt and cheese63. Further, the null-associations with 
intake of the other nine food groups might indicate that these food groups are not influenced 
by mood status.
Although the mechanistic understanding of the link between diet and depression is limited, 
several hypotheses exist. Diet influences physiologic processes, which consecutively 
influences development and progression of depression, such as neurotransmitter imbalances, 
neurogenesis and neuronal plasticity, oxidative stress and inflammation57. Regarding our 
findings, the protective effect of fish may be attributable not only to its omega-3 fatty acids, 
but also to other nutrients, such as vitamin D, vitamin B
12
, iodine and selenium; all play a role 
in the mentioned processes64. In the direction from depressive mood to diet, the underlying 
mechanisms might include sensory, physiological and psychological pathways65. Stress can 
influence food intake via physiological effects that change appetite or other eating behaviours, 
and it can also change food choices in persons with specific psychological characteristics, such 
as emotional eaters65.
To our knowledge, this is the first study that investigated bidirectional associations between 
several food groups and depressive symptoms within one cohort. Most previous prospective 
studies investigated the unidirectional association from one food group to depression, and 
studies in the other direction – with several dietary aspects as outcomes – were cross-
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sectionale.g. 24,25,26. Another strength is the use of repeated measurements of outcome ánd 
determinant, that is, CES-D scores ánd food group intakes assessed four times over 9 years. 
Whereas previous diet-depression studies mostly used only baseline dietary data and 
assumed no changes over time, we took into account individual changes in food group intake 
over time by using LMM. Furthermore, by using residual food group intakes as determinants 
and adjustment for energy intake, we were able to study the food group-depressive symptoms 
association independent of energy intake. Finally, by studying food groups instead of dietary 
patterns or diet indices, we could identify the important components of these patterns/indices 
that have a link with depressive symptoms.
Several limitations need to be addressed as well. In this Italian study population, intakes of three 
food groups (whole grain bread, savoury snacks and SSB) were very low, compared to intakes in 
studies that showed associations of these groups25,40,49. Despite this small consumption range, 
we were able to pick up an association with savoury snacks as outcome. Next, dietary data 
were derived by a self-reported FFQ: this assessment method, in combination with memory 
loss of the older participants, might lead to misreporting66; however, underreporting in older 
persons might partly reflect a true low caloric intake due to anorexia of aging67. Depressive 
symptoms were also self-reported without a clinical assessment of depression, whereas a 
meta-analysis showed that healthy patterns and food groups were not associated with a 
formal diagnosis of depression, only with self-reported depressive symptoms7. However, 
the CES-D scale is a validated instrument that has shown good psychometric properties in 
an older population32,33. Furthermore, residual confounding might be present attributable to 
imperfectly/not measured confounders, such as socio-economic status. Last, loss to follow-up 
is a limitation; the more healthy participants were available for this longitudinal study, which 
might have resulted in a less representative sample. This selection bias may have attenuated 
or strengthened our associations.
In summary, our study in an Italian (older) population, including repeated assessments of food 
group intakes and depressive symptoms, suggests that high intakes of fish and sweet foods 
are associated with, respectively, a decrease and increase in depressive symptoms. In the 
other direction, more depressive symptoms are associated with decreased intakes of red and 
processed meat and vegetables, and increased intakes of dairy products and savoury snacks. 
This bidirectional, prospective study confirms some of the hypothesised links between food 
groups and mood but not all. A bidirectional association between diet in general and depression 
seems to exist but not for specific food groups. Longitudinal studies on the association from 
depression to food group intakes are scarce, showing the need for more research. Future 
experimental studies should investigate the effects of a change in the intake of specific food 
groups on depression. This knowledge might be needed for the prevention of depression and 
the optimal nutritional care of depressed persons.
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Supplemental Table 1 | Food items of the food groups
Food group Included FFQ items
Fruit fruits
Vegetables  
(excluding potatoes and legumes)
leafy+fruiting+root vegetables, cabbage, mushrooms, union, garlic, 
tomatoes, tomato sauce, mixed salad
Nuts and legumes legumes, nuts, nut spread, seeds
Potatoes potatoes
Whole grain bread whole grain bread
Dairy products milk, yogurt, cheese
Red and processed meat beef, veal, pork, lamb, horse, game, offals, processed meat
Fish and shellfish fish, crustaceans, molluscs
Olive oil olive oil
Savoury snacks pizza slice, salty biscuits, breadsticks
Sweet foods biscuits, cakes, pies, pastries, puddings, ice cream, confections, 
chocolate, jam, sugar, honey
Sugar-sweetened beverages + fruit juices soft drinks, fruit juices
Coffee and tea coffee, tea
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ABSTRACT
Background
Evidence for the diet-depression link is growing but longitudinal studies on the reverse 
association are scarce. We investigated associations of 1) current depressive symptoms, 2) 
short-term changes in and 3) long-term history of depressive symptoms with three a priori 
diet quality indices.
Methods
Data were from participants (≥55 years) of the Longitudinal Aging Study Amsterdam 
(LASA). The Mediterranean Diet Score (MDS), Alternative Healthy Eating Index (AHEI-
2010) and Dietary Approaches to Stop Hypertension diet (DASH) were derived in 
2014/2015. Depressive symptoms (Center for Epidemiologic Studies Depression scale; 
CES-D) were assessed in 2014/2015 and at five regular 3-yearly cycles from 2001-2003 
to 2015/2016. Associations between three depression determinants and the diet indices 
were analysed by multivariable linear regression models.
Results
Cross-sectionally (n=1312), current depressive symptoms (CES-D ≥16) were associated 
with lower MDS (adjusted B=-1.21, 95% CI=-2.41, -0.023) and AHEI (B=-2.72, 95% CI=-
5.24, -0.20) scores in men only. Chronic/recurrent depressive symptoms (CES-D ≥16 in 
both 2011-2013 and 2015/2016) were associated with lower MDS scores (n=1233; B=-
2.22, 95% CI=-3.40, -1.04) and a trend for lower AHEI scores (B=-2.37, 95% CI=-4.92, 0.18), 
compared to no depressive symptoms (twice CES-D <16). History of depressive symptoms 
(ever CES-D ≥16 from 2001-2003 to 2011-2013; n=687) was associated with lower MDS 
(B=-1.87, 95% CI=-3.47, -0.27) and AHEI (B=-4.33, 95% CI=-7.54, -1.13) scores in men only. 
No associations were found with the DASH score. 
Limitations
Single dietary data collection impeded investigation of prospective depression-diet 
associations.
Conclusions
Our study in middle-aged and older adults suggests that current and past depressive 
symptoms are associated with poorer diet quality, particularly in men.
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INTRODUCTION
Diet has been investigated in relation to physical health for several decades; however, the role 
of diet in mental health is an emerging field of research. Diet might be an important, modifiable 
risk factor for mental illnesses, including depression. Reviews and meta-analyses on dietary 
patterns and depression concluded that ‘healthy’, ‘traditional’ and ‘Mediterranean’ dietary 
patterns may play a protective role, while ‘unhealthy’ and ‘Western’ dietary patterns may 
increase the risk of depression. However, the individual observational studies showed different 
findings, and evidence for a true causal association is still lacking1-6. Furthermore, a recent 
review on late life depression of Gougeon7 suggested that the evidence for an association 
appears less conclusive in older adults. It is also unclear whether the diet-depression link is 
sex-specific6,8-11.
Most previous studies investigated the association of dietary patterns with depressive 
symptoms. However, a poor diet may not be one of the causes of depression but (also) a 
negative consequence of the disorder. This is known as the ‘reverse causality hypothesis 
of diet and depression’. Depressive mood and stress can have an impact on food intake via 
physiological pathways that influence appetite or other behaviours12,13. Stressful events 
can lead to less healthy food choices, such as higher intake of energy-dense, high-fat foods, 
and subsequently to obesity14,15. Previous studies showed that depressive symptoms were 
associated with poorer overall diet quality16, higher intakes of saturated fat, sugar and sodium17 
and higher sweet foods and lower low-calorie foods consumption18. A positive association was 
also observed with total caloric intake from saturated fat and total sugars19. Other studies 
showed an inverse20-22 or no association21,23 between depressive symptoms and the likelihood 
of eating a healthy diet. All eight studies had a cross-sectional design, which does not assure 
the causality or temporality of associations.
Some prospective studies investigating the influence of diet on depression or depressive 
symptoms tested the possibility of ‘reverse causality’, whereby depression affects diet. This 
was conducted – mostly as sensitivity analysis – by excluding participants who reported 
depressive symptoms at baseline from the analysis or by analysing the reverse association 
as well. These studies suggested that diet influences depression or depressive symptoms 
but not vice versae.g. 8,9,24,25-31. However, a recent study in three age cohorts (20+, 40+, 60+ 
years) showed that reverse causality in the relationship between diet and depression existed, 
but that the association differed according to the disease status. Current depression was 
associated with lower scores on the healthy pattern, while past depression led to higher 
scores on the healthy dietary pattern and lower scores on the western pattern32. This study 
had as limitation that history of depression was asked retrospectively. Recently, a nested 
case-control study investigated whether incidence of depressive symptoms was associated 
with changes in nutrient intakes during the year 'depression' was detected33. This study did 
not show significantly different changes in intakes of energy, fibre, protein and saturated fat 
between cases (who became depressed) and controls (who remained non-depressed); however, 
small declines in dietary intake of three B vitamins may have preceded 'depression' incidence. 
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This study on the reverse causality hypothesis in older adults did not seem to support this 
hypothesis; however, the follow-up duration was only one year. More longitudinal studies of 
longer duration on the relationship from depression to diet are clearly needed.
Therefore, we aimed to study the association between depressive symptoms and three a 
priori diet quality indices: Mediterranean Diet Score (MDS), Alternative Healthy Eating Index 
(AHEI) and Dietary Approaches to Stop Hypertension diet (DASH). We chose these indices as 
they all measure a healthy diet and are used worldwide in relation to disease. Furthermore, 
because they differ in dietary components, it is possible to gain some insight into which food 
groups may be strongest associated with depression by comparing the indices. Next to the 
cross-sectional associations (research question 1; RQ1), we also investigated how history of 
depressive symptoms is associated with adherence to the diet indices. For this longitudinal 
approach, we studied associations of both short-term changes in depressive symptoms (2 to 
5 years) (RQ2) as well as the long-term history of depressive symptoms (2 to 14 years) (RQ3) 
with the three diet quality indices. In this way, we could discriminate whether recent mood 
changes or depressed mood during a longer life period are important determinants of diet 
quality.
METHODS
Study population
The Longitudinal Aging Study Amsterdam (LASA) is an ongoing cohort study in a nationally 
representative sample of the Dutch older population aged 55 years and older living in three 
geographic regions in the Netherlands. Data have been collected to study the determinants, 
trajectories and consequences of physical, cognitive, emotional and social functioning in 
relation to aging. Every 3 years measurement cycles are carried out at the participants’ homes, 
including a main interview, medical interview and questionnaire. In subpopulations, side studies 
have been performed. LASA comprises three cohorts: the first cohort (aged 55-85 years at 
baseline) was recruited at LASA’s start in 1992/1993, the second (55-65 years) in 2002/2003 
and the third (55-65 years) in 2012/2013. All participants provided written informed consent, 
and the Medical Ethics Committee of the VU University Medical Center approved this study 
and the side studies. A detailed description of the sampling and data collection procedures can 
be found elsewhere34,35.
Participants
For the present study, we used data of persons participating in the ‘LASA Nutrition and 
Food-related Behaviour study’: a side study conducted in 2014/2015 that consisted of a 
questionnaire (paper or online), including a food frequency questionnaire (FFQ) and questions 
on food-related behaviour and mental well-being. A total of 2089 persons of the three LASA 
cohorts were approached, of which 1439 persons participated in the side study – see Figure 
1 of Winkens et al.36 for a flow chart of this side study. We excluded 32 persons with no or 
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incomplete data on the Center for Epidemiologic Studies Depression scale (CES-D), 7 persons 
with more than 10 missing values on the FFQ questions, 26 persons with an implausible energy 
intake (<800 kCal or >4000 kCal for men and <500 kCal or >3500 kCal for women)37 and 62 
persons with missing data on relevant confounders. This resulted in an analytical sample of 
1312 persons for the cross-sectional analyses (RQ1). For the short-term change analyses 
(RQ2), 79 persons with no or incomplete CES-D data at the measurement cycle before (2011-
2013) or after (2015/2016) the side study were additionally excluded, leaving 1233 persons 
for the analytical sample. For the long-term history analyses (RQ3), cohort 3 (n=604) needed 
to be excluded from the analytical sample of RQ1 (n=1312) since this cohort just started in 
2012/2013, as well as 21 persons with no or incomplete CES-D data at any of the four cycles 
before the side study (from cycle 2001-2003); this resulted in an analytical sample of 687 
persons. Figure 1 shows the measurement cycles used for the three RQs: from 2001-2003 to 
2015/2016. 
Figure 1 | Schematic overview of measurement cycles used for each research question from the Longitudinal 
Aging Study Amsterdam. 
Abbreviations: CES-D, Center for Epidemiologic Studies Depression scale; FFQ, food frequency questionnaire; 
RQ, research question. 
At the regular cycles, the CES-D was assessed during an interview; at the side study, the CES-D was assessed 
with a self-reported questionnaire.
Dietary assessment
At the side study in 2014/2015, dietary intake was assessed with the Dutch version of the FFQ 
of the HEalthy LIfe in an Urban Setting (HELIUS) study38. This semi-quantitative FFQ consists 
of 238 food items and asks for consumption during the past 4 weeks. To calculate nutrient 
intake, each food item was linked to one or more foods of a nutrient database, which was based 
on the Dutch Food Composition Table 201139.
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Diet quality indices 
An overview of the scoring criteria of the three diet indices is presented in Table 1. The MDS of 
Panagiotakos et al.40 comprises 11 components (food groups), each scoring from 0 to 5 based 
on intake in weekly or daily servings. The AHEI-2010 of Chiuve et al.41 is based on foods and 
nutrients predictive of chronic disease risk and includes 11 components scoring from 0 to 10. 
The DASH of Fung et al.42 scores intake quintiles of 8 components (food groups and nutrient). 
Both the AHEI-2010 and DASH originally include sodium as one of the components. However, 
discretionary salt use was not asked in our FFQ, and sodium intake was not calculated from 
the FFQ items as this is very difficult43; thus, our versions of the AHEI and DASH include one 
component less. For all indices, a higher score indicates adherence to a healthier diet generally 
associated with a lower chronic disease risk. The food items of the indices’ components are 
shown in Supplemental Table 1. 
Depressive symptoms measurements 
At the side study and each regular measurement cycle, the CES-D was used to measure 
depressive symptoms during the past week44. This self-report symptom-rating scale consists of 
20 items, which are scored on a 4-point scale. The total score ranges from 0 to 60 with a higher 
score indicating a higher level of depressive symptoms. The CES-D has been used extensively 
in older population-based samples and is considered a valid and reliable screening instrument 
for Dutch older adults45. At regular cycles, the CES-D was assessed during an interview, while 
at the side study, the CES-D was assessed using a self-reported questionnaire.
The cutoff score of ≥16 was used to indicate clinically relevant depressive symptoms; this 
cutoff has a sensitivity of 100% and a specificity of 88% in the first LASA cohort45. For RQ1, 
the presence of depressive symptoms (yes/no) was used as determinant. For RQ2, short-
term changes in depressive symptoms from 2011-2013 to 2015/2016 were divided into 
four categories: ‘no depressive symptoms’ (no-no), ‘emerging depressive symptoms’ (no-
yes), ‘remitted depressive symptoms’ (yes-no) and ‘chronic/recurrent depressive symptoms’ 
(yes-yes). In line with Penninx et al.46 and Van Gool et al.47, a relevant change in depressive 
mood was defined as an increase (emerging depressive symptoms) or decrease (remitted 
depressive symptoms) of 4 CES-D points or more between the two measurements, thereby 
crossing the cutoff score of 16. Persons who did not fulfil the condition of relevant change 
(4 points) were categorised as ‘no depressive symptoms’ or ‘chronic/recurrent depressive 
symptoms’, depending on their starting level of depressive symptoms. For RQ3, long-term 
history of depressive symptoms (yes/no) was used as determinant: CES-D score <16 at all 
cycles versus CES-D score ≥16 at any of the four regular cycles before the side study (2001-
2003, 2005/2006, 2008/2009 and/or 2011-2013).
Covariates
Data on age and sex were derived from the municipal registries. Marital status was categorised 
into married/registered partnership, never married and widowed/divorced. The highest 
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completed level of education was divided into low (elementary school or less), middle (general 
secondary, intermediate vocational, intermediate general and lower vocational education) 
and high (university education, college or higher vocational). Body mass index (BMI) was 
calculated by dividing measured body weight (in kg) by the squared measured body height (in 
m). Waist circumference (in cm) was measured twice and the mean was calculated. Categories 
of self-reported smoking status were never, former and current smoking. Self-reported 
alcohol use was categorised into no, light, moderate and (very) excessive48. Total energy intake 
was calculated from the FFQ. Physical activity during the past 2 weeks (walking outdoors, 
cycling, light and heavy household activities and sports, in MET-hours/week) was assessed 
using the validated LASA Physical Activity Questionnaire49. Self-reported number of chronic 
diseases included major somatic diseases: asthma/chronic obstructive pulmonary disease, 
cardiac disease, peripheral arterial disease, diabetes mellitus, cerebrovascular accident/
stroke, osteoarthritis/rheumatoid arthritis, cancer, hypertension and other chronic diseases. 
General cognitive functioning was measured with the Mini-Mental State Examination (MMSE, 
only used in sensitivity analyses), which score ranges from 0 to 3050. Use of antidepressants 
(yes/no, only used in sensitivity analyses) was retrieved during the medical interviews at the 
regular cycles using ATC-codes of the medications used at that time by the participant. At the 
side study, a question asked about current use of antidepressants (yes/no). As most covariates 
were not included in the side study’s questionnaire, data on all covariates were measured 
at the cycle before the side study (2011-2013), with the exception of energy intake and 
antidepressant use at the side study (2014/2015).
Statistical analyses
Characteristics were described as means and standard deviations (SD) or medians and 
interquartile ranges (IQR), and as percentages. Intakes of the diet quality indices’ components 
were described as medians and IQRs.
The MDS, AHEI and DASH outcomes were checked by analysis of residuals and appeared 
normally distributed; therefore, they were analysed as continuous outcomes. Multivariable 
linear regression models were used to analyse the associations of all three RQs, i.e. the 
associations between the specific depression determinant and the diet indices (Figure 1). 
The reference categories used were: no current depressive symptoms (RQ1), no depressive 
symptoms at both time points (RQ2) and no history of depressive symptoms (RQ3). Effect 
modification by sex, age (continuous) and cohort was tested for all RQs as diet-depression 
associations have been found to be sex- and age-specific7,8 and as the LASA’s cohorts differ 
in age range and assessment period. The potential effect modifier and the interaction term 
between the depression determinant and the potential effect modifier were included in 
the crude regression models, and a P-value <0.10 of an interaction term was considered 
statistically significant. Potential confounders were added to the univariable models of the 
cross-sectional analyses (RQ1), and included in the final models if regression coefficients 
changed >10% for at least one of the diet indices. This led to the following models used for 
RQ1, RQ2, and RQ3: model 1 was the crude model, model 2 was adjusted for age, sex, cohort, 
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education level and marital status, and model 3 was additionally adjusted for physical activity, 
smoking and number of chronic diseases. Energy intake as well as waist circumference were 
additionally added to the models to examine the influence of these variables separately. For 
RQ3, model 3 was also adjusted for current depressive symptoms (at the side study, continuous) 
to investigate the associations independently of one’s mood status at the time of the FFQ. For 
completeness, this additional adjustment was also done for RQ2; however, current depressive 
symptoms (2014/2015) were measured before the second CES-D measurement of the change 
(2015/2016; see Figure 1).
To test the robustness of our findings, several sensitivity analyses were conducted. As alcohol 
is one of the components of the MDS and AHEI but not the DASH, all analyses with the DASH 
were additionally adjusted for alcohol use. Further, the regression analyses were repeated 
after the exclusion of participants with an MMSE score <24 at the regular cycle just before 
(2011-2013) and/or after (2015/2016) the side study (RQ1+2+3) to avoid any bias regarding 
dietary recall caused by cognitive impairment. Analyses were also repeated after excluding 
participants using antidepressants at the cycles the CES-D data were used for each RQ.
Two-sided P-values ≤0.05 were considered statistically significant. SPSS version 24 (SPSS Inc. 
Chicago, IL, USA) was used for all analyses.
RESULTS
Characteristics
Table 2 shows the characteristics of the three samples. The 1322 participants of the cross-
sectional sample (51.9% women) had a median age of 65.1 years (IQR: 61.1-72.0) at the cycle 
before the side study (2011-2013). The median age of the change sample (n=1233, 51.5% 
women) was 65.2 years (IQR: 61.2-71.9) and of the history sample (n=687, 50.5% women) 
71.2 years (IQR: 67.2-77.2). Compared to the cross-sectional and change samples, the history 
sample was lower educated, had a lower energy intake and had more chronic diseases.
Table 2 | Characteristics of the samples of middle-aged and older adults used for the three research questions 
in the Longitudinal Aging Study Amsterdama
Cross-sectional 
sample (RQ1)
Change  
sample (RQ2)
History  
sample (RQ3)
n 1312 1233 687
Age (years) 65.1 [61.1-72.0] 65.2 [61.2-71.9] 71.2 [67.2-77.2]
Sex, n (%) female 681 (51.9) 635 (51.5) 347 (50.5)
Cohort
First 252 (19.2) 230 (18.7) 241 (35.1)
Second 456 (34.8) 444 (36.0) 446 (64.9)
Third 604 (46.0) 559 (45.3) -
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Cross-sectional 
sample (RQ1)
Change  
sample (RQ2)
History  
sample (RQ3)
n 1312 1233 687
Education, n (%)
Low 159 (12.1) 143 (11.6) 111 (16.2)
Middle 769 (58.6) 719 (58.3) 403 (58.7)
High 384 (29.3) 371 (30.1) 173 (25.2)
Marital status, n (%)
Married 948 (72.3) 894 (72.5) 472 (68.7)
Never married 101 (7.7) 96 (7.8) 38 (5.5)
Widowed/divorced 263 (20.0) 243 (19.7) 177 (25.8)
Body mass index (kg/m2) 26.8 [24.3-29.6] 26.8 [24.3-29.5] 27.0 [24.7-29.6]
Waist circumference (cm) 97.8 ± 11.9 97.8 ± 12.0 98.9 ± 10.7
Physical activity (MET h/wk) 53.4 [33.0-79.3] 53.5 [33.6-79.1] 51.9 [33.8-76.8]
Smoking, n (%)
Never 364 (27.7) 336 (27.3) 192 (27.9)
Former 792 (60.4) 751 (60.9) 426 (62.0)
Current 156 (11.9) 146 (11.8) 69 (10.0)
Alcohol use, n (%)
Non-drinker 161 (12.3) 143 (11.6) 87 (12.7)
Light 620 (47.3) 581 (47.1) 354 (51.5)
Moderate 454 (34.6) 434 (35.2) 214 (31.1)
(Very) excessive 77 (5.9) 75 (6.1) 32 (4.7)
Energy intake (kCal/d) 2089 ± 574 2094 ± 574 2059 ± 562
Number of chronic diseases, n (%)
0 chronic disease 207 (15.8) 198 (16.1) 68 (9.9)
1 chronic disease 369 (28.1) 345 (28.0) 180 (26.2)
≥2 chronic diseases 736 (56.1) 690 (56.0) 439 (63.9)
Cognitive functioning (MMSE score) 29 [28-30] 29 [28-30] 29 [28-30]
Use of antidepressants, n (%) 71 (5.4) 66 (5.4) 26 (3.8)
Depressive symptoms (CES-D score) 8.0 [4.0-13.0] 8.0 [4.0-13.0] 9.0 [5.0-14.0]
Presence of depressive symptoms (CES-D score ≥16), n (%) 208 (15.9) 194 (15.7) 119 (17.3)
Short-term changes in depressive symptoms, n (%) 
No - 1046 (84.8) -
Emerging - 67 (5.4) -
Remitted - 57 (4.6) -
Chronic/recurrent - 63 (5.1) -
Long-term history depressive symptoms, n (%) - - 144 (21.0)
Mediterranean Diet Score 32.6 ± 4.8 32.7 ± 4.8 32.3 ± 4.8
Alternative Healthy Eating Index 2010 58.4 ± 10.2 58.6 ± 10.2 57.8 ± 9.7
Dietary Approaches to Stop Hypertension score 21.6 ± 4.4 21.6 ± 4.4 21.3 ± 4.2
Abbreviations: CES-D, Center for Epidemiologic Studies Depression scale; MET, Metabolic Equivalent of Task; RQ, 
research question; SD, standard deviation.
Values are displayed as mean ± SD or median [interquartile range], and as n (%).
a Characteristics are measured in 2011-2013, except for energy intake, use of antidepressants, (presence of) 
depressive symptoms, and the diet quality indices, which are measured at the Nutrition and Food-related Behaviour 
study (2014/2015).
Table 2 - Continued
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Depressive symptoms
For the cross-sectional sample, the median CES-D score was 8.0 (IQR: 4.0-13.0) (Table 2). 
Regarding the change sample, clinically relevant depressive symptoms (CES-D ≥16) were 
experienced by 120 participants (9.7%) in 2011-2013 and by 130 participants (10.5%) in 
2015/2016. The majority (84.8%) had no depressive symptoms at both cycles, while 5.4% 
experienced emerging, 4.6% remitted and 5.1% chronic/recurrent depressive symptoms 
(Table 2). For the history sample, the numbers of depressive symptoms were 69 (10.0%), 67 
(9.8%), 59 (8.6%) and 60 (8.7%) at the four regular cycles from 2001-2003 to 2011-2013. In 
total 144 participants (21.0%) had a history of depressive symptoms (ever CES-D ≥16 from 
2001-2003 to 2011-2013) (Table 2), of which 20 had a CES-D ≥16 only in 2011-2013.
Dietary intake
In Supplemental Table 1, median intakes of the components of the a priori indices are shown 
for the three analytical samples. Compared to the intakes of the cross-sectional and change 
samples, the intakes of vegetables, nuts and olive oil of the history sample were lower, whereas 
intakes of potatoes and full-fat dairy were higher.
RQ1: cross-sectional analyses
Interaction terms between the presence of depressive symptoms and age or cohort were not 
significant, but those with sex were significant for two indices (MDS: P=0.133, AHEI: P=0.004, 
DASH: P=0.022). To be able to compare the indices, all analyses were stratified by sex (Table 
3). In crude models, depressive symptoms were cross-sectionally associated with lower MDS 
scores; however, after adjustment for confounders, the association remained only statistically 
significant in men (B model 3: -1.21, 95% CI: -2.41, -0.023). Current depressive symptoms 
were also associated with a lower AHEI score in men (B model 3: -2.72, 95% CI: -5.24, -0.20) 
but not in women. An unexpected positive association with the DASH score in women became 
apparent in model 3 (B: 0.86, 95% CI: 0.072, 1.66). Additional adjustment for energy intake 
and waist circumference did not change the findings of any diet index.
RQ2: change analyses
Table 4 shows the results of the association between short-term changes in depressive 
symptoms and the diet indices. The emerging, remitted and chronic/recurrent groups were 
associated with lower scores on all diet indices; however, these associations were not all 
significant. After adjustment for confounders, participants with chronic/recurrent depressive 
symptoms had a lower MDS score compared to those with no depressive symptoms (B 
model 3: -2.22, 95% CI: -3.40, -1.04). This inverse association was also shown for the AHEI 
score, although the association was attenuated in model 3 (B: -2.37, 95% CI: -4.92, 0.18). No 
significant associations were found for the DASH score. The additional inclusion of energy 
intake and waist circumference in the models did not change the findings of any diet index. Of 
the 63 participants with chronic/recurrent depressive symptoms, 47 had current depressive 
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symptoms at the time of the FFQ. However, additional adjustment for current depressive 
symptoms did not change the findings (MDS: B: -1.93, 95% CI: -3.23, -0.62; AHEI: B: -2.29, 95% 
CI: -5.11, 0.53).
Only for the MDS, a significant interaction term was found with sex (remitted group: P=0.085). 
After stratification by sex, the association of the chronic/recurrent group with the MDS score 
was only significant for women (B: -2.71, 95% CI: -4.02, -1.30) but not for men in model 3. In 
addition, significant interaction terms were found between some of the change-groups and 
cohorts (P<0.09) for all diet indices; stratification by cohort showed associations between 
the chronic/recurrent group and the MDS score only in cohort 2 (B model 3: -2.04, 95% CI: 
-4.10, 0.006) and cohort 3 (B model 3: -2.46, 95% CI: -4.19, -0.74), but not in cohort 1, and no 
associations for the AHEI and DASH in any of the cohorts. Because of the small number of men 
(n=16) and of cohort 1 (n=14) in the chronic/recurrent group in the stratified analyses, the 
reliability of these stratified results is uncertain. Unstratified results are presented (Table 4) as 
interactions were not consistent for all indices.
RQ3: history analyses
Of the 144 participants with a history of depressive symptoms, 68 (47%) had current 
depressive symptoms. Interaction terms between history of depressive symptoms and age or 
cohort were not significant, but those with sex were significant for the AHEI and DASH (MDS: 
P=0.114, AHEI: P=0.001, DASH: P=0.010). After stratification of all indices by sex, men with a 
long-term history of depressive symptoms scored lower on the MDS (B model 4: -1.87, 95% 
CI: -3.47, -0.27) as well as on the AHEI (B model 4: -4.33, 95% CI: -7.54, -1.13), independent of 
current depressive symptoms (Table 5). In women, a history of depressive symptoms was not 
associated with the MDS, but with higher AHEI and DASH scores in two models; however, after 
adjustment for current depressive symptoms (model 4), these associations were no longer 
statistically significant. Additional adjustment for energy intake and waist circumference did 
not change the findings.
Sensitivity analyses
Additional adjustment for the use of alcohol for the DASH did not result in different findings 
for any of the three RQs. Similarly, exclusion of participants with an MMSE score <24 in 2011-
2013 and/or in 2015/2016 (RQ1: n=45; RQ2: n=44; RQ3: n=29) did not change the results 
of any RQ for any diet index. After exclusion of participants who used antidepressants at the 
indicated cycles (RQ1: n=71; RQ2: n=100; RQ3: n=64), the cross-sectional associations became 
non-significant in men for the MDS (B model 3: -0.92, 95% CI: -2.18, 0.34) and the AHEI (B 
model 3: -2.18, 95% CI: -4.85, 0.50), and in women for the DASH (B model 3: 0.66, 95% CI: 
-0.18, 1.50). The changes and history associations did not change, except that the association 
between history and the MDS in men attenuated (B model 4: -1.72, 95% CI: -3.50, 0.07).
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Table 3 | Cross-sectional associations between depressive symptoms and three diet quality indices stratified 
by sex in 1312 middle-aged and older LASA participantsa
MDS    AHEI     DASH    
  B 95% CI P B 95% CI P B 95% CI P
Model 1
Male -2.09 -3.31, -0.88 0.001 -4.48 -7.04, -1.93 0.001 -0.96 -2.09, 0.18 0.098
Female -0.93 -1.83, -0.03 0.043 0.19 -1.71, 2.09 0.845 0.65 -0.14, 1.45 0.108
Model 2
Male -1.52 -2.72, -0.32 0.013 -3.40 -5.93, -0.88 0.008 -0.64 -1.77, 0.49 0.270
Female -0.67 -1.56, 0.21 0.136 0.88 -1.01, 2.77 0.359 0.74 -0.05, 1.54 0.066
Model 3
Male -1.21 -2.41, -0.02 0.046 -2.72 -5.24, -0.20 0.034 -0.40 -1.53, 0.73 0.492
Female -0.50 -1.38, 0.38 0.264 1.20 -0.70, 3.10 0.215 0.86 0.07, 1.66 0.033
Abbreviations: AHEI, Alternative Healthy Eating Index 2010; B, unstandardised regression coefficient; CES-D, Center 
for Epidemiologic Studies Depression scale; CI, confidence interval; DASH, Dietary Approaches to Stop Hypertension; 
LASA, Longitudinal Aging Study Amsterdam; MDS, Mediterranean Diet Score.
Model 1: crude model.
Model 2: adjusted for age, cohort, education level and marital status.
Model 3: additionally adjusted for physical activity, smoking and number of chronic diseases.
a Clinically relevant depressive symptoms were defined as a CES-D score ≥16. Number of cases: men: 65 / 631; 
women: 143 / 681.
Table 4 | Associations between short-term changes in depressive symptoms and three diet quality indices in 
1233 middle-aged and older LASA participantsa
MDS    AHEI     DASH    
B 95% CI  P B 95% CI  P B 95% CI P
Model 1
No Reference Reference Reference
Emerging -1.32 -2.49, -0.14 0.028 -0.99 -3.51, 1.53 0.441 -0.32 -1.41, 0.76 0.556
Remitted -1.10 -2.37, 0.17 0.090 -1.16 -3.88, 1.56 0.402 -0.40 -1.57, 0.77 0.499
Chronic/recurrent -3.24 -4.45, -2.03 <0.001 -3.78 -6.38, -1.19 0.004 -0.63 -1.75, 0.48 0.263
Model 2
No Reference Reference Reference
Emerging -0.92 -2.08, 0.23 0.116 -0.57 -3.04, 1.91 0.653 -0.45 -1.52, 0.61 0.403
Remitted -0.70 -1.94, 0.54 0.268 -0.73 -3.38, 1.93 0.592 -0.36 -1.50, 0.78 0.531
Chronic/recurrent -2.58 -3.77, -1.38 <0.001 -3.02 -5.58, -0.46 0.021 -0.66 -1.76, 0.44 0.241
Model 3 
No Reference Reference Reference
Emerging -0.72 -1.85, 0.42 0.215 -0.15 -2.59, 2.30 0.905 -0.33 -1.38, 0.72 0.532
Remitted -0.33 -1.55, 0.89 0.596 0.08 -2.56, 2.71 0.955 -0.06 -1.19, 1.07 0.914
Chronic/recurrent -2.22 -3.40, -1.04 <0.001 -2.37 -4.92, 0.18 0.069 -0.43 -1.52, 0.67 0.445
Abbreviations: AHEI, Alternative Healthy Eating Index 2010; B, unstandardised regression coefficient; CES-D, Center 
for Epidemiologic Studies Depression scale; CI, confidence interval; DASH, Dietary Approaches to Stop Hypertension; 
LASA, Longitudinal Aging Study Amsterdam; MDS, Mediterranean Diet Score.
Model 1: crude model.
Model 2: adjusted for age, sex, cohort, education level and marital status.
Model 3: additionally adjusted for physical activity, smoking and number of chronic diseases.
a Changes in depressive symptoms were divided into four categories, based on the presence of depressive symptoms 
(CES-D score ≥16) in 2011-2013 and 2015/2016.
131
6
Depressive symptoms and diet quality indices
Table 5 | Associations between long-term history of depressive symptoms and three diet quality indices 
stratified by sex in 687 middle-aged and older LASA participantsa
MDS    AHEI     DASH   
B 95% CI  P B 95% CI  P B 95% CI  P
Model 1
Male -2.10 -3.53, -0.67 0.004 -4.52 -7.41, -1.63 0.002 -1.15 -2.48, 0.17 0.088
Female -0.62 -1.75, 0.51 0.279 1.73 -0.59, 4.05 0.144 0.97 0.01, 1.92 0.048
Model 2
Male -2.00 -3.44, -0.56 0.007 -4.92 -7.85, -1.99 0.001 -1.33 -2.70, 0.04 0.057
Female -0.14 -1.28, 1.00 0.812 2.71 0.34, 5.08 0.025 1.11 0.13, 2.10 0.027
Model 3
Male -1.88 -3.33, -0.42 0.012 -4.56 -7.47, -1.64 0.002 -1.17 -2.54, 0.21 0.096
Female -0.31 -1.45, 0.82 0.588 2.53 0.13, 4.92 0.039 0.95 -0.03, 1.93 0.056
Model 4
Male -1.87 -3.47, -0.27 0.022 -4.33 -7.54, -1.13 0.008 -1.12 -2.63, 0.40 0.148
Female 0.11 -1.20, 1.42 0.867 2.06 -0.71, 4.82 0.144 0.86 -0.27, 1.99 0.133
Abbreviations: B, unstandardised regression coefficient; CES-D, Center for Epidemiologic Studies Depression scale; 
CI, confidence interval; LASA, Longitudinal Aging Study Amsterdam.
Model 1: crude model.
Model 2: adjusted for age, cohort, education level and marital status.
Model 3: additionally adjusted for physical activity, smoking and number of chronic diseases.
Model 4: additionally adjusted for current depressive symptoms (continuous, at side study).
a History of depressive symptoms was defined as a CES-D score ever ≥16 from 2001-2003 to 2011/2012. Number of 
cases: men: 37 / 340; women: 82 / 347.
DISCUSSION
In Dutch middle-aged and older adults, current and past depressive symptoms were associated 
with poorer diet quality based on indices. Depressive symptoms were cross-sectionally 
associated with lower MDS and AHEI scores in men, but not in women. Chronic/recurrent 
depressive symptoms over 2 to 5 years were associated with lower MDS and AHEI scores, 
while emerging and remitted depressive symptoms were not associated with any of the diet 
indices. A history of depressive symptoms over 2 to 14 years was associated with lower MDS 
and AHEI scores in men. No consistent associations with the DASH score were found.
We found associations with a lower diet quality in men not only cross-sectionally for the 
presence of current depressive symptoms, but also longitudinally for history of depressive 
symptoms in both the short- and long-term. Hence, having a depressed mood currently or 
previously seems to be associated with a less healthy dietary pattern in men. However, the 
cross-sectional MDS and AHEI associations became non-significant when persons using 
antidepressants were excluded. This might indicate that these associations are partly driven by 
men with more severe depressive symptoms (who used antidepressants); yet, the regression 
coefficients did not differ that much (MDS: -1.21 (complete sample) vs. -0.92 (without 
antidepressant users); AHEI: -2.72 vs. -2.18). Regarding the short-term changes in depressive 
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symptoms, we only found an association for the chronic/recurrent group. This indicates that 
chronically/recurrently depressed persons consume a less healthy diet, but that emerging or 
remitted depression does not seem to negatively influence diet.
Next, we found that some associations differed between men and women. The current 
and long-term history associations were comparable in direction and effect size, showing 
inverse associations with the MDS and AHEI in men but not in women. Reasons for these sex 
differences are not clear, but it might be that depressive mood negatively influences food 
intake to a greater extent in men than in women. In contrast, women who have/had depressive 
symptoms might pay more attention to their food intake, resulting in ‘normal’ MDS and AHEI 
scores and, consequently, no associations. In cancer patients, changes towards a healthier diet 
were significantly more frequent in women compared to men51. The associations of chronic/
recurrent depressive symptoms with the MDS and AHEI were found in both sexes; though, 
when the MDS analysis was stratified, the association was only found in women. A potential 
explanation for this null-association in men is the low power (16 men with chronic/recurrent 
depressive symptoms). Lastly, our sex differences might also be explained by chance.
Our findings also showed that the associations of the three RQs were comparable for the 
MDS and the AHEI: current as well as past depressive symptoms were associated with lower 
index scores in men. In contrast, we did not find any associations between the depression 
determinants and the DASH, except for a higher DASH score in women with current depressive 
symptoms (only model 3). This unexpected direction – depressive symptoms may lead to a 
healthier diet – was also seen in women for the AHEI but only for the DASH significant. The 
null-findings for the DASH might be explained by its relatively smaller number of components 
and smaller score range, compared to the other indices. In contrast to the MDS, which includes 
fish and olive oil, and the AHEI, which includes eicosapentaenoic/docosahexaenoic acid and 
polyunsaturated fatty acids, the DASH does not include any fish or fatty acid component. 
The DASH also does not take into account alcoholic beverages. These food groups might be 
key components in the depression-diet link52,53. Another explanation may be the inclusion of 
fruit juices in the fruit component, i.e. scoring them as healthy. In the AHEI, fruit juices are 
scored as unhealthy, together with sugar-sweetened beverages. A final possible explanation 
is the healthy-scoring low-fat dairy component: this component was not included in the MDS 
or AHEI, and may have influenced the total DASH score in such a way that associations were 
attenuated.
This study is the first that addressed the reverse causality hypothesis by investigating 
depressive symptoms prospectively in relation to three diet quality indices. Our findings 
are somewhat different from previous studies. Gougeon et al.33 studied the hypothesis in 
an older sample, like us. They found no different changes in intakes of energy, fibre, protein 
and saturated fat between persons who became depressed and those who remained non-
depressed. However, a comparison with our study is hard, since their follow-up time was short 
(1 year), they did not examine diet indices, and their design did not eliminate the possibility of 
studying the reverse association (i.e. 1-year change in intake → incident depressive symptoms 
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in that year) because it was unknown in which month the changes in intake and mood occurred. 
Our study compares better to the Australian study of Jacka et al.32 in that they studied dietary 
patterns as well as current and past depression. Similar to our cross-sectional MDS and AHEI 
associations in men, they found that current depression was associated with lower scores on 
their healthy pattern (no sex-stratified analyses). However, those with a depression history 
reported higher scores on the healthy pattern (if they had received treatment) and lower 
scores on the unhealthy pattern. This contrasts with our significant associations between long-
term history of depressive symptoms and lower MDS and AHEI scores in men. Adjustment for 
current depressive symptoms was done in both studies, so could not explain these differences. 
Explanations could be age differences between the study populations and Jacka’s reliance on 
retrospectively recalled depression with no specified time frame, while we used prospective 
CES-D data from four regular interviews over 2 to 14 years.
Our findings that depressive symptoms were associated with lower diet quality are contrary 
to additional analyses of some prospective studies on the diet-depression link. None of 
these studies that additionally analysed the association in the reverse direction or excluded 
participants reporting depressive symptoms at baseline from the analysis, found evidence for 
reverse causalitye.g. 8,9,24,25-31. An important difference with our study is that most of them did 
not examine a priori diet indices, but a posteriori patterns24,26,28 or food groups9,29-31. Akbaraly 
et al.8 and Sánchez-Villegas et al.25 used, respectively, the AHEI and MDS, yet older versions. 
Similar to us, Skarupski et al.27 used the MDS of Panagiotakos et al.40 but they just excluded 
participants with depressive symptoms at baseline and did no analysis with the CES-D as 
determinant. Moreover, our cross-sectional associations were not significant in women. Some 
previous cross-sectional studies on diet quality (i.e. AHEI) were performed only in women; 
they showed that depressive symptoms were associated with a lower AHEI score in depressed, 
obese women17 and in Latinos at risk of type 2 diabetes20, but not in overweight African 
American women19. Additionally, current depressive disorder was associated with lower MDS 
and AHEI scores16. Potential explanations for these inconsistencies are differences in study 
populations, measures of depression and dietary assessment methods.
Strengths of our study include the large, nationally representative sample of Dutch middle-
aged and older adults, its longitudinal design, the use of three depression determinants across 
different time windows (current, short-term changes and long-term history), and the use 
of three commonly-used indices of a healthy diet. Some limitations of the study should also 
be discussed. Dietary data from an FFQ were used for the outcome measures of this study; 
potential memory loss in older participants might have led to misreporting54. Nonetheless, 
underreporting in older persons may partly reflect a true low caloric intake (undereating)55, 
and exclusion of participants with low cognitive functioning did not change the results. 
Another caveat is that the FFQ data were collected as part of the side study (2014/2015) 
and not at a regular cycle; this resulted in time differences with the cycles of the covariates 
(2011-2013) and the second CES-D measurement of RQ2 (2015/2016). Potential changes 
in lifestyle (diet, physical activity, smoking, alcohol use) within these time difference periods 
could have introduced information bias. Since dietary data were only collected once, it was 
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not possible to investigate the prospective depression-diet association in order to completely 
test the reverse causality hypothesis within LASA. Moreover, our study was limited by the use 
of the CES-D scale, which assesses self-reported depressive symptoms but not clinical major 
depressive disorder. Also, its mode at the side study (questionnaire) differed from the one at 
regular cycles (face-to-face interview). Finally, as participation in the side study was the main 
inclusion criteria, our sample might be relatively healthy and less representative.
In conclusion, our longitudinal study in middle-aged and older adults shows that current 
depressive symptoms, short-term chronic/recurrent depressive symptoms and a long-term 
history of depressive symptoms were all associated with lower diet quality scores, indicating 
a less healthy diet. These associations were found for adherence to the MDS and AHEI and 
were particularly present among men. Depressive symptoms did not seem to be associated 
with the DASH. This all gives an indication of reversed causality of diet and depression, 
while emphasising potential sex differences. As longitudinal studies on the depression to 
diet association are scarce, more prospective studies are needed to confirm our results. 
Such studies should preferably include repeated diet measurements and investigate gender 
differences. If future studies find more evidence for an association between low mood and 
poor diet (in men), clinicians and practitioners need to be aware of this in order to prevent this 
undesirable change in diet and subsequent increased disease risk.
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Supplemental Table 1 | Food items and intakes of the diet indices components
Intake (g/d)b
Cross-
sectional 
sample 
(RQ1)
Change 
sample 
(RQ2)
History 
sample 
(RQ3)
Component Food itemsa  n 1312 1233 687
Fruits All fruits [excluding olives and avocado] (10)  200  
[96-266]
197  
[95-266]
201  
[101-266]
Fruit juice Pure 100% fruit juices (2) 15.6  
[0.0-100]
15.6  
[0.0-100]
15.6  
[0.0-100]
Sugar-sweetened 
beverages
100% fruit juices (not for the DASH), fruit drinks, 
soft drinks, syrups/lemonade, energy drinks, sport 
drinks [excluding ‘light’ drinks with only artificial 
sweeteners] (11)
0.0  
[0.0-33.5]
0.0  
[0.0-34.3]
0.0  
[0.0-30.5]
Vegetables All vegetables [excluding roots/tubers, plantain and 
potatoes] (21)
153  
[99-208]
154  
[100-208]
140  
[90-198]
Legumes Beans and lentils (including in soup), tofu and meat 
substitutes based on soy (4)
11.3  
[0.0-25.0]
11.3  
[0.0-25.0]
11.0 
 [0.0-23.8]
Nuts Nuts, peanuts, peanut butter (6) 4.0  
[0.59-11.6]
4.3  
[0.70-11.6]
3.3  
[0.0-9.9]
Potatoes All forms of potatoes (boiled, mashed, oven 
prepared) [excluding French fries and other fried 
potatoes] (4)
68.4  
[40.0-116]
66.9  
[40.0-113]
77.5  
[41.7-120]
Whole grains 
/ Non-refined 
cereals
Wholemeal/brown/multigrain bread, wholemeal/
brown/multigrain bread rolls, rye bread, wholemeal 
crackers; oats, muesli, other wholegrain cereals; 
wholemeal pasta, brown rice, bulgur, couscous (12)
125  
[86.4-170]
126  
[86.6-170]
122  
[85.2-157]
Red and 
processed meat
All meat and meat products (beef, pork, organ, lamb, 
sausages, cold cuts) (22) 
62.5  
[35.4-96.6]
62.3  
[35.4-93.6]
59.7  
[35.5-89.5]
Poultry Chicken (4) 11.4  
[4.5-22.9]
11.4  
[4.5-18.0]
11.2  
[3.8-17.9]
Fish Lean and fatty fish, shellfish (9) 17.1  
[8.8-28.6]
17.1  
[8.8-29.5]
17.1  
[7.3-28.4]
Olive oil Olive oil used for cooking, frying, in dressings and as 
a dip for bread (g/d)
2.6  
[0.0-6.2]
2.6  
[0.0-6.2]
1.7  
[0.0-5.9]
EPA + DHA Derived from all food items 0.17  
[0.09-0.30]
0.17  
[0.09-0.31]
0.16  
[0.09-0.30]
Polyunsaturated 
fatty acids (E%)
Derived from all food items 6.9  
[5.7-8.2]
6.9  
[5.7-8.2]
6.9  
[5.5-8.3]
Trans fat (E%) Derived from all food items 0.43  
[0.35-0.50]
0.42  
[0.35-0.50]
0.44  
[0.36-0.51]
Low-fat dairy 
products
Low fat/fat-free yogurt and quark (≤1.5 g fat/100 
ml); reduced-fat/skim milk, chocolate milk and 
yogurt drink (≤1.5 g fat/100 ml); low-fat cheese, 
cottage cheese, ricotta, goat cheese (22)
194  
[43.1-346]
196  
[46.5-351]
200  
[42.0-354]
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Intake (g/d)b
Cross-
sectional 
sample 
(RQ1)
Change 
sample 
(RQ2)
History 
sample 
(RQ3)
Component Food itemsa  n 1312 1233 687
Full-fat dairy 
products
Full fat/low fat yoghurt and quark (>1.5 g fat/100 
ml); full fat/reduced-fat milk, chocolate milk; 
desserts; ice cream; cream; evaporated milk, coffee 
creamer; high fat hard and soft cheese (24)
78.7  
[32.4-156]
78.4  
[32.5-156]
86.4  
[35.7-166]
Alcoholic 
beverages 
(beverages/d)
Beer, wine, liqueur, gin and other alcohol containing 
beverages (5)
0.8  
[0.1-2.0]
0.8  
[0.1-2.0]
0.7  
[0.04-1.9]
Sodium Not calculated from the FFQ      
Abbreviations: DHA, docosahexaenoic acid; E%, energy percentage; EPA, eicosapentaenoic acid; IQR, interquartile range.
a The number of food items within a food group is indicated between brackets. 
b Median [interquartile range] intakes unless otherwise stated.
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The overall aim of this thesis was to investigate longitudinal associations of nutrient status, 
food groups and dietary patterns with depressive symptoms in adults. We used data from 
two European prospective cohort studies of older populations to assess these associations: 
LASA and the InCHIANTI study. This chapter summarizes and discusses the results presented 
in Chapters 2 to 6 by providing the main findings and an interpretation of them, a discussion 
of methodological considerations, recommendations for future research and implications for 
public health and clinical practice.
MAIN FINDINGS AND THEIR INTERPRETATION
The findings of the studies described in this thesis are summarised in Figure 1, which was 
introduced in the General introduction. These findings are discussed below.
Figure 1 | Schematic overview of the findings of the studies in this thesis.  
The arrows indicate the direction of the investigated associations. Abbreviations: BL, baseline; NS, no 
significant association. Explanation of symbols: +, positive association; –, negative association; Δ, change.
Research question 1. What is the longitudinal association between nutrient status 
and depressive symptoms? 
Two vitamins, potentially important in mental health, were investigated in relation to 
depressive symptoms. The cross-sectional and longitudinal associations between serum 
vitamin B
12
 concentration and depressive symptoms were examined in LASA participants 
aged ≥65 years (Chapter 2). Baseline vitamin B
12
 was not cross-sectionally associated with the 
severity of depressive symptoms. Prospectively, no associations were found with course of 
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depressive symptoms nor with incidence of depression over 16 years. As serum vitamin B
12
 is 
inversely correlated with plasma total homocysteine, we repeated the analyses using baseline 
homocysteine concentration as determinant. Homocysteine was also neither cross-sectionally 
nor prospectively associated with depressive symptoms, confirming the null findings of 
vitamin B
12
. A possible explanation for our prospective null results for both vitamin B
12
 and 
homocysteine is that the follow-up period of 16 years was too long to detect any association; 
however, post hoc analyses with depressive symptoms 3 years after baseline also showed no 
associations. Our results do not support previous studies that found a relationship between 
vitamin B
12
 and depressive symptoms. 
Cross-sectional and prospective 6-year associations between serum 25-hydroxyvitamin D 
(25(OH)D) concentration and depressive symptoms were examined in both the older (≥65 years 
at baseline) and younger (55-65 years at baseline) LASA cohort (Chapter 3). No cross-sectional 
associations were found between baseline serum 25(OH)D and the severity of depressive 
symptoms after adjustment for confounders. This is in contrast with a previous study within 
the older LASA cohort that did find a cross-sectional association between depression status 
and serum 25(OH)D1. The inconsistency might be explained by their categorised definition 
of depression, depression as determinant and 25(OH)D concentration as outcome, and 
different confounders. However, our cross-sectional associations were in the same direction 
but became non-significant after adjustment. In our prospective associations, sex was an 
effect modifier in the older cohort; older women with low baseline 25(OH)D concentrations 
experienced more depressive symptoms in the following 6 years, compared to women with 
25(OH)D concentrations >75 nmol/l. In older men and in the younger cohort, no significant 
associations were found. The differences between the cohorts might be explained by the better 
health status of the younger cohort: the younger participants had higher 25(OH)D levels, fewer 
chronic diseases and better physical functioning, compared to the older cohort. This may have 
acted as a ‘buffer’ to protect them from the negative effect of low 25(OH)D levels on mood. 
Furthermore, only in women of the older cohort we found an association, which might be due 
to the generally lower 25(OH)D concentrations in women compared to men. These findings 
contrast most observational studies but resemble most intervention studies by showing no 
conclusive associations between vitamin D and depressive symptoms.
Subsequently, an investigation on the longitudinal association between change in serum 
25(OH)D and parallel change in depressive mood over time was performed (Chapter 4). No 
associations between change in 25(OH)D and change in depressive symptoms were found 
in the older LASA cohort over a period of 13 years. Neither did we find associations in the 
younger cohort over 6 years with a baseline 25(OH)D concentration above 59 nmol/l. However, 
in participants from the younger cohort with a lower baseline 25(OH)D, an increase in serum 
25(OH)D of 10 nmol/l was associated with a decrease in the Center for Epidemiologic Studies 
Depression (CES-D) score of 0.62 points. Possible explanations for our null results in the older 
cohort are the limited power (n=173) and the long follow-up period (13 years). The null findings 
in younger participants with relatively high baseline 25(OH)D concentrations suggest that a 
change in 25(OH)D only influences depressive symptoms when baseline 25(OH)D is below 
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a certain level. This indicates that an increase in vitamin D level might be protective against 
depressive mood but only in middle-aged persons with a low vitamin D level. 
In summary, we found no cross-sectional and prospective associations between baseline serum 
vitamin B
12
 and depressive symptoms in Dutch older adults. Our prospective associations that 
were significant for serum vitamin D were only found in specific subsamples that differed 
per study: older women (Chapter 3) vs. young older adults with low 25(OH)D concentrations 
(Chapter 4). This disparity in subsamples might be explained by different study samples (n=1075 
vs. n=450), the limited power and differently handled measures of 25(OH)D concentrations 
(original values vs. standardised, ‘deseasonalised’ values). Overall, these results suggest 
that serum vitamin B
12
 and vitamin D are not associated with depressive mood in Dutch 
older adults in general. However, vitamin D might be related to depression risk in specific 
population groups.
Research question 2. What is the bidirectional, longitudinal association between 
food group intakes and depressive symptoms?
Prospective associations between food group intakes and depressive symptoms were 
investigated in two directions in participants of the InCHIANTI study (Chapter 5). Of thirteen 
food groups, higher intakes of fish and sweet foods were associated with respectively a 
3-year decrease and increase in CES-D scores over a 9-year period. In the reverse direction, 
higher CES-D scores were associated with a decrease in the intakes of vegetables and red 
and processed meat, and an increased intake of dairy and savoury snacks. No significant 
associations in either direction were found for fruit, nuts and legumes, potatoes, whole grain 
bread, olive oil, sugar-sweetened beverages and fruit juices, and coffee and tea. These results 
confirm bidirectional, longitudinal associations between specific food group intakes and 
depressive symptoms in an Italian sample of mainly older adults; however, no associations 
in both directions were found for a single food group, indicating that reverse causality is not 
the reason for the observed associations.
Research question 3. What is the association of depressive symptoms and history 
with diet quality indices?
We examined associations between several depression determinants and diet quality in 
Dutch persons aged ≥55 years (Chapter 6). Next to cross-sectional associations using current 
depressive symptoms (1), longitudinal associations were studied in using short-term changes 
in depressive symptoms (2) and long-term history of depressive symptoms (3). Scores on 
three worldwide-used a priori diet quality indices were used as outcomes: the Mediterranean 
Diet Score (MDS), Alternative Healthy Eating Index (AHEI) and Dietary Approaches to Stop 
Hypertension diet (DASH). Findings showed that current depressive symptoms as well as 
history of depressive symptoms over 2 to 14 years were associated with lower MDS and 
AHEI scores – indicating a lower diet quality – in men but not in women. Chronic/recurrent 
depressive symptoms over 2 to 5 years were also associated with lower MDS and AHEI scores 
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and a trend for lower AHEI scores. No consistent associations were found with the DASH 
score, and emerging and remitted depressive symptoms were also not associated with any diet 
index. Regarding current and past depressive symptoms, a potential explanation for the null 
associations in women may be that depressive mood affects food intake in an adverse way to 
a greater extent in men than in women. For all three depressive determinants, no associations 
with the DASH were found, potentially due to its smaller number of components and smaller 
score range, compared to the MDS and AHEI. These findings suggest that current and past 
depressive symptoms are linked to poorer diet quality, particularly in men.
Overall findings
Based on these findings in older adults, we can conclude that vitamin B
12
 and vitamin D status 
seem not to be associated with depressive symptoms, while intake of fish is inversely and 
sweets positively associated. In the reverse direction, depressive symptoms are associated 
with changes in the intake of other food groups (i.e. vegetables, meat, dairy and savoury 
snacks) as well as, particularly in men, a lower diet quality.
METHODOLOGICAL CONSIDERATIONS
Throughout the individual chapters, specific strengths and limitations of the performed 
studies have already been addressed. This section describes generic methodological issues 
and considerations most relevant for the overall thesis. 
Assessment of nutrient status and dietary intake
In nutritional research, different levels of nutritional factors are studied. Nutrient status was 
used as determinant in Chapters 2, 3 and 4, whereas dietary intake was used in Chapters 5 
and 6.
Assessment of nutrient status
Nutrient status was measured by serum concentrations of vitamin B
12
 and 25(OH)D (Chapters 
2, 3 and 4). The main advantage of serum concentrations is that they are objective markers, 
which are a more valid estimate of status compared to estimates of intake from foods and 
supplements2,3. Serum levels are integrated measures of nutritional status, reflecting not only 
the actual intake of the vitamin but also individual differences in metabolism, absorption and 
storage. For serum vitamin B
12
, gastric and intestinal diseases as well as folate status influence 
its level. Also, vitamin B
12
 deficiency in older persons is mostly not caused by low dietary 
intake but by food-bound malabsorption, which is in part due to gastric atrophy4, illustrating 
that levels are a better measure of status in an aged population5. Regarding serum 25(OH)D 
concentration, an important source of vitamin D – much more important than intake from 
foods and supplements – is the exposure to sunlight. For most people, around 90% of their 
vitamin D requirement comes from casual exposure to sunlight6,7, indicating that levels are 
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a better measure of vitamin D status. So, when focusing on a single nutrient, such as vitamin 
B
12
 or vitamin D, the use of blood concentrations is a strength compared to studies that used 
dietary intakes of these vitaminse.g. 8,9-12.
On the other hand, measurements of serum concentrations entail some weaknesses. One 
is that methods to measure the concentrations differ from each other in their methodology, 
which can result in serious discrepancies in measured levels between methods13-15. An example 
from our study with 25(OH)D at baseline is the use of two different assays (competitive protein 
binding assay and radioimmunoassay), which hampered a direct comparison between the older 
and younger cohort (Chapter 3). Further, in the assessment of vitamin B
12
 status, no golden 
standard for deficiency exist. Assays of serum vitamins B
12
 have a high sensitivity around 95 
to 97%, but a low specificity of <80%16. In other words, only 3 to 5% of the persons who are 
clinically deficient will have a normal serum level (>148 pmol/l; false negative), but more than 
20% of those who are subclinically deficient (i.e. asymptomatic) will have a low serum level (<148 
pmol/l; false positive). Therefore, to diagnose vitamin B
12
 deficiency in the research setting, the 
combination of several biomarkers is preferred, including methylmalonic acid, homocysteine, 
holotranscobalamin and folate16-20. Of these, we were able to study only homocysteine since 
the other markers have not been measured within LASA (homotrancobalamin) or only in 
participants from one geographical region (northeast) of the Netherlands (methylmalonic acid 
and folate). Hence, we were not able to examine vitamin B
12
 deficiency specifically, but the 
full continuum of vitamin B
12
 concentration instead. Nevertheless, our analyses with plasma 
homocysteine confirmed our results of serum vitamin B
12
: in both we found no associations 
with depressive symptoms. Thus, future studies may include these markers, preferably at least 
two, when examining health effects of vitamin B
12
 deficiency.
Assessment of dietary intake
In contrast to nutrient status, dietary intake cannot be measured objectively; the measurement 
errors of dietary intake depend on the subject. Measuring people’s dietary intakes has always 
been a challenge as all dietary assessment methods encompass measurement errors. In 
Chapters 5 and 6, dietary intakes were derived using a food frequency questionnaire (FFQ), 
which was administered by trained interviewers in the Italian cohort and was self-administered 
in the Dutch. Although assistance of interviewers prevented misunderstanding of some 
of the questions, FFQs rely on memory and are subject to misreporting, depending on age, 
gender, educational level, type of food and body weight status21,22. Self-reported dietary data 
include misclassification that is not always non-differential and can accordingly result in an 
underestimation as well as overestimation of the association23,24. As our samples consisted of 
middle-aged and older adults, cognitive decline might have affected retention and reporting25. 
Though, due to anorexia of aging, underreporting in older persons may partly reflect a true low 
caloric intake (i.e. undereating)26. Simultaneously, this self-reporting aspect is an advantage 
of an FFQ as it makes it feasible to assess dietary intake in large, epidemiological studies. 
Other advantages are the modest burden on participants and the ability to assess longer-term, 
habitual food consumption27. Moreover, the FFQ of the European Prospective Investigation 
into Cancer and nutrition (EPIC) study, used in the Italian cohort, was validated against other 
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dietary assessment methods and showed to have acceptable validity28,29. The FFQ of the 
HELIUS (HEalthy LIfe in an Urban Setting) study30, which was used in the Dutch cohort, was 
validated using biomarkers: plasma carotenoid levels for fruit and vegetable intake (partial 
Spearman’s r: 0.53); and fatty acids measured in the cholesterol-ester fraction of plasma for 
fish (r: 0.51) and for high-fat dairy intakes (r: 0.60) (personal communication). In addition, a 
validation study with 24-hour recalls will soon be available (personal communication). 
Nutrition and seasonality
A common issue for nutrition is the influence of season. Seasonal variation exists for nutrient 
status, including serum vitamin B
12
31 and vitamin D6. Dietary intake is also influenced by season, 
including food groups and – to a lesser extent – macronutrients32,33. This does not only hold for 
FFQs that asked about intake during a short period, such as during the last 4 weeks in the FFQ 
in LASA (Chapter 6), but also for FFQs with a reference period of one year, such as the FFQ 
used in the InCHIANTI study (Chapter 5), whereby current diet intake influences the retention 
of habitual past diet intake33. Furthermore, seasonal variation is most recognised for vitamin 
D concentrations as the skin can synthesise vitamin D
3
 when exposed to ultraviolet radiation. 
Seasonal variation in 25(OH)D concentrations exists especially in high latitude regions, 
including the Netherlands6,34. Since blood samples were collected during a period of more than 
a year in both the older and younger (Dutch) cohort, our analyses with 25(OH)D concentrations 
at baseline may have been affected by season (Chapter 3). However, we adjusted the models 
for season of blood collection (summer/winter). For the study with change in 25(OH)D, we 
used a more accurate method: we ‘deseasonalised’ the 25(OH)D concentrations using a 
sinusoidal regression model before calculating the intra-individual change (Chapter 4)35,36. This 
‘deseasonalising’ method can be a benefit for future studies on serum 25(OH)D.
Assessment of depressive symptoms
In all studies, the 20-item CES-D scale was used to assess self-reported depressive symptoms 
experienced in the past week. Regarding the longitudinal analyses, depressive symptoms were 
only measured once about every 3 years. The lack of information about depressive mood at 
the intermediate time periods is a drawback: given the fluctuating nature of depression we 
might have missed episodes, which might have biased the observed associations.
Another issue of self-reported symptom rating scales is whether to use ‘severity of depressive 
symptoms’ (continuous score) or ‘clinically relevant depressive symptoms’ above a validated 
cutoff (dichotomous). As shown in the study on vitamin B
12
 (Chapter 2), results of a continuous 
outcome can slightly differ from those with a dichotomous outcome (Table 3 vs. Table 4). However, 
the used statistical methods also differed between both analyses (linear mixed models vs. Cox 
regression) and stratification by age was only done for analyses with the dichotomous outcome. 
In most studies (Chapters 2, 3, 4 and 5), we chose for a continuous CES-D score because this 
is more sensitive than a dichotomous score. In addition, depression is known not to be a yes/
no condition: people range in their extent of depressive symptoms. In Chapters 2 and 3, we 
additionally used dichotomous CES-D scores in order to compare analyses of both dimensions.
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Instead of symptom rating scales for depressive symptoms, we could have investigated clinical 
diagnosis of depression, such as major depressive disorder (MDD). InCHIANTI has no data 
on clinical depression but at each measurement cycle of LASA, data have been collected by 
the Diagnostic Interview Schedule (DIS)37,38. However, the number of cases would have been 
too low for our analyses. This is not only due to the moderate sample size of both cohorts, but 
also to the kind of symptoms because late-life depression, as in LASA and InCHIANTI, often 
does not meet the criteria of MDD because of fewer emotional symptoms39. Still, if we had 
enough power to use MDD as outcome, our associations might have been attenuated, as a 
recent meta-analysis showed an inverse association between healthy dietary exposures and 
a lower depression incidence only in studies using symptom severity scales and not a formal 
diagnosis40. This reflects the presence of the more physical symptoms that are not unique 
for depression, such as fatigue and weight gain, while the affective symptoms of depression, 
depressed mood and worthlessness, are absent. Such persons have (relatively) high scores on 
symptom rating scales but do not fulfil the criteria of a clinical diagnosis. In our middle-aged 
and older study samples, it is possible that for some participants the non-specific symptoms do 
not reflect ‘true’ depressive mood but are related to other (chronic) diseases and disabilities 
common in older age41-43. In contrast, our associations can also be underestimated since social 
desirability could have led to underreporting of depressive symptoms on the CES-D44,45. In 
addition, as both our samples were population-based, associations may have been different 
if we had used a clinically depressed sample. In trying to increase accuracy, we also used 
data on use of antidepressants: we incorporated new antidepressant use in the ‘incident 
depression’ outcome (Chapter 2) or excluded persons using antidepressants in sensitivity 
analyses (Chapters 2, 4, 5 and 6). Findings did not substantially change after exclusion, except 
for attenuation of some associations of food groups and diet indices, which could indicate that 
the associations mainly exist in more depressed persons (Chapter 5 and 6).
Similar to nutrition, mood can be influenced by season. Seasonal Affective Disorder (SAD), a 
type of major depression, is characterised by recurrent depressive episodes with a seasonal 
pattern that typically starts in late fall or winter and remits in spring or early summer46,47. The 
aetiology of SAD is not certain, but hypotheses focus on circadian phase shifting, abnormal 
pineal melatonin secretion and abnormal serotonin synthesis48. SAD affects 1-3% of adults 
and a higher prevalence at higher northern latitudes is only inconsistently demonstrated49. In 
our studies, we did not take into account this influence of season on the presence of depressive 
symptoms. The reported symptoms may have been depending on the season. As data collection 
in LASA and InCHIANTI were performed throughout the year, differences in season of the 
assessment of depressive symptoms between participants (cross-sectional analyses) as well as 
within participants (longitudinal analyses) may have obscured our findings. We only adjusted 
for season in the vitamin D studies (Chapters 3 and 4), as described above. Nonetheless, in 
depression research it is not usual to adjust for season.
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Covariates
Observational studies, as in this thesis, are biased through confounding. The extensive data 
collection of both the Dutch and Italian cohort allowed adjustment for several, relevant, 
potential confounders. Still, unknown or imprecisely measured variables may have been missed, 
resulting in residual confounding. For depression, lifestyle variables, such as diet, physical 
activity and smoking, are correlated with each other as well as with depression, potentially in a 
bidirectional way. This makes it complicated to tease apart their individual contribution to the 
association with depression50. Residual confounding can also originate from other behavioural 
and social factors that also affect health23. The potential bias of confounder selection is shown 
by many studies, including the confounding effect of socioeconomic position51. In our analyses, 
we added smoking status and physical activity as confounders to the adjusted models of the 
diet-depression links, leading mostly to small attenuations of the association. Furthermore, 
if variables could also be mediators of the association with depression (i.e. be on the causal 
pathway), for example number of chronic diseases and weight status (body mass index (BMI) 
or waist circumference), we added these potential mediators/confounders to the final model 
separately (Chapters 2, 4, 5 and 6); often this did not change the results, indicating that these 
variables had little influence on the studied associations.
In nutritional epidemiology, adjustment for energy intake is often crucial. Inconsistencies 
between studies on the diet-depression link might be explained by whether or not energy 
intake was adjusted for52. When examining associations between dietary intake and disease, it 
is often desirable to use intake data that are independent of total energy intake. A first reason 
is that energy intake is often related to disease risk. Second, as intake of most nutrients/food 
groups is positively correlated with total energy intake (e.g. higher energy intake ↔ higher 
fruit intake), a part of the individual differences in nutrient/food group intake are unrelated 
to diet composition; this added variation may be an extra source of error. Third, when energy 
intake is associated with disease but is not a direct cause, the effects of specific nutrients/food 
groups may be distorted or confounded by energy intake53. Several ways exist to adjust for 
energy, and we used the standard adjustment for energy intake in the multivariable models 
(Chapters 5 and 6) as well as the ‘residual method’ from Willett et al.53 (Chapter 5). When 
studying intakes of nutrients, food items or food groups, the residual method results in intake 
data that are independent of total energy intake by a regression of these intakes on energy 
intake. So, in our study on food groups, we used food group intake residuals to investigate their 
association with depressive symptoms, irrespective of the participants’ energy intake. In other 
words, the residuals represent the composition of the diet, for example fruit intake. In addition, 
we adjusted the model for total energy intake (model 2 of the analyses with food group intake 
as determinant; ‘residual model’). This combination is preferred over only using residuals 
(not adjusting) because the random error may be reduced if energy intake is associated with 
the outcome (here: depressive symptoms)53. In Chapter 6, we studied a different kind of 
association: the reverse association from depression to diet indices, in which energy intake 
might be a confounder or mediator. Therefore, we added energy intake as covariate in an 
additional model (together with waist circumference), but this did not affect the findings. 
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Temporality and causality
The aim of this thesis was to investigate associations between nutrition and depressive 
symptoms with a focus on longitudinal studies. The diet-depression link can also exist in the 
reverse direction: mood influencing food intake. In cross-sectional studies, determinant and 
outcome are assessed at the same time point and, therefore, these studies cannot differentiate 
whether diet is a cause or consequence of depression. Longitudinal studies examine the 
temporal order in which determinants and outcomes occur, thereby limiting the reverse 
causality issue. For that reason, all included studies investigated longitudinal associations, 
of which the studies on vitamin B
12
, baseline 25(OH)D and diet indices also included cross-
sectional associations. Using these prospective study designs, we were able to explore 
associations from nutrition to course and onset of depressive symptoms over time (Chapters 
2, 3, 4 and 5) and in the other direction (Chapters 5 and 6), while limiting reverse causality.
The InCHIANTI cohort with repeated measurements of both food intake and mood provided us 
the opportunity to study longitudinal associations accurately and bidirectionally (Chapter 5). 
In our analyses, we used a 3-year time-lag model and adjusted for the outcome at baseline. We 
chose for a time-lag model because this shaped the associations in a ‘prospective’ way, which 
approximated the temporal order the best as possible. The time-lag was also needed to make 
a good comparison with the associations in the other, reverse direction: without a time-lag, we 
would have studied almost similar associations in the two directions. In this manner, we tried 
to minimise the issue ‘Is it a cause or consequence?’. We found significant associations in both 
directions; though, as for none of the food groups these associations existed in both directions, 
we could exclude reverse causality as the reason for the observed associations.
Although we designed our longitudinal analyses in such ways to address temporality and 
reverse causality as best as we could (e.g. adjustment for baseline outcome, time lag model, 
exclusion of persons using antidepressant at baseline as sensitivity analysis), causal inference 
cannot be made from observational research. True causality needs to be explored in future 
experimental studies.
Repeated measurements 
Following on the previous section, it is inherent to longitudinal research to use repeated 
measurements; however, which and how many measurements are used can vary. In most 
prospective studies, the determinant is measured once at baseline, while the outcome is 
measured at least once after baseline. We did this in the prospective analyses of Chapters 
2 and 3 by studying both the course and incidence of depressive symptoms over time, using 
CES-D measurements from five (Chapter 2) and two (Chapter 3) follow-up cycles, adjusting 
for baseline CES-D score. An assumption of this type of prospective studies is no changes in 
nutrient status or dietary intake after baseline, the same change in everyone or, at least, no 
influence of such changes on the association. This limitation was also noticed in recent meta-
analyses on longitudinal studies40,54.
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A more accurate way is to take into account these changes in nutrient status or food intake by 
using multiple measures of the determinant. We did this with serum 25(OH)D levels (Chapters 
4) and FFQ data (Chapter 5), which are quite unique data for large cohort studies. In the change 
in vitamin D study (Chapter 4), we used two measurements of both serum 25(OH)D and 
depressive symptoms and calculated changes over 13 and 6 years. Compared to the findings of 
Chapter 3, this yielded new insights into the longitudinal link between this vitamin and mood 
in older adults, i.e. an increase in 25(OH)D level is associated with a decrease in depressive 
symptoms only in young older adults with relatively low 25(OH)D levels. Further, repeated 
measurements of four cycles were available in the food group study (Chapter 5): data of the 
first three cycles were included in the time-varying determinant and data of the last three 
cycles in the time-varying outcome, in order to generate a time-lag model. With linear mixed 
models, the averaged intakes of the food groups were used as determinants, thereby better 
approaching habitual diet. So, we can say that the habitual intake of sweets and fish were 
related to changes in depressive mood. 
In the study on diet indices (Chapter 6), we used repeated measurements of the CES-D to 
define two determinants of history of depression. The associations of long-term history of 
depressive symptoms resembled those of current depressive symptoms, while short-term 
changes in depressive symptoms deviated. Unfortunately, adherence to diet indices were 
single measured outcomes since an FFQ has been administered within LASA only once. A next 
step for future studies on the depression-diet link is to include repeated dietary data as well in 
order to examine dietary habits and changes in intake as outcome (resembling our depressive 
symptoms-food groups analyses of Chapter 5).
Generalisability
A concern of all epidemiologic studies is the generalisability of the results to other individuals 
and settings. The type of population as well as selection and survival bias are points of 
consideration.
Both LASA and the InCHIANTI study consist mainly of older persons: LASA participants were 
55 years or older at baseline, and 75.3% of the InCHIANTI participants were 65 years or older 
at baseline. In our studies on vitamin B
12
 and vitamin D (Chapters 2, 3 and 4), the older LASA 
cohort with blood data consisted of persons aged 65 years or older. This implies that the studies 
described in this thesis are mainly applicable to middle-aged and older persons. Although 
studies on the diet-depression link have been performed in all age groups, many studies 
focused on middle-aged and older populations, not only because this age group is increasing 
worldwide but also because of the changes in eating behaviour, dietary intake and mental 
health in old age. A review on dietary patterns and late-life depression suggested that the 
evidence for an association appears more contradictory in older adults compared to middle-
aged adults55. This might be explained by the earlier-mentioned more somatic presentation of 
depression in older adults. So, our samples were not representative for the general population 
that includes younger adults, adolescents and children.
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Next to age, a point to consider is ethnic diversity. Although LASA’s sampling procedure 
included three geographical regions in the Netherlands with rural as well as urban areas, a 
diversity in ethnic background was not obtained. Over 99% of the LASA participants are 
Caucasian34. Similarly, no other ethnicities than Caucasian were included in the InCHIANTI 
sample as all InCHIANTI participants lived in two small towns located in the countryside in 
Tuscany56. Differences between ethnicities exist not only in dietary habits57 but also in serum 
vitamin D levels (attributable to skin pigmentation58 and potential polymorphisms in the gene 
for the vitamin D binding protein59,60) and in mental health61,62. This lack of ethnic diversity 
limits the generalisability of our findings to other ethnicities.
Our observed associations might be biased as a result of the method used to select study 
participants or factors that influence study participation. This selection bias might be present 
in our studies in different ways. First, the recruitment for cohort studies merely attracts a 
selection of all eligible persons. Hence, persons who are more interested in healthy aging or 
science are more likely to participate in LASA or the InCHIANTI study. Second, we performed 
mostly complete case analyses in our studies. In other words, participants were excluded from 
the analytical samples when having missing data not only on the determinant or outcome, but 
also on any other covariate. This resulted in smaller and possibly less representative analytical 
samples. An option would have been imputation of the covariates, for example multiple 
imputation by chained equations (MICE)63. We chose not to impute because the numbers of 
persons excluded due to missing data on covariates were not that high (<7%). Third, the sample 
of the LASA Nutrition and Food-related Behaviour study with FFQ data consisted of LASA 
respondents from all three cohorts, i.e. different generations (Chapter 6). However, we did 
not approach all respondents to participate in this side study, for example not those who had 
indicated to participate only at regular cycles or those with severe vision problems. In addition, 
1439 of the 2089 invited persons (response rate 68.9%) participated in the side study; this 
might be a selective sample of persons interested in food and eating behaviour behaviour. 
These forms of selection bias may have attenuated or strengthened our associations.
In older cohorts, survival bias is an inevitable issue: healthier persons will be more likely to 
survive and to be followed-up in subsequent measurement cycles. When participants who 
have lower vitamin B
12
 or vitamin D concentrations, consume a less healthy diet or have more 
depressive symptoms are earlier lost to follow-up due to a higher mortality risk or refusal 
because of health reasonse.g. 64,65,66, the remaining study population is less representative for the 
original study population at baseline. This was the case in our studies that had as an exclusion 
criterion missing data at follow-up: the analytical samples comprised relatively healthy 
respondents. The comparisons between included and excluded participants consistently 
showed that included participants were more healthy (Chapters 2, 3, 4 and 5). For example, the 
included persons generally had less depressive symptoms, which might be due to a selective 
response, i.e. skipping the CES-D questions. An additional remark is that participants with 
data of serum vitamin B
12
 and vitamin D had to visit the hospital for blood sampling, implying 
that they needed to be motivated and mobile. In longitudinal analyses such as in this thesis, 
survival bias could have resulted in an underestimation of our associations.
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RECOMMENDATIONS FOR FUTURE RESEARCH
Throughout this thesis, the importance of research on diet and depression is discussed. Below, 
our main findings are embedded in the existing literature, and suggestions for future studies 
are given. 
Future studies on the nutrient-depression link
Evidence indicates that vitamin B
12
 does not play a major role in depressive mood. We found 
no associations of serum vitamin B
12
 with depressive symptoms. This is partly in line with the, 
to our knowledge, latest meta-analysis of randomised controlled trials (RCTs) showing that 
vitamin B
12
 and folate supplementation have no short-term effect on depressive symptoms 
but may reduce severity and onset over the longer term (over one year) in people at risk67. 
Additionally, secondary analyses of a recent RCT in older adults with elevated homocysteine 
concentrations showed no effect of 2-year supplementation of vitamin B
12
 and folic acid 
(in combination with vitamin D
3
 due to the primary outcome: osteoporotic fractures) on 
depressive symptoms68. Yet, to truly rule out a causal relationship it would be interesting to 
perform an RCT with only vitamin B
12
 supplements – and no other vitamins – in persons with 
vitamin B
12
 deficiency. 
For the second studied vitamin of this thesis, vitamin D, we did find some but no consistent 
associations with depressive symptoms. While previous observational studies mostly 
confirmed an association69, three of four meta-analyses of RCTs did not show a protective 
effect of vitamin D supplementation on depressive mood70-73. However, the included RCTs 
differed substantially and entailed several weaknesses in design. Better designed, adequately 
powered trials are currently undertaken, including the ViDA Study74, Vital-Dep75 and the 
D-Vitaal study76. Although depression is not the primary outcome for most of these ongoing 
trials, secondary analyses can elucidate whether the ‘sunshine vitamin’ can prevent and/or 
treat depressive symptoms, and for whom the use of vitamin D supplements can be beneficial. 
If these trials will find evidence for a protective effect of vitamin D (in specific groups), 
supplementation should be implemented in mental health care (in these groups). But, if they 
will not show any effect, the hypothesis of the vitamin D level-depression link can be forgotten.
Other nutrients potentially beneficial for depression have previously been studied but 
to different extents and on different levels (blood concentration, dietary intake and/or 
supplementation). Supplementation of omega-3 polyunsaturated fatty acids as augmentation 
to antidepressants seem to have a small effect in reducing depressive symptoms in MDD 
patients77-79. For other nutrients, including folate, vitamin B
6
, magnesium, selenium and zinc, 
evidence for their influence in the general population and in depressed patients is currently 
very limited79-86. A large prevention trial has recently been performed within the MooDFOOD 
project. In four European countries, the 1-year effect of multi-nutrient supplementation 
and/or food-related behavioural change therapy on the development of MDD was studied in 
around 1000 overweight persons with elevated depressive symptoms87. This trial will show 
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– amongst other things – whether a multi-nutrient supplement containing omega-3 fatty acids, 
selenium, folic acid and vitamin D
3
 plus calcium can prevent the development of MDD88. If 
the multi-nutrient supplement will be effective, supplementation of these nutrients could 
be implemented in treatment guidelines. Conversely, if not effective, researchers can better 
focus their attention on nutritional factors at higher levels, i.e. dietary intake.
Future studies on the dietary intake-depression link
In contrast to the research field of nutrients, the field of dietary intake in relation to depression 
is relatively new. While many cross-sectional and prospective studies on dietary patterns 
have been performed, the literature on food groups is less extensive. Prospective findings 
have most consistently been reported for fruit89,90, vegetables40,89,90, fish40,91,92, coffee93 and, to 
a lesser extent, sweets94-97. Of these, we could only confirm that a higher intake of fish and 
shellfish and a lower intake of sweet foods were associated with less depressive symptoms. 
More longitudinal studies on intakes of food groups are warranted; they should include 
populations with a large variation in food group intakes, of different age ranges and from 
different countries and ethnicities. In addition, experimental studies on food groups have not 
yet been performed. Although RCTs in nutrition are challenging, only trials can demonstrate 
whether food groups are causally related to depression or not. Before performing RCTS on 
specific food groups, trials should first focus on the whole dietary pattern since more evidence 
is currently available on patterns.
To date, only a few experimental studies attempted to improve mental health by dietary 
interventions focusing on dietary patterns. Secondary analyses of the Prevención con Dieta 
Mediterránea (PREDIMED) prevention trial showed protective effects of the Mediterranean 
diet on depression risk over a 3-year period in persons with a high cardiovascular risk98; however, 
effects were only significant in those with diabetes mellitus type 2, and the randomisation 
appeared to include irregularities99. When studying depressed adults, treatment trials showed 
significant, positive effects on depressive symptoms over 3100 or 6 months101. Still, these RCTs 
included persons with diagnosed or self-reported depression, which implicates no inference 
to prevention in mentally healthy people. As mentioned above, the recent MooDFOOD trial 
studied the potential of not only a multi-nutrient supplement but also food-related behavioural 
activation therapy on the prevention of MDD; it will demonstrate whether dietary counselling 
can lead to changes in diet and can prevent depression88. More large intervention studies 
are needed that examine the influence of dietary intake on both the incidence of depressive 
symptoms and MDD (prevention) as well as the development/recurrence of depression 
(treatment). Furthermore, as current evidence is stronger for dietary patterns than for foods, 
these RCTs should first pay attention to the whole patterns, and thereafter – if effective – on 
specific food groups. Last, trials need to include persons with a less healthy diet at baseline, 
be adequately powered, and conduct stratified analyses in subgroups (e.g. weight status, 
depression status). 
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Future studies in the reverse direction: the depression-diet link
Do depressive symptoms influence dietary intake? We added some evidence to the literature 
for the existence of a reverse association: we found prospective associations of depressive 
symptoms with changed intakes of some food groups (vegetables, meat, dairy and savoury 
snacks) and demonstrated that both current and past depressive symptoms were associated 
with lower scores on the MDS and AHEI, mainly in men. The limited number of previous 
longitudinal studies in this direction often found no associations94,102-105 or suggested, 
unexpectedly, that those with a history of depression had a more healthy dietary pattern106. As 
an extension of this inconsistent and incomplete state of the evidence, more prospective studies 
are required that examine associations of depressive symptoms with food group intakes and 
dietary patterns, thereby using repeated measurements of diet (to account for changes and 
assess habits) and preferably also of depressive mood (to incorporate mood fluctuations). Since 
experimental studies in this direction may be unethical (i.e. restrain depressed persons from 
antidepressant medication), future longitudinal cohort studies should be properly designed, 
adjusted for relevant confounders, and checked for potential effect modifiers including gender. 
Additional recommendations for future studies
In addition to the above-mentioned suggestions, some additional points are of importance for 
future studies. 
First, while several systematic reviews on the link between diet and depression have been 
published since 201052,55,107-109, only some of them could actually perform a meta-analysis of 
the results40,54,110,111. Still, the heterogeneity was high due to differences between the individual 
studies, and the number of included studies per sub-analysis was sometimes very small. To 
overcome this, we require more single, high-quality, prospective studies that use similar 
methodologies and measurement instruments. In the field, consensus need to be reached 
on 1) methods used to derive food group intakes ('which food products belong to which food 
group?'), dietary pattern scores ('by factor analysis or cluster analysis?') and diet quality indices 
('which version of the MSD, AHEI and DASH?'); 2) similar definitions of depressive symptoms 
or depression; 3) standardised statistical techniques; 4) adjustment for similar covariates (e.g. 
energy intake) etcetera. This standardisation and harmonisation will make it possible to perform 
meta-analyses that will have a lower heterogeneity. Within the MooDFOOD project, such a 
meta-analysis has been conducted for the association between healthy diet quality indices 
and depressive symptoms using six population-based cohorts112. More harmonised meta-
analyses are needed that will examine other dietary patterns, food groups, clinically diagnosed 
depression, different countries and ethnicities, and both directions of the diet-depression link.
Second, an essential question in nutritional psychiatry is: what are the biological pathways 
through which diet influences mental health? And for the reverse direction: which underlying 
mechanisms mediate the depression-diet link? These pathways may provide indications for 
interventions. Previous attention has focused on neurotransmitter disturbances, hypothalamic-
pituitary-adrenal axis disturbances, oxidative stress, neurogenesis and neuronal plasticity, 
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mitochondrial disturbances and inflammation113. Recent interest is increasing for the influence 
of gut health and microbiota on brain and behaviour114,115. To unravel the complex associations 
between diet, underlying mechanisms and depression more studies are needed: from in vitro 
via in vivo to humans. Less often used statistical approaches can be helpful for epidemiological 
studies, such as mediation analyses116,117 and structural equation modelling118,119. 
Third, in this thesis, we mainly focused on nutrient status and food intake as determinants of 
mental health. As depression is a multifactorial disorder caused by biological, psychological and 
social factors120-122, it is additionally interesting to examine the role of behavioural mechanisms, 
such as eating behaviour. More specifically, the following factors may be associated with food 
intake and/or depression: meal patterns (patterns, format and context of meals and snacks, 
including meal skipping and combinations of foods in meals123), eating styles (e.g. emotional 
eating124) and mindful eating (‘eating with awareness and attention’)125,126.
Fourth, all studies in this thesis used self-reported depressive symptoms. However, depression 
is a disease that varies in severity, symptoms and consequences. A distinction can be made 
between the melancholic and atypical subtype127,128. As signs and symptoms of these subtypes 
are contrasting, it might be that their links with diet differ from each othere.g.129. Studies with 
data on key characteristics (e.g. changes in sleep and appetite) could compare associations 
between diet and both types.
Last, while middle-aged and older people comprise a very important study group in view of 
the aging population, younger populations should also be considered. The diet-depression link 
has also been studied in children and adolescents. However, the existing evidence is limited to 
two systematic reviews of observational studies on the relationship of dietary patterns and 
diet quality with depression and mental health, suggesting associations between a healthy diet 
and better mental health130,131. More research early in the life span, with more homogenous 
assessment methods, are needed since during childhood and adolescence, dietary habits are 
mainly developed and more easily adapted132.
Prioritising future studies
The above-described recommendations for future studies on the bidirectional link between 
nutrition and depression are numerous. As research time and budget are always limited, the 
main attention should currently be focused on RCTs that examine the causal effect of dietary 
interventions (focusing on a healthy dietary pattern) on the prevention as well as treatment 
of depression. In addition, in the reverse direction, well-designed longitudinal studies on 
the association between depression and (changes in) dietary intake are urgently warranted. 
Nevertheless, although less of a priority, harmonised and standardised meta-analyses, studies 
on underlying pathways, food-related behavioural mechanisms and subtypes of depression, 
and studies in children and adolescents can additionally increase our understanding of the 
diet-depression link.
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IMPLICATIONS FOR PUBLIC HEALTH AND CLINICAL PRACTICE
Because of our observed small, inconclusive and null associations, inconsistent findings in the 
literature and the subsequent need for future research, solid implications for public health 
nutrition and clinical practice regarding nutritional strategies against depression cannot be 
recommended at this moment. No firm conclusions can be drawn on causal effects of the 
observed relationships between nutrition and depressive symptoms, given that our studies 
are based on observational data. However, using data of determinants and outcomes from 
several time points, we shaped the longitudinal analyses in the assumed temporal order, which 
limited the possibility of reverse causality. From the longitudinal perspective of this thesis, we 
can discuss the following concerning implications.
In terms of the different levels of nutritional factors that were studied in this thesis, it is worth 
to mention the following. For vitamin D and, particularly, vitamin B
12
 status, our studies do not 
show beneficial relationships with mood. Therefore, there is currently no imperative to advise 
supplementation of these vitamins in persons with depressive symptoms. If investigations 
of coming RCTs, in contrast to our results, will show effects in some population groups, then 
supplementation might be advised to alleviate depressive symptoms. 
Compared to nutrients, more evidence for an effect on mood is available for the whole diet, i.e. 
food groups and dietary patterns. It seems to be positive for mood to consume not only more 
of fish but also of vegetables, fruit and coffee. This also holds for a better adherence to ‘healthy’ 
dietary patterns, such as the Mediterranean diet and the AHEI. In contrast, a higher intake of 
sweet foods as well as sweet beverages and non-whole grains might lead to more depressive 
symptoms, similar to a higher intake of ‘unhealthy’ dietary patterns; thus far, the evidence for 
unhealthy foods and diets is more limited than for healthy ones. Although true causal links 
between dietary intake and depression have yet to be established, it is known that eating a 
healthy diet will benefit physical health. So, promotion of a healthy diet including fish, fruit and 
vegetables – as currently done by many national dietary guidelines – might also benefit mental 
health. This implies that nutritional strategies for establishing a lifelong healthy diet can only 
be more beneficial in terms of prevention of diseases for the general population.
Evidence for the reverse depression-diet link is still scarce. The first longitudinal studies on the 
association between (history of) depressive symptoms and food intake showed negative as well 
as positive and null associations. If our observed relationships of current and past depression 
with a lower diet quality (Chapters 5 and 6) will be replicated, then health professionals, such 
as psychiatrists, should give more attention to diet and facilitate access to a dietitian. Healthy 
dietary habits are of importance to prevent the gain of body weight, which will subsequently 
help to prevent the development of metabolic and other chronic diseases.
Current guidelines for the management of depression of some countries include 
recommendations about lifestyle. For example, in Australia and New Zealand, a healthy 
lifestyle – including good sleep hygiene, regular exercise and a healthy diet – is included as 
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first step in the guidelines133,134. In the Netherlands, individual recommendations to promote 
a healthy lifestyle are given firstly as well135. Based on this thesis and other literature, there 
is no strong indication to change these recommendations, especially since a healthy diet 
benefits overall health and has no negative consequences. Though, following the ‘lifestyle 
steps’ of these guidelines – including the advice for a healthy diet – should be emphasised to 
health care providers. For countries without lifestyle recommendations in their depression 
guidelines, it is advised to include such first step of considering the patient’s dietary habits and 
other lifestyle factors. However, when more evidence regarding the effect of nutrient status 
and dietary intake becomes available in the future, recommendations should be reviewed and 
altered accordingly.
GENERAL CONCLUSIONS
This thesis adds some longitudinal evidence to the potential bidirectional link between 
nutrition and depressive symptoms. The findings show that serum vitamin B
12
 concentration 
was not associated with subsequent depressive mood in older adults. Higher serum vitamin 
D concentrations were found to be related to less subsequent depressive symptoms but only 
in specific population groups. Furthermore, high intakes of fish and sweets were found to be 
associated with respectively a decrease and increase in depressive symptoms in mainly older 
adults. In the reverse direction, more depressive symptoms were found to be associated with a 
decreased intake of meat and vegetables, and an increased intake of dairy and savoury snacks. 
Moreover, current and past depressive symptoms were, particularly in older men, found to 
be related to a lower diet quality. Overall, this work shows some associations but the modest 
effect sizes and several null associations prompt us to be cautious about the existence of 
bidirectional links between nutrition and depression.
In light of this thesis as well as previous literature, currently, specific nutrients seem to be of 
less importance in relation to depressive symptoms compared to intake of food groups and 
whole dietary patterns. An effect on depressive mood is more plausible for healthy foods 
and dietary patterns than for single nutrients, such as vitamin B
12
 and vitamin D. Reversely, 
depressive mood appears to be related to a subsequent lower diet quality, i.e. less healthy food 
groups and dietary patterns. However, the literature in this direction is scarce.
Given the high and rising burden of depression worldwide, strategies to prevent or reduce 
depressive symptoms are urgently needed. Eating a healthy diet, including fruit, vegetables 
and fish, is recommended for the general population because of its beneficial effect on 
physical health and, potentially and partially supported by this thesis, also on mental health. 
As evidence for bidirectional, causal associations between diet and depressive symptoms is 
still limited, future research is needed to further elucidate the role of food group intakes and 
dietary patterns in the course and development of depression as well as to examine if and how 
depressive mood influences dietary intake. This knowledge is required for the prevention of 
depression and the optimal nutritional care of depressed persons.
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SUMMARY
Introduction
Depression is one of the most prevalent and disabling mental disorders, and causes a 
significant burden to both individuals and society. Major depressive disorder is characterised 
by emotional and behavioural alterations, including depressed mood and loss of interest or 
pleasure as core symptoms. Depressive symptoms are linked to a decreased quality of life 
and functioning, physical morbidity and mortality. Due to its high and increasing prevalence, 
affecting 350 million people globally, depression is a major contributor to the global disease 
burden. Therefore, attention to prevention is very important.
Evidence for a link between nutrition and depression is growing; nutritional factors may 
modulate physiological pathways that affect depression risk, such as neurotransmitter 
processes, neuroprogression, oxidative stress, mitochondrial function and inflammation. 
Nutrient status, including vitamin B
12
 and vitamin D status, has been studied in relation to 
depressive mood. A link between the intake of specific food groups, such as fruit, vegetables, 
fish, coffee, olive oil, whole grains and sweets, and depressive symptoms has also been 
suggested. In addition, ‘healthy’ dietary patterns may be associated with less depressive 
symptoms, whereas ‘unhealthy’ dietary patterns might relate to more depressive symptoms. 
It has also been proposed that the link exists in the reverse direction: depressive mood may 
change diet. However, evidence for associations between nutritional factors and depression 
is inconclusive and limited, indicating the urgent need for more high-quality, longitudinal, 
potentially bidirectional studies on nutritional factors and depressive symptoms.
After a general introduction, Chapter 1 describes the overall aim of this thesis: to investigate 
longitudinal associations of nutrient status, food groups and dietary patterns with depressive 
symptoms in adults.
Specific research questions are: 
1. What is the longitudinal association between nutrient status and depressive symptoms? 
a. What is the association between serum vitamin B
12
 and (subsequent) depressive 
symptoms?
b. What are the associations between (change in) serum vitamin D and (change in) 
depressive symptoms?
2. What is the bidirectional, longitudinal association between food group intakes and 
depressive symptoms?
3. What is the association of depressive symptoms and history with diet quality indices?
Data from two ongoing, population-based cohort studies of general older populations are used 
to examine these longitudinal associations: the Dutch Longitudinal Aging Study Amsterdam 
(LASA) and the Italian Invecchiare in Chianti (InCHIANTI) study. The research questions are 
addressed in the three parts of this thesis.
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Part I: Nutrient status and depressive symptoms
In Chapter 2, the cross-sectional and prospective associations between vitamin B
12
 
concentration and depressive symptoms were investigated in the oldest LASA cohort of 1205 
participants aged ≥65 years. Serum vitamin B
12
 at baseline was not cross-sectionally associated 
with the severity of depressive symptoms. In addition, no prospective associations were found 
of baseline vitamin B
12
 with course of depressive symptoms nor with incidence of depression 
(Center for Epidemiologic Studies Depression scale (CES-D) ≥16 and/or antidepressant use) 
over 16 years, except for an unexpected higher risk of depression in younger participants with 
higher vitamin B
12
 concentrations (aged 64.8-73.4 years at baseline). As serum vitamin B
12
 
and plasma total homocysteine are inversely correlated with each other, the analyses were 
repeated using baseline homocysteine concentration as determinant. Homocysteine also 
showed no cross-sectional nor prospective associations with depressive symptoms, supporting 
the null findings of vitamin B
12
. This study in older adults does not confirm previously shown 
associations of vitamin B
12
 concentration with depressive symptoms.
Chapter 3 describes cross-sectional and prospective 6-year associations between 
25-hydroxyvitamin D (25(OH)D) concentration and depressive symptoms. To gain a better 
understanding of the underlying mechanisms, the second aim was to explore the mediating 
role of physical functioning in the prospective association. In both the older (≥65 years at 
baseline, n=1282) and younger (55-65 years at baseline, n=737) LASA cohort, baseline serum 
25(OH)D was cross-sectionally not associated with the severity of depressive symptoms in 
the fully-adjusted models. In the older cohort, sex was an effect modifier in the prospective 
associations, and older women with baseline 25(OH)D concentrations <30 nmol/l experienced 
23% more depressive symptoms in the following 6 years, compared to women with 25(OH)D 
concentrations >75 nmol/l. Reduced physical performance partially mediated this association. 
No significant associations were found in older men and in the younger cohort. The findings 
indicate no associations of vitamin D status with severity and course of depressive symptoms, 
except for an inverse association in older women.
A more detailed investigation on the longitudinal association between serum 25(OH)D and 
depressive mood is described in Chapter 4. Two 25(OH)D measurements were used to study 
the association between change in serum 25(OH)D and parallel change in depressive symptoms 
over time. Change in serum 25(OH)D was not associated with change in depressive symptoms 
in the older LASA cohort (n=173) over a period of 13 years and also not in the younger cohort 
over 6 years with a baseline 25(OH)D concentration above 59 nmol/l (n=225). However, in 
participants from this younger cohort with a lower baseline 25(OH)D (n=225), an increase in 
serum 25(OH)D of 10 nmol/l was associated with a decrease of 0.62 points in CES-D score. An 
increase in vitamin D concentration might be protective against depressive mood but only in 
middle-aged adults with a low vitamin D concentration.
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Part II: Food groups and depressive symptoms
Chapter 5 reports on the prospective associations – in two directions – between food group 
intakes and depressive symptoms in 1058 participants (aged 20-102 years) of the InCHIANTI 
study. Four times repeated measurements of both dietary intake and CES-D scores were fully 
used in time-lag models. Associations were investigated of intakes of thirteen food groups 
with 3-year changes in CES-D scores over a 9-year period, and vice versa. Higher intakes of 
fish and shellfish were associated with a decrease and sweet foods with an increase in CES-D 
scores. In the reverse direction, higher CES-D scores were associated with decreased intakes 
of vegetables and red and processed meat, and increased intakes of dairy and savoury snacks. 
No significant associations in either direction were found for fruit, nuts and legumes, potatoes, 
whole grain bread, olive oil, sugar-sweetened beverages, and coffee and tea. In this sample of 
mainly older adults, bidirectional, longitudinal associations between food group intakes and 
depressive symptoms were found. However, bidirectional associations for a single food group 
were not found, which excludes reverse causality as reason for the observed associations.
Part III: Depressive symptoms and dietary patterns
In Chapter 6, associations between depression determinants and diet quality were investigated 
in 1322 LASA participants aged ≥55 years. Next to current depressive symptoms (1), short-
term changes in depressive symptoms (2) and long-term history of depressive symptoms (3) 
were used as determinants. Scores on three a priori diet quality indices in 2014/2015 were 
used as outcomes: the Mediterranean Diet Score (MDS), Alternative Healthy Eating Index 
(AHEI) and Dietary Approaches to Stop Hypertension diet (DASH). Cross-sectionally, current 
depressive symptoms (CES-D ≥16) were associated with lower MDS and AHEI scores in men 
but not in women. Chronic/recurrent depressive symptoms over 2 to 5 years (CES-D ≥16 in 
both 2011-2013 and 2015/2016) were also associated with lower MDS scores and a trend 
for lower AHEI scores, compared to no depressive symptoms (CES-D <16 at both cycles). 
History of depressive symptoms over 2 to 14 years (ever CES-D ≥16 from 2001-2003 to 2011-
2013) was associated with lower MDS and AHEI scores in men only. None of the depression 
determinants was consistently associated with the DASH score, and emerging and remitted 
depressive symptoms were also not associated with any diet index. This study suggests that 
current and past depressive symptoms are related to poorer diet quality, particularly in men. 
Conclusion
In Chapter 7, a summary of the main findings of this thesis is provided, and methodological 
strengths and limitations are considered. Furthermore, recommendations for future studies 
and implications for public health and clinical practice are discussed.
It is concluded that in older adults, vitamin B
12
 concentration is not associated with subsequent 
depressive symptoms. Higher vitamin D concentrations were found to be associated with less 
subsequent depressive symptoms but only in specific population groups. In mainly older adults, 
intake of fish was found to be inversely and sweets positively associated with subsequent 
171
S
Summary
depressive symptoms. In the reverse direction, depressive symptoms were found to be related 
to a decrease in the intakes of meat and vegetables, and an increase in the intakes of dairy 
and savoury snacks. Last, both current and past depressive symptoms were, particularly in 
older men, found to be associated with a lower diet quality. Overall, this work shows some 
longitudinal associations but the modest effect sizes and several null associations prompt us 
to be cautious about the existence of bidirectional links between nutrition and depression.
In light of this thesis as well as previous literature, currently, specific nutrients seem to be 
of less importance in relation to depressive symptoms compared to intake of food groups 
and whole dietary patterns. Reversely, depressive mood appears to be negatively related to 
subsequent diet quality, i.e. related to less healthy food groups and dietary patterns.
Eating a healthy diet is recommended for the general population because of its beneficial 
effect on physical health and, potentially and partially supported by this thesis, also on mental 
health. However, evidence on the causality and bidirectionality of the diet-depression link is 
still limited. Future research is warranted to further examine the role of food group intakes 
and dietary patterns in the course and development of depression as well as to explore if and 
how depressive mood influences dietary intake. This knowledge is required for strategies to 
prevent depressive symptoms and the optimal nutritional care of depressed persons.
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Voeding en depressieve symptomen: een longitudinaal perspectief
Introductie 
Depressie is één van de meest voorkomende en beperkende psychische aandoeningen 
en veroorzaakt een aanzienlijke ziektelast voor zowel individuen als de samenleving. Een 
depressieve stoornis wordt gekarakteriseerd door veranderingen in emoties en gedrag met 
als kernsymptomen een sombere stemming en verlies van interesse of plezier. Depressieve 
symptomen gaan gepaard met een vermindering van kwaliteit van leven en functioneren, 
lichamelijke ziekten en voortijdige sterfte. Omdat de prevalentie van depressie hoog en 
stijgende is, er worden wereldwijd 350 miljoen mensen door getroffen, behoort deze stoornis 
tot de aandoeningen die voor de grootste ziektelast zorgen. Daarom is aandacht voor preventie 
erg belangrijk. 
Bewijs voor een verband tussen voeding en depressie neemt toe: voedingsfactoren zouden 
kunnen inwerken op fysiologische reactiepaden in het menselijk lichaam die het risico op 
depressie beïnvloeden, zoals processen van neurotransmitters, neuroprogressie, oxidatieve 
stress, mitochondriale functie en ontsteking. Er is onderzoek gedaan naar voedingsstatus, 
waaronder vitamine B
12
 en vitamine D status, in relatie tot depressieve stemming. Een 
verband tussen de inname van specifieke voedingsgroepen, zoals fruit, groenten, vis, 
koffie, olijfolie, volkorenproducten en zoetigheden, en depressieve symptomen wordt ook 
gesuggereerd. Bovendien zou een ‘gezond’ voedingspatroon samenhangen met minder 
depressieve symptomen, terwijl een ‘ongezond’ patroon gerelateerd zou zijn aan meer 
depressieve symptomen. Daarnaast zijn er aanwijzingen dat de relatie in de omgekeerde 
richting bestaat: depressieve stemming kan het voedingspatroon veranderen. Het bewijs voor 
associaties tussen voedingsfactoren en depressie is niet eenduidig en beperkt. Daarom zijn er 
meer longitudinale en – indien mogelijk – bidirectionele studies van hoge kwaliteit nodig naar 
voeding en depressieve symptomen.
Na een algemene introductie wordt in Hoofdstuk 1 het centrale doel van dit proefschrift 
beschreven: het onderzoeken van longitudinale associaties van voedingsstatus, 
voedselgroepen en voedingspatronen met depressieve symptomen onder volwassenen. 
De specifieke onderzoeksvragen zijn:
1. Wat is de longitudinale associatie tussen voedingsstatus en depressieve symptomen? 
a. Wat is de associatie tussen serum vitamine B
12
 en (daaropvolgende) depressieve 
symptomen?
b. Wat zijn de associaties tussen (verandering in) serum vitamine D en (verandering in) 
depressieve symptomen?
2. Wat is de bidirectionele, longitudinale associatie tussen inname van voedselgroepen en 
depressieve symptomen? 
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3. Wat is de associatie tussen (voorgeschiedenis van) depressieve symptomen en 
voedingskwaliteit-indexen?
Om deze longitudinale associaties te onderzoeken zijn gegevens gebruikt van twee lopende, 
observationele cohortstudies van oudere populaties: de Nederlandse Longitudinal Aging 
Study Amsterdam (LASA) en de Italiaanse Invecchiare in Chianti (InCHIANTI) studie. De 
onderzoeksvragen worden behandeld in de drie delen van dit proefschrift.
Deel  I: Voedingsstatus en depressieve symptomen
In Hoofdstuk 2 werden de cross-sectionele en prospectieve associaties tussen vitamine B
12
 
concentratie en depressieve symptomen onderzocht in het oudste cohort van LASA, bestaande 
uit 1205 deelnemers van 65 jaar of ouder. Een cross-sectioneel of dwarsdoorsnede onderzoek 
gebruikt gegevens die op eenzelfde tijdstip zijn gemeten, terwijl een prospectief onderzoek ook 
gegevens van latere tijdstippen gebruikt. Serum vitamine B
12
 op baseline (gemeten bij aanvang 
van de studie) was cross-sectioneel niet gerelateerd aan de ernst van depressieve symptomen. 
Bovendien werden er geen prospectieve associaties gevonden over een periode van 16 jaar van 
baseline vitamine B
12
 met het beloop van depressieve symptomen noch met de incidentie (het 
aantal nieuwe ziektegevallen) van depressie (gedefinieerd als een score op de depressieschaal 
van het Centrum voor Epidemiologische Studies (CES-D) van 16 of hoger, en/of het gebruik van 
antidepressiva). Onverwacht werd er bij de jongere deelnemers (64,8-73,4 jaar) met hogere 
vitamine B
12
 concentraties  een hoger risico op depressie gevonden. Aangezien serum vitamine 
B
12
 en plasma totaal homocysteïne omgekeerd met elkaar samenhangen, werden de analyses 
herhaald met baseline homocysteïne concentratie als determinant. Ook homocysteïne liet 
geen cross-sectionele of prospectieve associatie met depressieve symptomen zien, wat de 
nulbevindingen van vitamine B
12
 ondersteunde. Deze studie bij ouderen bevestigt eerder-
aangetoonde associaties tussen vitamine B
12
 concentratie en depressieve symptomen niet.
Hoofdstuk 3 beschrijft cross-sectionele en prospectieve associaties tussen vitamine D 
(25-hydroxyvitamine D, 25(OH)D) concentratie en depressieve symptomen. Om een  beter 
begrip van de onderliggende mechanismen te krijgen, was het tweede doel om de mediërende 
rol van fysiek functioneren in de prospectieve associatie te onderzoeken. In zowel het oudere 
(1282 deelnemers van ≥65 jaar) als jongere (737 deelnemers van 55-65 jaar) LASA cohort was 
baseline serum 25(OH)D cross-sectioneel niet geassocieerd met de ernst van depressieve 
symptomen wanneer er gecorrigeerd was voor verschillende socio-demografische, leefstijl- en 
gezondheidsfactoren. In het oudere cohort bleken de prospectieve associaties verschillend te 
zijn voor mannen en vrouwen (geslacht was een effectmodificator): alleen oudere vrouwen met 
lage baseline 25(OH)D-concentraties (<30 nmol/l) hadden 23% meer depressieve symptomen 
in de volgende 6 jaar, vergeleken met vrouwen met hoge 25(OH)D-concentraties (>75 nmol/l). 
Deze associatie werd gedeeltelijk gedreven door verminderd fysiek functioneren. Bij oudere 
mannen en in het jongere cohort werden geen associaties gevonden. De resultaten van deze 
studie laten geen associaties zien tussen vitamine D status en zowel de ernst als het beloop 
van depressieve symptomen, behalve bij oudere vrouwen.
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Een meer gedetailleerd onderzoek naar de longitudinale associatie tussen serum vitamine D 
en depressieve stemming is beschreven in Hoofdstuk 4. Twee metingen van serum 25(OH)D 
werden gebruikt om het verband tussen verandering in serum 25(OH)D en de gelijktijdige 
verandering in depressieve symptomen over de tijd te bestuderen. Verandering in serum 
25(OH)D was niet geassocieerd met verandering in depressieve symptomen in het oudere 
LASA cohort (173 deelnemers) over een periode van 13 jaar noch in het jongere cohort met 
een hogere baseline 25(OH)D concentratie (>59 nmol/l, 225 deelnemers) over 6 jaar tijd. 
Echter, bij deelnemers van dit jongere cohort met lagere baseline 25(OH)D concentraties (<59 
nmol/l, 225 deelnemers) hing een verhoging van serum 25(OH)D van 10 nmol/l samen met 
een verlaging van de CES-D score met 0,62 punten. Kortom, een verhoging van vitamine D 
zou beschermend kunnen werken tegen depressieve stemming, maar alleen bij mensen van 
middelbare leeftijd met een lage vitamine D status.
Deel  II: Voedselgroepen en depressieve symptomen
Hoofdstuk 5 beschrijft de prospectieve associaties – in twee richtingen – tussen de inname 
van voedselgroepen en depressieve symptomen bij 1058 deelnemers (20-102 jaar) van de 
InCHIANTI studie. Zowel voedingsinname als depressieve symptomen zijn over een periode 
van 9 jaar viermaal gemeten en al deze gegevens werden gebruikt in de analyses. Associaties 
tussen de inname van dertien voedselgroepen en 3-jaars veranderingen in depressieve 
symptomen over de 9 jaar werden onderzocht, evenals de omgekeerde associaties tussen 
depressieve symptomen en 3-jaars veranderingen in inname van voedselgroepen. Een hogere 
inname van vis en schelp- en schaaldieren ging gepaard met een afname van depressieve 
symptomen, terwijl zoetigheden juist samenhingen met een toename van depressieve 
symptomen. In de omgekeerde richting waren depressieve symptomen geassocieerd met een 
verminderde inname van zowel groenten als rood en bewerkt vlees, en een verhoogde inname 
van zowel zuivel als hartige snacks. In geen van beide richtingen werden significante associaties 
gevonden voor fruit, noten en peulvruchten, aardappelen, volkorenbrood, olijfolie, suiker-
gezoete dranken en vruchtensappen, en koffie en thee. In deze Italiaanse studiepopulatie van 
voornamelijk ouderen werden bidirectionele, longitudinale associaties gevonden tussen de 
inname van voedselgroepen en depressieve symptomen. Er werden echter voor geen enkele 
voedselgroep associaties in beide richtingen gevonden, wat ‘omgekeerde causaliteit’ (‘reverse 
causality’) uitsluit als reden voor de gevonden associaties.
Deel  III: Depressieve symptomen en voedingspatronen
In Hoofdstuk 6 werden associaties tussen verschillende depressie-determinanten en het 
gehele voedingspatroon, gekwantificeerd met voedingskwaliteit-indexen, onderzocht bij 
1322 LASA deelnemers van 55 jaar en ouder. Naast huidige depressieve symptomen (1) 
werden veranderingen in depressieve symptomen op korte termijn (2) en voorgeschiedenis 
van depressieve symptomen op lange termijn (3) gebruikt als determinant. Scores op drie 
voedingskwaliteitsindexen in 2014/2015 werden gebruikt als uitkomstmaat: ‘Mediterranean 
Diet Score’ (MDS), ‘Alternative Healthy Eating Index’ (AHEI) en ‘Dietary Approaches to Stop 
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Hypertension diet’ (DASH); een hogere score duidt op een gezonder voedingspatroon. Huidige 
depressieve symptomen (CES-D score ≥16) waren gerelateerd aan lagere MDS- en AHEI-scores 
bij mannen, maar niet bij vrouwen. Ook chronische/recidiverende depressieve symptomen 
over 2 tot 5 jaar (CES-D score ≥16 in zowel 2011-2013 als in 2015/2016) hingen samen met 
lagere MDS-scores en een trend voor lagere AHEI-scores, vergeleken met geen depressieve 
symptomen (CES-D score <16 op beide tijdstippen). Een voorgeschiedenis van depressieve 
symptomen over 2 tot 14 jaar (ooit CES-D score ≥16 van 2001-2003 tot 2011-2013) was 
alleen bij mannen geassocieerd met lagere MDS- en AHEI-scores. Geen van de depressie-
determinanten was consistent geassocieerd met de DASH-score. Bij mensen die depressieve 
symptomen ontwikkelden of waarvan de depressieve symptomen verdwenen werd met 
geen enkele voedingskwaliteit-index een associatie gevonden. Deze studie suggereert dat 
zowel huidige depressieve symptomen als een voorgeschiedenis van depressieve symptomen 
gerelateerd zijn aan een ongezonder voedingspatroon, voornamelijk bij mannen.
Conclusie
In Hoofdstuk 7 wordt een samenvatting van de belangrijkste bevindingen van dit proefschrift 
gegeven en worden methodologische aspecten bediscussieerd. Verder worden aanbevelingen 
voor vervolgonderzoek en implicaties voor de volksgezondheid en klinische praktijk besproken.
Er wordt geconcludeerd dat vitamine B
12
 concentratie niet geassocieerd is met 
daaropvolgende depressieve symptomen bij ouderen. Hogere vitamine D concentraties leken 
samen te hangen met (het ontwikkelen van) minder depressieve symptomen, maar alleen in 
specifieke bevolkingsgroepen. Een hogere visinname en een lagere inname van zoetigheden 
waren geassocieerd met minder daaropvolgende depressieve symptomen in ouderen. In 
de omgekeerde richting hingen depressieve symptomen samen met een afname van de 
inname van vlees en groenten, en een toename van de inname van zuivel en hartige snacks. 
Tenslotte waren, vooral bij oudere mannen, zowel huidige depressieve symptomen als een 
voorgeschiedenis van depressieve symptomen gerelateerd aan een lagere voedingskwaliteit. 
Samenvattend laten de studies in dit proefschrift enige longitudinale associaties zien, maar 
de bescheiden effectschattingen en het regelmatig ontbreken van associaties geven aan dat 
voorzichtigheid geboden is over het bestaan  van bidirectionele associaties tussen voeding en 
depressie.
In het licht van dit proefschrift en eerdere literatuur lijken specifieke voedingsstoffen minder 
belangrijk te zijn in relatie tot depressieve symptomen dan de inname van voedselgroepen en 
het hele voedingspatroon. Omgekeerd lijkt een depressieve stemming negatief gerelateerd 
te zijn aan de daaropvolgende voedingskwaliteit, d.w.z. gerelateerd aan minder gezonde 
voedselgroepen en voedingspatronen.
Het eten van een gezond voedingspatroon wordt aanbevolen voor de algemene bevolking 
vanwege de gunstige effecten op de lichamelijke gezondheid en, mogelijk en gedeeltelijk 
ondersteund door dit proefschrift, ook op de psychische gezondheid. Er is echter nog 
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steeds beperkt bewijs voor de causaliteit en bidirectionaliteit van de voeding–depressie 
relatie. Toekomstig onderzoek is nodig om de rol van de inname van voedselgroepen en 
voedingspatronen in het beloop en de ontwikkeling van depressie nader te onderzoeken en om 
te bestuderen of en hoe depressieve stemming de voedingsinname beïnvloedt. Deze kennis 
is vereist voor strategieën ter preventie van depressieve symptomen en de optimale zorg op 
voedingsgebied voor mensen met een depressie.
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